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Summary 
 
The cardiac ryanodine receptor (RyR2) contains structural elements within the 
channel pore that function as gates to regulate the release of intracellular calcium, 
initiating cardiac muscle contraction. The precise regulation of these gates is critical 
in maintaining normal cardiac function, and channel dysfunction, resulting in altered 
calcium handling, underlies the mechanisms of arrhythmia and sudden cardiac 
death.  
 
The enormous size of RyR2 has impeded the gathering of detailed structural 
information, hence the structural determinants for channel gating remain unknown. 
Structural modelling studies have revealed similarities between the RyR2 pore and 
the K+ channel, KcsA, providing a framework in which to test channel gating 
mechanisms. A region termed the selectivity filter is a gating component in K+ 
channels, involved in inactivation and flicker closings, and its conformation is 
maintained by a transient hydrogen-bonding network.  
 
This project examined the role of the RyR2 selectivity filter in channel gating by 
generating mutants at analogous positions to KcsA that either disrupted (Y4813A, 
D4829A and Y4839A) or maintained (Y4813W, D4829E and Y4839W) a proposed 
hydrogen-bonding network, and assessed their intracellular Ca2+ release, ryanodine 
modification and biophysical properties. Y4813A and D4829A had drastic effects on 
channel function, whereas retaining physicochemical properties of conservative 
mutations, Y4813W and Y4839W, maintained the functional characteristics of WT 
RyR2. Flicker closings were affected by Y4839A mutation however, in general, 
single-channel gating for Y4813W, Y4839A and Y4839W was comparable to WT 
RyR2. Interestingly, monitoring single-channels for prolonged periods revealed 
novel insights into channel behaviour, characterised by inherent fluctuations in 
channel activity under steady-state conditions. 
 
This thesis reveals that the selectivity filter region is an important component for 
RyR2 channel function. However, it remains unclear whether the selectivity filter 
regulates channel gating, as the proposed hydrogen-bonding network would not be 
possible due to altered residue distances revealed from recent high-resolution RyR 
structural models. 
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1.1 – Introduction  
 
1.1.1 Cardiac muscle – An electrical system 
 
The average human heart will beat 100,000 times per day (Nio et al., 2015). This 
intrinsic (involuntary) process ensures that blood is pumped around the body to 
meet the constant demand for oxygen and nutrients whilst removing metabolic 
waste. In order to trigger the heart muscle to contract, a system is required to send 
and receive electrical signals. Such a system is established by ion channels that are 
integral membrane proteins that regulate the flow of ions across a membrane, 
establishing a potential difference. Ion channels are involved in many physiological 
processes such as maintaining resting membrane potential (Em), cell depolarisation, 
shaping action potentials and regulating signal transduction (Schrempf et al., 1995; 
Jiang et al., 2002b). Ion channel dysfunction, termed channelopathies, can result in 
cardiac arrhythmia that may lead to sudden cardiac death (Abriel and 
Zaklyazminskaya, 2013). It is therefore vital to understand how ion channels 
function in both health and disease. This thesis focuses on one particular Ca2+ ion 
channel termed the cardiac ryanodine receptor (RyR2) channel and is discussed in 
detail throughout.  
 
1.1.2 The cardiac myocyte  
 
The heart consists of different cell types such as cardiac myocytes (CM), fibroblasts, 
pacemaker cells, vascular endothelial cells and smooth muscle cells that contribute 
to structural, biochemical, mechanical and electrical properties of the functional 
heart (Xin et al., 2013). CMs are the predominant cell type that form the heart 
muscle, termed the myocardium, and function to contract and expel blood to the 
body and lungs (Leri et al., 2015). These cells are typically cylindrical shaped, ~ 10-
15 µm in diameter and ~ 100 µm in length, forming striated branching myofibres 
(Marian et al., 2001). CMs are connected by intercalated disks that contain 
abundant gap junctions, allowing impulses to spread across the membrane quickly 
forming an efficient synchronous contracting unit as shown in figure 1.1 (Golob et 
al., 2014).  
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Figure 1.1. Cardiac muscle structure. CMs are composed of sarcomere 
structures that consist of thick (myosin) and thin (actin) filaments arranged in 
repeating elements. CMs form muscle fibres connected by intercalated disks that 
allow for efficient signal transduction. Figure taken from Golob et al., (2014). 
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1.1.3 The cardiac action potential 
 
An intrinsic, self-generating (automaticity), action potential (AP) arises from 
specialised CM, termed pacemaker cells (Verkerk et al., 2007). These groups of 
cells are located in the right atrium and between the atria and ventricles that form 
the sinoatrial node (SAN) and the atrioventricular node (AVN), respectively. These 
specialised CMs possess the ability to spontaneously depolarise, providing the 
electrical excitation required to initiate excitation-contraction coupling (ECC) 
discussed in section 1.2. The morphology and mechanisms of cardiac APs are 
different to those seen in neuronal APs due to a prolonged plateau phase (~ 300 
ms) as a result of the involvement of calcium channels (Pinnell et al., 2007). A 
typical representation of a cardiac AP arising from ventricular muscle is 
characterised by five distinct phases (Phases 0-4), generated by changes in 
membrane voltage established via a complex interaction of sodium (Na+), potassium 
(K+) and calcium (Ca2+) ion channels and their respective electrical currents, shown 
in figure 1.2 (Schmitt et al., 2014).       
 
1.1.4 The role of Ca2+ as a signaling molecule 
 
Calcium is one of the most versatile signaling molecules in living systems and plays 
an important regulatory role in a number of cellular processes including muscle 
contraction, neuronal transmission, cellular motility, fertilisation, cell growth, memory 
and cell programmed death (Laude and Simpson, 2009). Its ability to fulfil diverse 
functions is exhibited by highly regulated spatial and temporal dynamics around the 
cell milieu (Krebs and Michalak, 2007). Responses are dependent on the duration, 
amplitude, frequency and location of Ca2+ transients (Berridge et al., 2003). For 
example, the duration of a Ca2+ signal can be variable lasting milliseconds, for 
muscle contraction, and up to several hours for fertilisation and cell proliferation 
(Fearnley et al., 2011).  
 
5 
 
 
 
Figure 1.2. The main ionic currents responsible for the different phases of the 
cardiac action potential from ventricular muscle. Depolarising (red) and 
repolarising (blue) ionic currents are indicated by relative current amplitude, 
duration and direction. The shape of the current is aligned with its approximated 
time of action during the cardiac AP. Figure adapted from Abriel and 
Zaklyazminskaya, (2013). 
 
1.2 – Excitation-Contraction Coupling in cardiac myocytes  
 
In CMs, ECC is the process of converting an electrical signal into a mechanical 
response (Bers, 2002). This involves an array of biochemical and biophysical 
processes that allow the cell to contract. CMs contain highly organised arrays of 
myofilament proteins comprised of actin (thin) and myosin (thick) filaments and 
numerous accessory proteins, such as tropomyosin and the troponin complex 
(troponins T, I and C), which form the contractile apparatus, termed the sarcomere 
shown in figure 1.1 (Golob et al., 2014). Importantly, Ca2+ ions are direct activators 
of the myofilaments and the elevation of intracellular Ca2+ within the myocyte 
cytosol, discussed in section 1.2.1, is essential for the initiation of muscle 
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contraction. The transient intracellular rise in Ca2+ results in binding to troponin C, 
resulting in a conformational rotation of tropomyosin revealing the myosin-binding 
sites on actin filaments (Bootman et al., 2006). Effectively, Ca2+ unblocks the 
binding site allowing myosin to bind to actin. This, in conjunction with the hydrolysis 
of adenosine triphosphate (ATP) to adenosine diphosphate (ADP), provides the 
energy to begin the cross-bridge cycling process (Leonard and Herzog, 2010).   
 
1.2.1 Cardiac muscle contraction – Calcium-Induced Calcium Release  
 
For ventricular CMs, the initial stage in the ECC process is depolarisation of the 
sarcolemma transverse tubules (T-tubules) by an inward Na+ current (INa) through 
Nav1.5 channels. This rapid change in membrane potential, shifting the charge 
within the cell from negative to positive, results in the activation of voltage gated 
calcium channels located in the plasma membrane termed L-type calcium channels 
(LTCC) or Cav1.2 (also termed dihydropyridine receptors (DHPR)) (Nakai et al., 
1996). T-tubules are cylindrical invaginations of the sarcolemma that extend into the 
myocyte and are in close proximity to sarcoplasmic/endoplasmic reticulum (SR/ER) 
junctional organelles. The intracellular myocyte architecture creates a 10-12 nm 
gap, termed the dyadic cleft, between the T-tubules and SR membrane expressing 
RyR2 channels (Franzini-Armstrong et al., 1999; Koh et al., 2005). Depolarisation 
activates LTCCs and, in conjunction with high extracellular Ca2+ concentration, the 
established electrochemical gradient drives Ca2+ into the myocyte (Trafford et al., 
1997). The inward Ca2+ current (ICa) increases the Ca
2+ concentration within the 
dyadic cleft from ~ 100 nM to ~ 10 µM (Wang et al., 2001). This initial Ca2+ influx, 
termed a Ca2+ sparklet, is not sufficient to initiate muscle contraction and accounts 
for only ~ 15 % of the total increase in intracellular Ca2+ (Fearnley et al., 2011). The 
close spatial proximity in the dyadic cleft ensures that ICa binds to RyR2, a Ca
2+ 
ligand-gated channel, resulting in a large Ca2+ release from SR stores through 
activated RyR2 channels in a process termed calcium-induced calcium release 
(CICR) shown in figure 1.3 (Fabiato, 1983).  
 
RyR2 channels are packed into elongated clusters in the SR membrane that exhibit 
a disordered “checkerboard-like” organisation (Franzini-Armstrong et al., 1999; 
Hayashi et al., 2009b; Baddeley et al., 2009). These clusters of individual RyRs are 
physically interlocked via specific protein-protein interactions (Yin et al., 2005; 
Baddeley et al., 2009). A study by Marx et al observed multiple RyR2 channels 
opening and closing in a uniform fashion, supporting the idea of an allosteric 
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mechanism in channel regulation based on a direct communication among 
individual RyR channels within an array, termed coupled gating (Marx et al., 2001; 
Ondrias and Mojzisová, 2002; Liu et al., 2010; Porta et al., 2012; Gaburjakova and 
Gaburjakova, 2013). The ICa and activation of individual RyR2 channels functions as 
a signal amplifier resulting in the release of stored Ca2+ through a RyR2-cluster, 
termed a Ca2+ spark (Cheng et al., 1993). As cytosolic Ca2+ is the primary ligand for 
RyR2, adjacent neighbouring RyR2-clusters are activated, resulting in a 
synchronised release of multiple Ca2+ sparks throughout the CM (Ca2+ wave) 
causing a global intracellular Ca2+ transient of sufficient magnitude to initiate muscle 
contraction (Bers, 2004). 
 
 
 
Figure 1.3. Overview of subcellular events occurring in cardiac ventricular 
muscle contraction in excitation-contraction coupling. Schematic 
representation of (1) depolarisation of T-tubules, activating L-type calcium channels 
(LTCCs). (2) Inward Ca2+ current (ICa) activates RyR2 channels (only one RyR2 
channel shown) in the SR (Ca2+ store). (3) Ca2+ release through open RyR2 
channels increases the intracellular Ca2+ concentration (CICR), Ca2+ subsequently 
binds to myofilaments and initiates muscle contraction.  
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1.2.2 Cardiac muscle relaxation – Intracellular Ca2+ homeostasis  
 
The elevation of intracellular Ca2+ is followed by sequestration and extrusion of Ca2+ 
from the myocyte resulting in muscle relaxation (diastole). While the exact initiating 
trigger of diastole is unknown, it is thought that muscle relaxation occurs through the 
combination of three predominant processes; (1) closure of LTCCs and RyR2 
channels (Györke and Terentyev 2008; Blayney and Lai, 2009), (2) reuptake of Ca2+ 
into the SR through the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump 
(Schmidt et al., 1998; Periasamy and Kalyanasundaram, 2007) and (3) removal of 
Ca2+ from the myocyte by the Na+-Ca2+ exchanger (NCX) (Bers, 2000), depicted in 
figure 1.4. To a lesser extent the plasma membrane Ca2+ ATPase (PMCA) and the 
mitochondrial uniporter are also involved in the extrusion and uptake of intracellular 
Ca2+, respectively (Fearnley et al., 2011; Kamer and Mootha, 2015). Cytosolic Ca2+ 
is rapidly removed and Ca2+ homeostasis is achieved where systolic influx and SR 
release of Ca2+ are balanced such that there is no net gain or loss of Ca2+ with each 
contraction-relaxation cycle (Scoote and Williams, 2004). 
 
 
 
Figure 1.4. Subcellular events occurring in cardiac muscle relaxation.  
Schematic representation of intracellular Ca2+ homeostasis achieved by several 
membrane proteins that co-ordinate to (1) inhibit Ca2+ release, (2) sequester Ca2+ 
into the SR and (3) extrude Ca2+ described in section 1.2.2.   
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1.2.3 Sympathetic β-adrenergic stimulation of cardiac myocytes 
 
Heart rate (chronotropy), strength of contraction (inotropy) and extent of relaxation 
(lusitropy) increase during periods of stress, exercise or perceived physical threat, 
resulting in an enhanced cardiac output defined as the amount of blood the heart 
pumps in one minute (Bers, 2008). This process, termed the fight-or-flight response, 
is an evolutionary physiological reaction for survival and occurs through the 
activation of the sympathetic nervous system resulting in an increase of 
catecholamines epinephrine and, importantly for cardiac myocytes, the 
neurotransmitter norepinephrine (Hell, 2010; Tank and Wong, 2015). 
 
Myocytes express β–adrenergic receptors (β-AR), which are integral G-protein 
coupled receptors, on the sarcolemma (Zalewska et al., 2014). Once bound, 
norepinephrine activates β-AR, initiating a signal transduction cascade that 
activates adenylyl cyclase (AC), figure 1.5 (1), catalysing the conversion of ATP into 
cyclic adenosine monophosphate (cAMP) shown in figure 1.5 (2) (Ishikawa and 
Homcy, 1997). cAMP detaches the regulatory subunits on protein kinase A (PKA), 
activating the enzyme and allowing PKA to phosphorylate multiple sites in the 
myocyte, as seen in figure 1.5 (3) (Fu et al., 2013). PKA-mediated phosphorylation 
of LTCCs and RyR2 enhances inotropy, and increases lusitropy by enhanced 
dissociation of Ca2+ from troponin C (Backx, 2014). In addition, PKA 
phosphorylation of phospholamban (PLB) releases its inhibition of SERCA, 
subsequently increasing the activity of SERCA and its ability to sequester Ca2+ into 
the SR (Tada and Katz, 1982; Kranias and Hajjar, 2012). These processes 
ultimately lead to augmented Ca2+ cycling; increasing SR Ca2+ content and Ca2+ 
transients, characterised by enhanced cardiac output.  
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Figure 1.5. Schematic representation of subcellular events occurring in 
cardiac muscle during β-adrenergic sympathetic stimulation. Protein kinase A 
(PKA) phosphorylates (highlighted by a yellow ‘P’) multiple myocyte Ca2+ handling 
proteins including L-type calcium channel (LTCC), RyR2, phospholamban (PLB) 
and troponin I (Domeier et al., 2012). Figure described in section 1.2.3. 
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1.3 – The Ryanodine Receptor (RyR) channel  
 
One of the key regulators of the ECC process is the ryanodine receptor (RyR). 
RyRs are large homotetrameric calcium ion channels with a molecular weight of ~ 
2.2 MDa (Yan et al., 2015). These calcium channels are the largest known ion 
channels found in eukaryotic systems (Takeshima et al., 1989; Zorzato et al., 1990; 
Nakai et al., 1990) and are responsible for regulating the release of stored Ca2+ 
from intracellular ER/SR organelles, thus playing an essential role in the ECC 
process, outlined in section 1.2. RyRs were first observed in the 1970s and were 
originally described as ‘feet’ structures in electron micrographs of striated muscle 
localised at the junctions of intracellular SR membranes (Franzini-Armstrong, 1970; 
Campbell et al., 1980). Dysregulation of RyR has been implicated in acquired and 
genetic disease such as heart failure, cardiac arrhythmia and skeletal 
neuromuscular disorders outlined in section 1.4.4. It has therefore emerged over the 
last decade that RyRs are a therapeutic target and that further research is required 
to pin point the exact mechanisms of how RyRs function in health and disease.   
 
1.3.1 Ryanodine receptor channel isoforms  
 
Three mammalian RyR isoforms have been identified with each one encoded by a 
distinct gene residing on separate chromosomes (RyR1, RyR2 and RyR3). RyR1 
was first detected in skeletal muscle (Takeshima et al., 1989; Zorzato et al., 1990) 
where it is abundantly expressed and was termed the skeletal isoform (Marks et al., 
1989; Giannini et al., 1995; Ogawa et al., 1999). Subsequently, RyR2 was found to 
be predominantly expressed in cardiac muscle (Nakai et al., 1990; Otsu et al., 1990) 
and was termed the cardiac isoform. RyRs are not restricted to striated muscle, 
RyR3 was initially referred to as the brain isoform (Hakamata et al., 1992) but was 
found in a variety of other tissues including smooth muscle and diaphragm (Giannini 
et al., 1995; Marziali et al., 1996). The three isoforms have also been found to be 
expressed in the ER of neurons, exocrine cells, epithelial cells, lymphocytes and 
sea-urchin eggs at varying levels (Lanner et al., 2010). Their exact role in these 
tissues however, is to be determined.  
 
The RyR isoforms share ~ 65 % sequence identity (Hakamata et al., 1992). Despite 
a high degree of sequence identity, RyRs display an isoform-specific response to 
some physiological regulators (Meissner, 2002; Fill and Copello, 2002; Bers, 2004). 
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These differences are important as they are likely to be related to the specialised 
functions of each tissue-specific isoform (Capes et al., 2011).  
 
This thesis focuses on the human cardiac isoform of the ryanodine receptor channel 
(hRyR2). On occasion, other isoforms (RyR1), from different species are discussed 
to draw comparisons between RyR channels or, due to limited availability, of 
structural/functional information. 
 
1.3.2 Ryanodine receptor structure 
 
RyRs are mushroom shaped with a ‘cap’ composed of the N-terminal cytoplasmic 
domain and a ‘stalk’ consisting of the C-terminal transmembrane domain, shown in 
figure 1.6. The symmetrical structure arises from four identical monomers each 
consisting of approximately 5000 amino acids with a molecular weight of 550 kDa 
(Otsu et al., 1993). The cytoplasmic domain of RyRs constitutes ~ 80 % of the total 
protein, this large structure has numerous distinctive structural regions and 
intervening cavities that act as a scaffold suitable for interaction with modulators 
that bind within the N-terminal region, discussed in section 1.4.1 (Hamilton and 
Serysheva, 2009; Zalk et al., 2014). When viewed from above, the cytoplasmic 
domain is square shaped with dimensions of 275 Å x 275 Å and a depth of 120 Å 
(Efremov et al., 2014). The remaining C-terminal ‘stalk’, forms the transmembrane 
(TM) assembly (120 Å x 120 Å x 60 Å) enclosing a central ion-conducting pore (Zalk 
et al., 2014). The pore-forming region (PFR) of hRyR2, defined as the S5 helix, pore 
helix, selectivity filter and S6 helix shown in figure 1.17, forms the basis of this 
thesis and is discussed in detail in sections 1.3.3, 1.5 and chapters 3, 4, 5, 6 and 7. 
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(A)             (B)          (C) 
 
 
Figure 1.6. Architecture of RyR1 at an overall resolution of 3.8 Å. The structure 
was generated in PyMol and represents the (A) cytoplasmic view, (B) luminal view 
and (C) side view of the rabbit RyR1 channel. The homotetramer is composed of 
four identical monomers encompassing a central pore. One monomer (blue) and 
pore-forming region (red) are highlighted. This is the highest resolution of the 
structure of RyR1 to date and has revealed an enormous level of detail. A 
schematic representation of distinctive structural regions is shown in figure 1.8. The 
figure was constructed from the PDB file (3J8H) obtained with permission from 
Chang-cheng Yin (Yan et al., 2015). 
 
The lack of sufficient high resolution structural detail has impeded understanding of 
RyR gating and regulatory mechanisms discussed in section 1.5.1 (Zalk et al., 
2014). Details of RyR structure to date have been obtained through cryo-electron 
microscopy (cryo-EM) at ~ 10–25 Å resolution (Wagenknecht and Samsó, 2002; 
Samsó et al., 2005; Ludtke et al., 2005; Samsó et al., 2006; Hamilton and 
Serysheva, 2009), comparative modelling (Welch et al., 2004; Ramachandran et al., 
2009; Ramachandran et al., 2013) and X-ray crystallography of small RyR N-
terminal segments (Lobo and van Petegem, 2009; Tung et al., 2010; Lau and van 
Petegem, 2014). These structures have been invaluable in determining the overall 
dimensions and approximate domain boundaries of the channel but have been 
insufficient to allow determination of secondary structural elements or identification 
of key domains (Yan et al., 2015). Recent years have seen improvements in protein 
preparation, instrumentation, image processing, and three-dimensional 
reconstruction techniques enabling several breakthroughs in resolving high-
resolution structures (Fernández et al., 2013). Recent cryo-EM structures of the 
rabbit skeletal RyR1, in the closed-state, are the highest resolution images to date, 
solved at an overall resolution of 3.8 Å (Yan et al., 2015) and 4.8 Å (Zalk et al., 
2014). In addition, Efremov et al resolved the rabbit RyR1 in an open-state structure 
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at a resolution of 8.5 Å (Efremov et al., 2014). These current structures are, 
however, models constructed using data obtained from cryo-EM together with single 
particle analysis. The validity of these models must be tested to assess their 
credibility as described in chapters 5, 6 and 7.  
 
1.3.3 Ryanodine receptor transmembrane domain  
 
The C-terminal TM region encompasses ~ 20 % of the RyR protein and contains the 
channel’s PFR. The end portion of the C-terminal tail serves a critical functional 
role, controlling RyR2 oligomerisation, enabling the protein to form a functional Ca2+ 
release channel (Stewart et al., 2003). This was first observed in 1997 when small 
tetrameric RyR complexes (~ 130 kDa) consisting of the C-terminal region were 
constructed using trypsinisation and were found to be cation-selective channels that 
were activated by calcium and modulated by ryanodine (Bhat et al., 1997). An 
additional study by Euden et al showed that the PFR of RyR2 could function as a 
separate entity, forming a functional tetrameric ion conducting channel (Euden et 
al., 2013a). When characterised in planar lipid bilayers, differences in gating and ion 
handling were observed between full-length RyR2 and the separately expressed 
RyR2 PFR channel, suggesting that domains encoding the cytoplasmic region are 
important for mechanisms governing channel function (Euden et al., 2013a).  
 
The N- and C-terminal fragments of RyR reside on the cytoplasmic side of the 
membrane, suggesting that the transmembrane domain contains an even number 
of membrane-spanning segments (Grunwald and Meissner, 1995). Previous models 
predicted that the TM was composed of four (Takeshima et al., 1989), six (Tunwell 
et al., 1996), six to eight (Du et al., 2002) or 12 (Zorzato et al., 1990) membrane-
spanning regions per monomer. Recently, using high resolution cryo-EM it has been 
confirmed that RyR channels are comprised of six TM regions, shown in figures 1.7 
and 1.8 (Zalk et al., 2014; Efremov et al., 2014; Yan et al., 2015).  
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Figure 1.7. Hydropathy plot of the human cardiac RyR channel. Initial 
identification of six conserved hydrophobic regions of the protein that constitute the 
membrane-spanning segments, indicated by vertical arrows. Figure taken from 
Tunwell et al., (1996).  
 
 
 
 
Figure 1.8. A schematic representation of the six transmembrane segments 
(S1-S6) of RyR1. The structure of the 6TM, inter-helical linkers and PFR are 
highlighted in orange. The cytoplasmic domains are colour-coded; N-terminal 
domains-A, B and N-solenoid (blue), SPRY1, 2 and 3 (cyan), Calstablin/FKBP12 
binding site (yellow), R12 (clamp)/R34 (phosphorylation) repeats (magenta), bridge-
solenoid/helical domain (green), core-solenoid/central domain (red), EF-hand 
domain (purple) and C-terminal domain/CTD (orange). Figure taken from Zalk et al., 
(2014). 
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Interestingly, the region encoding the RyR1 and RyR2 channel pore share almost 
identical homology with 93.4 % sequence alignment, shown in figure 1.9, 
suggesting analogous structural and functional channel gating mechanisms, 
discussed in section 1.5.  
 
 
 
Figure 1.9. Sequence alignment of the C-terminal pore-forming region of 
human skeletal and cardiac ryanodine receptors (RyR1 and RyR2). Highlighted 
residues represent the S5 helix (green), pore helix (blue), selectivity filter (red) and 
S6 helix (purple) based on the RyR2 analogy model (Welch et al., 2004) discussed 
in section 1.5.2. Figure was constructed using a web-based software, aligning entry 
codes P21817 (RyR1) and Q92736 (RyR2) (http://www.uniprot.org/align). 
 
 
1.4 – The Cardiac Ryanodine Receptor (RyR2) channel  
 
1.4.1 RyR2 regulation  
 
The primary role of the RyR2 channel is to release large amounts of Ca2+, from the 
SR, within several milliseconds to induce cardiac muscle contraction in a process 
termed CICR (Fabiato, 1983; Baylor and Hollingworth, 2003). This process must be 
strictly regulated to ensure appropriate duration and amount of Ca2+ release as 
altered Ca2+ handling may lead to pathology such as arrhythmia, discussed in 
section 1.4.4. The sustainability of this cycle is crucially dependent upon precise 
regulation of RyR2 by numerous cytosolic and luminal ligands and accessory 
proteins (Capes et al., 2011). Within the myocyte milieu, RyR2 forms a 
macromolecular complex composed of, but not limited to, triadin, junctin and 
calsequestrin on the luminal side, and FKBP12.6, calmodulin, protein kinases and 
protein phosphatases on the cytoplasmic side (Meissner, 2002; Berridge et al., 
2003; Lanner et al., 2010). The interaction of these ligands with both the 
cytoplasmic and luminal sides of RyR2 creates a complex functional structure that 
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exceeds 3 MDa (Zalk et al., 2014). The majority of these modulators, depicted in 
figure 1.10, interact with the cytoplasmic domain of the protein at locations some 
distance from the channel pore (Yan et al., 2015). This suggests that RyR2 channel 
gating is regulated by an allosteric mechanism with a complex coupling network of 
inter- and intra-subunit interactions.  
 
There are many other modulators that interact with RyR2 which are not listed in 
figure 1.10, the figure does however illustrate the enormous complexity of RyR2 
regulation and highlights one of the challenges in studying RyR2 function. The 
regulation of RyR2 by these modulators and accessory proteins is not the focus of 
this thesis and is discussed in detail elsewhere (Berridge et al., 2003; Györke and 
Terentyev, 2008; Lanner et al., 2010; Dobrev and Wehrens 2014).  
 
 
 
Figure 1.10. RyR2 modulators. A schematic representation of small molecule and 
protein modulators that provide either positive (+) or negative (-) input signals. 
Some of these modulators are concentration dependent, such as Ca2+ and 
ryanodine, and fall in to both categories. Figure adapted from van Petegem., (2012). 
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1.4.2 Regulation of RyR2 by Ca2+ 
 
Aside from accessory proteins, RyR2 channel function is regulated by various 
physiological ligands (Ca2+, Mg2+ and ATP), the most important being its primary 
ligand Ca2+ (Endo et al., 1970; Fabiato, 1983; Meissner, 1994). It is well established 
that cytoplasmic levels of Ca2+ are critical for the regulation of channel activity 
(Fabiato, 1983; Cheng et al., 1993; Williams et al., 2001; Bers, 2002; Scoote and 
Williams, 2004; Fearnley et al., 2011). Mukherjee et al investigated the effects of 
cytosolic Ca2+ concentration ([Ca2+]cyt) activation on recombinant hRyR2 channels 
reporting that elevated Ca2+, ranging from 0-500 µM, increased channel Po shown in 
figure 1.11 (Mukherjee et al., 2012). The dependence of RyR2 Po on [Ca
2+]cyt is a 
physiological necessity and essential for the initiation of cardiac cell contraction by 
activation of RyR2-clusters and subsequent amplification of Ca2+ sparks, described 
in section 1.2.1 (Wang et al., 2001; Williams et al., 2001).  
 
 
 
Figure 1.11. The activation of recombinant human RyR2 by cytosolic Ca2+. 
Figure depicts the sigmoidal relationship between hRyR2 activation by increasing 
cytosolic Ca2+, ranging from 0-500 µM, and channel Po. EC50 1.65 ± 0.43 µM. Figure 
taken and adapted from Mukherjee et al., (2012). 
 
Recently, it has been demonstrated that luminal (intra-SR) Ca2+ may also play a key 
role in regulating Ca2+ release (Radwański et al., 2013; Bers, 2014). Early 
observations reported that spontaneous Ca2+ release occurred when the SR Ca2+ 
content reached a particular threshold in a process termed store-overload-induced 
Ca2+ release (SOICR) (Jiang et al., 2004). In addition, luminal Ca2+ has been shown 
to increase RyR2 channel Po (Sitsapesan and Williams, 1994; Sitsapesan and 
Williams, 1995; Györke and Györke, 1998; Tencerova et al., 2012; Chen et al., 
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2014). The regulation of RyR2 by luminal Ca2+ is proposed to occur through a 
variety of mechanisms; activation of different high and low affinity cytosolic sites by 
permeant Ca2+ ions through the channel, termed ‘feed-through’ (Laver, 2007; Laver, 
2009), regulation of luminal accessory proteins (junctin-triadin-calsequestrin 
complex) (Györke and Terentyev, 2008), or luminal Ca2+ sensing at the proposed 
inner-helix bundle crossover (IHBC) gate (Chen et al., 2014). Understanding the 
regulation of RyR2 channels by luminal Ca2+ is of therapeutic significance, as 
SOICR is one of the proposed mechanisms prominent in cardiac disease described 
in section 1.4.4.2. 
 
1.4.3 Pharmacological modulation of RyR channels by ryanodine   
 
The plant alkaloid, ryanodine, found in the stem and roots of the Ryania speciosa 
plant was first isolated as a plant insecticide and was later identified to induce rigid 
and flaccid paralysis in skeletal and cardiac muscle, respectively (Jenden and 
Fairhurst, 1969; Nayler et al., 1970; Fairhurst, 1973). The ryanodine molecule, 
depicted in figure 1.12, was found to bind with high affinity to all three Ca2+ release 
channel isoforms and thus the channel was given the name the ryanodine receptor 
(RyR1, 2 and 3) (Ogawa, 1994). 
 
 
Figure 1.12. Structure of the ryanodine molecule.  
 
The ryanodine molecule can only access its high affinity binding site when the 
channel is in an open conformation (Lai and Meissner, 1989; Chu et al., 1990; 
Sutko et al., 1997). Experimental data suggests that the RyR-ryanodine binding site 
is located within or near the channel pore and is further discussed in chapter 4.1.3 
(Tinker and Williams, 1993b; Tu et al., 1994; Callaway et al., 1994). The interaction 
of ryanodine with RyR is also concentration dependent. At low concentrations 
(nanomolar to micromolar), binding induces a complex change in single RyR 
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channel function characterised by reduced unitary conductance and increased open 
probability (Po), figure 1.13 (Rousseau et al., 1987; Tinker and Williams, 1993b; 
Lindsay et al., 1994). A previous study investigating the effects of ryanodine-bound 
single RyR2 channel gating revealed that the pore adopts an extremely stable open 
conformation (Mukherjee et al., 2014). In contrast, at high concentrations (> 100 
µM), interaction of ryanodine locks the channel in a closed configuration, suggesting 
that there is a separate low-affinity binding site (Zimányi et al., 1992; Wang et al., 
1993).  
 
 
 
Figure 1.13. Single channel hRyR2 ryanodine modification. (O) Open and (C) 
closed states denoted by blue line. Typical WT hRyR2 channel gating prior to 
ryanodine modification in symmetrical 210 mM KCl. (M) Ryanodine modified state, 
indicated by a blue arrow, is characterised by reduced unitary conductance and 
increased channel Po. 
 
The properties of the interaction of ryanodine with RyR channels have enabled it to 
be used as an important biomarker. Ryanodine has been used to identify the protein 
during purification (Campbell et al., 1987; Lai et al., 1988; Hymel et al., 1988), to 
monitor the activity of a population of channels in mixed-membranes (Chu et al., 
1990), discussed in chapter 4.4.2, and to study the modulatory effect on single-
channel function (Tinker et al., 1996; Wang et al., 2003; Mukherjee et al., 2014), 
outlined in chapter 5.3.2. 
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1.4.4 RyR2 Dysfunction  
 
1.4.4.1 Catecholaminergic polymorphic ventricular tachycardia  
 
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic cardiac 
disease which is triggered by exercise or emotional stress (Priori et al., 2001; 
Medeiros-Domingo et al., 2009; Ylänen et al., 2010). Patients with CPVT have 
structurally normal hearts and at rest display a typical regular electrocardiogram 
(ECG) (Viskin and Belhassen, 1998). Symptoms arise during sympathetic (β-
adrenergic) drive with patients displaying bidirectional ventricular tachycardia (VT) 
(Napolitano and Priori, 2007), figure 1.14, manifesting as episodes of dizziness, 
syncope and seizures that may lead to sudden cardiac death if left untreated (Priori 
et al., 2001; Mohamed et al., 2007). This rare disease, with an estimated 
prevalence of 1 : 10000, typically presents during childhood and adolescence, and 
has a high mortality rate with ~ 30 % reported before the age of 30 (Swan et al., 
1999; Napolitano et al., 2014). At present CPVT is not curable (Napolitano et al., 
2014).  
 
 
 
Figure 1.14. Representative echocardiogram of an episode of bidirectional 
ventricular tachycardia (VT) observed in a patient with CPVT. Bidirectional VT 
represented by beat-to-beat 180 degrees rotation of the QRS complex. Figure 
adapted from Mohamed et al., (2007).  
 
CPVT was first described by Reid et al and Coumel et al, and later by Leenhardt et 
al (Reid et al., 1975; Coumel et al., 1978; Leenhardt et al., 1995). It is now 
understood that there are five variants of the disease identified from genetic familial 
investigations. CPVT1, an autosomal dominant form associated with mutations in 
the gene encoding RyR2 was identified on chromosome 1 (1q42-q43) (Swan et al., 
1999; Laitinen et al., 2001; Priori et al., 2001) and CPVT2, a recessive form 
associated with homozygous mutations in the gene encoding the cardiac isoform of 
calsequestrin (CASQ2), was identified and located on chromosome 1 (1p13-p21) 
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(Lahat et al., 2001a; Lahat et al., 2001b). Bhuiyan et al identified a highly malignant 
autosomal recessive form of CPVT (CPVT3) that was mapped to a 25 Mb interval 
on chromosome 7 (7p14-p22), however screening of candidate genes in the region 
has not revealed a disease-associated gene (Bhuiyan et al., 2007). CPVT4 is 
caused by a heterozygous mutation in the calmodulin gene (CALM1) mapped to 
chromosome 14 (14q31-q32) (Nyegaard et al., 2012) and CPVT5 is caused by 
mutation in the triadin gene (TRDN) identified on chromosome 6 (6q22) (Roux-
Buisson et al., 2012). The highest proportion of CPVT cases (~ 55 %) are 
accounted for by mutations in RyR2 (CPVT1) (Napolitano et al., 2014). 
 
1.4.4.2 CPVT – Molecular mechanisms  
 
To date, there have been 155 hRyR2 CPVT1-linked mutations reported from the 
“Gene Connection for the Heart” database (http://www.fsm.it/cardmoc). These point 
mutations are generally clustered in hot-spots, depicted in figure 1.15, and typically 
result in a gain-of-function phenotype characterised by spontaneous or 
inappropriate channel openings (Jiang et al., 2004; di Barletta et al., 2006; George 
et al., 2007; van Petegem, 2014). 
 
 
 
Figure 1.15. RyR2 polypeptide sequence highlighting four ‘hotspot’ clusters (I-
IV) of CPVT channel point mutations. Figure taken and adapted from George et 
al., (2007).  
 
While the exact mechanism of CPVT is unknown, the likely pathogenic source is a 
combination of proposed theories such as; ‘leaky’ RyR2 channels, altered channel 
Ca2+ sensitivity (SOICR), dissociation of accessory proteins (FKPB 12.6) or 
phosphorylation during sustained β-adrenergic drive (Priori et al., 2001; George et 
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al., 2007; Priori and Chen, 2011). Together these factors result in disrupted Ca2+ 
signaling, whereby Ca2+ release during diastole is thought to be the underlying 
mechanism that gives rise to CPVT (Jiang et al., 2004; MacLennan and Chen, 
2009; Priori and Chen, 2011). The augmented intracellular Ca2+ concentration 
during diastole leads to INa through activation of NCX, functioning in the forward 
mode and if sufficient, the inward depolarising current results in delayed after 
depolarisations (DADs) that may cause triggered arrhythmia as shown in figure 1.16 
(Reuter et al., 2004; Despa and Bossuyt, 2006).  
 
 
 
Figure 1.16. Schematic representation of a delayed after depolarisation (DAD) 
following a cardiac action potential. Abnormal or spontaneous SR Ca2+ release 
through RyR2 during diastole (phase 4) may induce a triggered arrhythmia (dotted 
line) if the NCX-mediated INa is sufficient to reach threshold.    
 
Interestingly, point mutations in analogous positions in RyR1 result in skeletal 
muscle diseases such as malignant hyperthermia (MH) and central core disease 
(CCD) (Robinson et al., 2006). The similarity between these diseases and CPVT in 
terms of requiring a ‘trigger’ highlights common structural defects caused by 
mutation in RyR1 and RyR2. While the triggering factor may be different, 
dysfunction in Ca2+ signaling through faulty RyR channels may occur through a 
similar mechanism (Dirksen and Avila, 2002; Brini et al., 2005; Betzenhauser and 
Marks, 2010). Altogether, approximately 500 missense mutations resulting in 
disease have been mapped to the primary sequences of RyRs (van Petegem, 
2014). In addition, the role of RyR channels in other pathological states such as 
epilepsy are starting to emerge (Johnson et al., 2010), emphasising the therapeutic 
potential of RyR as a molecular target. 
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1.4.4.3 CPVT – Current therapies  
 
β-blockers are considered to be the first-line therapy for patients with CPVT, 
inhibiting sympathetic drive during periods of stress or exercise (Haugaa et al., 
2010). However, 30 % of CPVT patients are reported to be non-responsive to β-
blocker therapy, therefore β-blockers are usually used in conjunction with an 
implantable cardioverter-defibrillator (ICD) (Priori et al., 2002; Sumitomo et al., 
2003; Priori and Napolitano, 2005; Hayashi et al., 2009a; Haugaa et al., 2010; 
Williams and Viswanathan, 2013). Although again, ICDs are not fully protective and 
can also be proarrhythmic in CPVT patients as both appropriate and inappropriate 
ICD shocks can trigger catecholamine release (ICD storm) that may subsequently 
result in arrhythmia and death (Mohamed et al., 2006; Pizzale et al., 2008; van der 
Werf et al., 2011).  
 
1.4.4.4 RyR2 dysfunction in Heart Failure  
 
In addition to genetic disease such as CPVT, altered RyR2 function has been 
implicated in heart failure (HF) (Marx et al., 2000; Belevych et al., 2007; Belevych et 
al., 2013). HF progression is characterised by maladaptive changes in Ca2+ 
homeostasis and at the subcellular level, SR Ca2+ and amplitude of Ca2+ release is 
gradually reduced resulting in insufficient activation of the myoﬁlaments (Shannon 
et al., 2003; Piacentino et al., 2003; Dorn and Molkentin, 2004; Belevych et al., 
2007). The amount of Ca2+ released from the SR through RyR2 dictates the 
amplitude of the Ca2+ transient, which correlates with the strength of systolic 
contraction (Wehrens et al., 2005; Dobrev and Wehrens, 2014). The depressed 
intracellular Ca2+ cycling and reduced CICR in HF results in weaker cardiac 
contractile force that is a common feature of failing hearts (Ather et al., 2013). 
 
A long standing mechanism of HF was proposed that altered Ca2+ handling 
occurred through diastolic SR Ca2+ leak (Yano et al., 2000; Ono et al., 2000; 
Shannon et al., 2003; George, 2007; Belevych et al., 2007). The progressive long-
term adrenergic drive that leads to sustained phosphorylation in HF was considered 
to result in leaky RyR2 channels due to dissociation of FKBP12.6, destabilsing the 
channel, increasing its Po (Marx et al., 2000; Lehnart et al., 2005; Shan et al., 2010; 
Andersson and Marks, 2010; Marx and Marks, 2013). However there is an ongoing 
debate with studies contradicting these findings showing that PKA phosphorylation 
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of RyR2-S2808 neither dissociated FKBP12.6 nor substantially modified RyR2 
channel gating or open probability (Li et al., 2002b; Jiang et al., 2002a; Stange et 
al., 2003; Xiao et al., 2006; Benkusky et al., 2007; MacDonnell et al., 2008). The 
mechanism of RyR2-PKA phosphorylation dysfunction in HF therefore remains 
unclear.  
 
In addition to PKA-mediated phosphorylation, Ca2+/calmodulin-dependent protein 
kinase II (CaMKII) phosphorylation of RyR2-S2814 has been identified to promote 
HF progression (Currie et al., 2004; Ai et al., 2005; Kushnir et al., 2010; Dobrev and 
Wehrens, 2014). The expression and activity levels of CaMKII in animal models of 
HF and in failing human hearts are both increased, however the underlying role of 
CaMKII in HF development is still unclear (Kirchhefer et al., 1999; Hoch et al., 1999; 
Bers, 2010; Respress et al., 2012). CaMKII-mediated RyR2 phosphorylation has 
been shown to increase RyR2 Po at the single-channel level and also in ventricular 
CMs indicated by an increase in Ca2+ spark frequency (Wehrens et al., 2004; van 
Oort et al., 2010; Bers, 2012). Several groups have identified that CaMKII inhibition 
is an effective therapeutic strategy in HF, and may be cardioprotective in other 
arrhythmias by reducing RyR2 channel Po (Bers, 2010; Li et al., 2012; Swaminathan 
et al., 2012; Pellicena and Schulman, 2014). The pathogenic effect of sustained 
PKA and/or CaMKII phosphorylation in HF is likely to be a combination of factors 
that promote altered RyR2 function and subsequently inappropriate Ca2+ handling, 
contributing to compromised systolic and diastolic cardiac function (Marx and 
Marks, 2013; Dobrev and Wehrens, 2014). 
 
With the emergence of RyR2 as a potential therapeutic target and emphasis on 
understanding the underlying pathogenic nature arising from point mutations 
occurring in CPVT1 and RyR2 dysfunction in HF, it is essential to further elucidate 
mechanisms involved in channel function, in particular, how channel gating is 
governed in health and disease.  
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1.5 – Structural mechanisms of gating at the selectivity filter of hRyR2  
 
1.5.1 Research Limitations 
 
RyR channels play a pivotal role in the ECC process and dysfunction has been 
observed in both genetic and acquired diseases. The molecular basis of their 
function is however poorly understood, and is largely due to the absence of atomic-
level structural details for the entire channel (Ramachandran et al., 2013; Efremov 
et al., 2014; Zalk et al., 2014). Hindering efforts to uncover the structure of RyR 
channels by X-ray crystallography or cryo-EM are their association with the lipid 
bilayer, the need to extract them from the membrane and the identification of 
suitable detergents (Baker et al., 2015). There are major challenges in obtaining 
stable RyR channel protein for structural-functional studies due to the channels’ 
enormous size, inherent flexibility and location within the intracellular SR/ER 
membrane. In absence of high-resolution structural information; molecular, cellular 
and biophysical techniques have been tailored over the last three decades to 
investigate the functional characterisitics of RyR2 channels, discussed in chapters 
3, 4, 5 and 6.  
  
It is essential to investigate the effects of disease-linked point mutations, potential 
therapeutic compounds and physiological regulatory factors on RyR2 channel 
function, however before this can be achieved, more fundamental information is 
required on their molecular basis of function. Identifying structural elements involved 
in RyR2 channel gating remains a key determinant to understand channel function. 
This project focuses on a particular region of the hRyR2 channel pore termed the 
selectivity filter and its interactions with the pore helix. It is proposed that 
interactions between these structural elements are pivotal in mechanisms of 
channel gating. 
 
1.5.2 The Pore-Forming Region Analogy Model  
 
Molecular modelling and cryo-EM data imply that the PFR of RyR channels are 
composed of structural elements equivalent to those found in other cation-selective 
channels (Welch et al., 2004; Samsó et al., 2005; Ludtke et al., 2005; Samsó et al., 
2009; Ramachandran et al., 2009; Ramachandran et al., 2013; Efremov et al., 
2014; Zalk et al., 2014; Yan et al., 2015). Previous observations comparing the RyR 
PFR and a prokaryotic potassium channel, KcsA, found striking similarities between 
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the primary sequences and it was suggested that these structures were likely to 
have a similar topology (Balshaw et al., 1999). The original RyR2 PFR analogy 
model described by Welch et al was constructed using the 3.2 Å high-resolution 
crystal structure of KcsA as a template, depicted in figure 1.17 (Doyle et al., 1998; 
Welch et al., 2004). The PFR model has provided an invaluable framework in which 
the involvement of domains and individual residues in the processes of ion 
translocation and gating mechanisms can be predicted and tested. 
 
         (A)         (B) 
 
 
Figure 1.17. Schematic representation of the RyR2 Pore Forming Region 
(PFR) analogy model based on the crystal structure of the potassium channel, 
KcsA. (A) KcsA (PDB file: 1BL8) and (B) the RyR2 PFR analogy model. Structural 
elements are coloured as follows; outer helix or S5 in blue, pore helix in red, 
selectivity filter in green and inner helix or S6 in cyan. Two monomers are shown for 
clarity. The four monomers align symmetrically forming a central pore to allow for 
the selective passage of either K+ (KcsA) or Ca2+ (RyR2) ions across the 
membrane. Figure was adapted and constructed in PyMol from Welch et al., (2004). 
 
The original analogy model of the PFR hRyR2 (Welch et al., 2004), proposed at the 
onset of this project, was used as a framework within which predictions of 
mechanisms of gating occurring at the selectivity filter could be made as (i) a crystal 
structure of KcsA was resolved at high resolution, section 1.5.3 (Doyle et al., 1998), 
(ii) physicochemical characteristics and structural elements including the selectivity 
filter of RyR2 PFR were comparable with KcsA, section 1.5.5 (Welch et al., 2004) 
and (iii) mechanisms of selectivity filter gating in potassium channels are well 
known, section 1.5.6 (Cuello et al., 2010a; Cordelo-Morales et al., 2011; Ostmeyer 
et al., 2013). 
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1.5.3 The potassium channel KcsA - Crystal structure 
 
The potassium channel, KcsA, from the Gram-positive soil bacteria Streptomyces 
lividans was discovered by Schrempf et al, and has been subjected to detailed 
structural and functional analysis over the last two decades (Schrempf et al., 1995). 
MacKinnon et al were pioneers in obtaining the first high resolution structural 
images, from KcsA crystals at 3.2 Å, figure 1.18 (Doyle et al., 1998). This was later 
improved to 2.0 Å by attaching monoclonal Fab fragments to the channel (Zhou et 
al., 2001). The latter structure by Zhou et al., gave the first in depth visualisation of 
K+ ions interacting within the pore and selectivity filter (Zhou et al., 2001). 
 
 (A)     (B) 
 
 
Figure 1.18. Crystal structure of the bacterial potassium channel, KcsA. The 
K+ channel is a tetramer with fourfold symmetry encompassing a central pore. View 
of a ribbon representation illustrating the three-dimensional fold of the KcsA 
tetramer viewed from the side (A) and extracellular side (B). Four subunits are 
distinguished by colour. Figure taken and adapted from Doyle et al., (1998).  
 
1.5.4 KcsA as a prototypical ion channel  
 
KcsA is an integral membrane protein that shares high sequence homology and 
pore architecture with many other K+ channels including voltage-gated K+ (Kv), 
inward rectifier (Kir), Ca
2+-activated K+ (KCa) and cyclic nucleotide-gated (CNG) 
channels (Doyle et al., 1988; Yellen, 2002; McCoy and Nimigean, 2012). Compared 
to Kv channels, that have 6TM depicted in figure 1.19A, KcsA has a simple topology 
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with only two membrane spanning segments per subunit similar to Kir channels, 
shown in figure 1.19B.    
 
(A)       (B) 
 
 
Figure 1.19. Topology diagram of transmembrane ion channels. (A) Voltage-
gated potassium (Kv) channel contain six transmembrane helices. Helices S5 and 
S6 form the pore. (B) Each KcsA subunit is composed of two transmembrane 
helices connected by a P-loop. Pore forming helices are cyan and the pore-helix in 
pink. Figure adapted from McCoy and Nimigean, (2012).  
 
KcsA is well characterised, with numerous crystal structures resolved in different 
conformations (Zhou et al., 2001; Uysal et al., 2009; Cuello et al., 2010b). The 
structure of KcsA has provided practical insight into the pores of all homologous K+ 
channels and has therefore been used as a prototypical ion channel to understand 
the mechanistic aspects of channel gating and ion permeation (McCoy and 
Nimigean, 2012). 
 
1.5.5 Structural elements of the Pore-Forming Region – Selectivity filter 
 
In K+ channels, the selectivity filter is a structural element that controls ion 
permeation and selectivity and is located at the extracellular end of the pore (Doyle 
et al., 1998; Zhou et al., 2001). Four identical subunits, containing a highly 
conserved signature sequence (TVGYGD) are symmetrically aligned to form a 
central pore (Doyle et al., 1998). This filter forms a backbone of inward facing 
carbonyl oxygens, shown in figure 1.20, providing an ideal environment for K+ ion 
translocation and ensuring high conductance while selectively excluding similar 
cations such as Na+ (LeMasurier et al., 2001; Nimigean and Miller, 2002).  
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(A)          (B) 
       
 
Figure 1.20. Structure of the selectivity filter of KcsA. (A) An electron density 
view of the selectivity filter of KcsA. Two diagonally opposed subunits are shown 
with K+ ions (green spheres) along the ion pathway and water molecules (red 
spheres). Figure taken from Zhou et al., (2001). (B) A distinct hydrogen-bonding 
network surrounding the selectivity filter and pore helix of KcsA. The E71-D80 and 
W67-D80 hydrogen bond interactions between the pore helix and external vestibule 
are implicated as the driving force for C-type inactivation, regulating gating at the 
selectivity filter, outlined in section 1.5.7. Figure taken from Cordero-Morales et al., 
(2011).  
 
The selectivity filter of the PFR of RyR was identiﬁed through the recognition of a 
GIGD sequence similar to the GYGD signature sequence identiﬁed in K+ channels 
(Doyle et al., 1998; Balshaw et al., 1999; Zhao et al., 1999). The GIGD motif in the 
PFR analogy model is predicted to be in a location equivalent to the selectivity filter 
of K+ channels (Welch et al., 2004). Early biophysical experiments using molecular 
sieving and electrical distance measurements established that the RyR2 pore radius 
was 3.5 Å with a length of ~ 10.4 Å (Tinker and Williams, 1993a; Tinker and 
Williams, 1995). These experimental data are in agreement with recent high-
resolution cryo-EM structures, showing that the PFR of RyR is composed of similar 
structural elements to KcsA and other K+ channels, shown in figure 1.21 (Welch et 
al., 2004; Efremov et al., 2014; Zalk et al., 2014; Yan et al., 2015).  
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Figure 1.21. Similarity between the architecture of RyR1 pore-forming region 
and KcsA. Comparison of the backbone of the RyR1 PFR and KcsA superimposed. 
Two monomers are depicted for each protein, coloured monomers (red and green) 
represent RyR1 whereas KcsA is depicted in grey. Figure adapted from Efremov et 
al., (2014). 
 
1.5.6 Potassium channel gating mechanisms 
 
Following the crystallisation of KcsA and other K+ channels such as MthK, KvAP and 
Kv1.2 in various trapped open-conductive, open-inactivated, closed-conductive and 
closed-inactivated conformations, in combination with experimental evidence it 
became possible to elucidate gating mechanisms (Doyle et al., 1998; Zhou et al., 
2001; Jiang et al., 2002b; Jiang et al., 2003; Long et al., 2005; Cuello et al., 2010b). 
Transitions between these distinct four states are finely controlled by the coupling of 
two distinct gates; an activation gate located at the inner-helix bundle crossover 
(IHBC) (Jiang et al., 2002b) and an inactivation gate situated at the selectivity filter 
shown in figure 1.22 (Cuello et al., 2010a). 
 
These structures provide an atomic view of the four most important functional states 
in which the IHBC (activation) gate is either closed or open, and the selectivity filter 
(inactivation) gate is either conductive or inactivated depicted in figure 1.23 (Zhou et 
al., 2001; Cuello et al., 2010a; Cuello et al., 2010b).  
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Figure 1.22. Gating in the potassium channel, KcsA. Highlighted regions 
represented by circles (A) the activation gate at the inner-helix crossover bundle 
(IHBC) and (B) the inactivation gate located at the selectivity filter.  
 
 
 
Figure 1.23. The gating cycling of inactivation and recovery in the potassium 
channel KcsA. Schematic depiction of the four dominant functional states observed 
from crystal structures and experimental evidence. Figure adapted from Ostmeyer 
et al., (2013).  
(A) 
(B) 
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1.5.7 Potassium channel - C-type inactivation 
 
A considerable amount of experimental evidence suggests that, as well as the 
IHBC, a secondary gate exists at the selectivity filter of some K+ channels 
(Bernèche and Roux, 2005; Cordero-Morales et al., 2006; Cordero-Morales et al., 
2007; Cuello et al., 2010a; Cuello et al., 2010b; van der Cruijsen et al., 2013). The 
process of gating in the C-terminal region (selectivity filter), known as C-type 
inactivation, involves conformational changes in the filter structure which alters its 
relationship with permeant ions (Cuello et al., 2010a). Unlike the fast N-type 
inactivation which involves a blocking particle linked to the N-terminal region of the 
channel (the ‘ball-and-chain’ mechanism), C-type inactivation is a slower process 
and is characterised by prolonged periods of closed channel events, with the 
selectivity filter residing in a stable collapsed and inactive conformation (Zagotta et 
al., 1990; Hoshi et al., 1991; Yellen, 1998; Cordero-Morales et al., 2011). This 
inactivation displays a wide range of functions from modulating the firing patterns of 
neurons to regulating the duration and frequency of the cardiac AP (Smith et al., 
1996; Spector et al., 1996; Bean, 2007).   
 
The precise mechanisms that govern C-type inactivation are thought to revolve 
around a distinct hydrogen-bonding network between residues located on the 
selectivity filter and in the pore helix (PH). In KcsA, an aspartic acid at position 80 
(D80), located at the top of the selectivity filter signature sequence, forms a 
hydrogen bonding network with a glutamic acid and tryptophan residue (E71 and 
W67), both situated on the pore helix, shown in figure 1.20 (Cordero-Morales et al., 
2006). The network of interactions between these three residues holds the 
selectivity filter in the inactivated state, pinching the central glycine residue of the 
signature sequence (TVGYGD) (Zhou et al., 2001), thereby preventing K+ ion 
occupancy and translocation through the pore (Cuello et al., 2010a). Replacing E71 
with alanine (E71A) greatly increases the open probability of KcsA as the channel 
cannot inactivate (Cordero-Morales et al., 2006; Chakrapani et al., 2007), 
presumably as a result of disrupting the network as alanine is not capable of 
hydrogen bonding (Cordero-Morales et al., 2011). Introducing a conservative 
substitution, tyrosine, to the pore helix (W67Y) at this position retains channel 
inactivation, similar to WT KcsA, and does not signiﬁcantly affect the overall kinetics 
and extent of gating (C-type inactivation) as the ability to form hydrogen bonds is 
preserved (Cordero-Morales et al., 2011). Likewise, conservative Shaker (W434Y) 
and Kv1.2 (W366Y) mutants were also found to retain inactivation currents similar to 
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their respective WT channels (Cordero-Morales et al., 2011). This underlies the 
importance of the selectivity filter in the inactivation process and also highlights a 
proposed conserved mechanism occuring throughout a variety of K+ channels, 
figure 1.24.  
 
 
 
Figure 1.24. Sequence alignment of KcsA with other K+ channels. The three 
highlighted columns represent a proposed conservative network between K+ 
channels analogous to the E71-D80-W67 interaction established in KcsA. Figure 
adapted from Cordero-Morales et al., (2011). 
 
The role of the selectivity filter in RyR2 inactivation remains to be established. Data 
emerging from previous RyR2 investigations indicate that the filter is likely to 
contribute to channel gating and that mutation of acidic residues in and around the 
selectivity filter affects both open probability and rates of ion translocation (Mead-
Savery et al., 2009; Mukherjee et al., 2012). These observations suggest that the 
selectivity filter of RyR2 may collapse in a manner analogous to the filter of KcsA 
during C-type inactivation.  
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1.5.8 Gating mechanisms at the selectivity filter – Flicker gating 
 
In addition to C-type inactivation outlined in section 1.5.7, another mechanism 
occurring at the selectivity filter termed flicker gating has been described in K+ 
channels such as BK, MthK and KcsA (Ferguson et al., 1993;  Talukder and Aldrich, 
2000; Piskorowski and Aldrich, 2006; Zadek and Nimigean, 2006; Thomson and 
Rothberg, 2010; Cuello et al., 2010b). These flicker events are characterised by 
rapid channel closures switching between conducting and non-conducting states 
and have been attributed to the dynamic flexible nature of the filter (Shrivastava et 
al., 2002; Noskov et al., 2004; Welch et al., 2004; Mukherjee et al., 2014). Mutations 
in the selectivity ﬁlter or surrounding structure of K+ channels have large effects on 
flicker gating transitions, and have been shown to increase the closed dwell-time 
duration (Lu et al., 2001; Alagem et al., 2003; Chapman et al., 2006). However, their 
physiological function is still unknown. 
 
Analysis of recent experimental data of recombinant hRyR2 single channel gating 
kinetics has revealed fast flicker closing events that are independent of activating 
ligand concentration (cytosolic Ca2+) (Mukherjee et al., 2012). This mode of gating 
closely resembles the brief closing transitions reported in K+ channels that relate to 
conformational changes in the selectivity filter of these channels (Lu et al., 2001; 
Alagem et al., 2003; Chapman et al., 2006). Together these observations indicate 
that the filter of RyR2 is likely to be an important component of the overall gating 
process and contribute to the regulation of Ca2+ release from the SR during ECC.   
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1.6 – Aims and Hypotheses  
 
Comparing the residues involved in the formation of a hydrogen-bonding network in 
KcsA (W67, E71 and D80) with those at similar positions in the Welch et al analogy 
PFR model (Y4813, D4829 and Y4839), figure 1.25, highlights the potential for a 
similar mechanism in RyR2. Residue D4829 (hRyR2) occupies an equivalent 
position in the selectivity filter signature sequence to D80 in KcsA and is located at 
an ideal position to form hydrogen bonds with Y4813 and Y4839, analogous to E71 
and W67 in KcsA. The PFR analogy model also indicates distances of 
approximately 2.5 Å which are within the ideal range for hydrogen bond formation 
(Welch et al., 2004; Hubbard and Haider, 2010).  
 
(A)            (B) 
        
 
Figure 1.25. A cartoon representation of the selectivity filter and pore helix of 
(A) KcsA and (B) the PFR analogy model of RyR2. Residues thought to be 
involved in a hydrogen-bonding network are shown in stick format. The figures were 
constructed in PyMol using the PDB file 1BL8 for KcsA and the analogy RyR2 
model by Welch et al., (2004). 
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1.6.1 Hypotheses 
 
This project used a variety of biochemical, molecular biological and 
electrophysiological techniques to assess the importance of the selectivity filter 
region in the gating process of hRyR2 by testing the following hypotheses:  
 
 That hRyR2 contains an intricate network of hydrogen-bonded residues 
(Y4813, D4829 and Y4839) at and around the selectivity filter analogous to 
that seen in KcsA and other K+ channels. 
 
 That the selectivity filter of hRyR2 is an important gating component. Alanine 
mutations in and around the selectivity filter will result in altered gating as a 
consequence of disrupted residue interactions. 
 
 That retaining the physicochemical properties and hydrogen-bonding 
capabilities of conservative mutants (Y4813W, D4829E and Y4839W) 
maintains the functional characteristics of WT hRyR2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
1.6.2 Project Aims  
 
To generate three alanine (Y4813A, D4829A and Y4839A) and three conservative 
(Y4813W, D4829E and Y4839W) mutant hRyR2 channels by site-directed 
mutagenesis using a cassette based strategy, and to ensure protein expression and 
transfection efficiencies were comparable with WT hRyR2 for downstream 
functional assays. 
 
To confirm the functional homotetrameric status of a population of mutant selectivity 
filter and pore helix hRyR2 channels in a cellular context utilising intracellular Ca2+ 
imaging.  
 
To assess the activity of mutant hRyR2 channels by measuring equilibrium binding 
of [3H] ryanodine. 
 
To screen purified mutant hRyR2 channels in order to assess their stability and ion 
conduction properties compared to WT hRyR2 when isolated, solubilised and 
incorporated into a planar lipid bilayer. 
 
To compare single mutant hRyR2 channel open probabilities and dwell-times with 
WT hRyR2 under regulated conditions.   
 
To investigate the gating mechanism of WT and mutant RyR2 channels in response 
to activating Ca2+ under minimal conditions.  
 
To identify the prevalence and nature of flicker gating events (thought to originate in 
the selectivity filter) in mutant hRyR2 channels, to see if substitution has affected 
this particular conformational transition. 
 
To compare differences between previous and new RyR structural modelling data in 
regards to residue positioning around the selectivity filter region, and to correlate 
novel hRyR2 gating information with these models to enhance the credibility of 
these static structures.  
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Chapter Two: 
 
Materials and Methods 
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2.1 – Materials 
 
2.1.1 General Lab Materials  
 
All chemical and reagents used were of analytical grade and were obtained from 
Sigma-Aldrich, unless otherwise stated. Equipment for electrophoresis, DNA 
agarose and SDS-PAGE, were supplied from Bio-Rad. All solutions and buffers 
were dissolved in bottled deionised water (dH2O) (AnalaR NORMAPUR®, VWR 
Chemicals) and stored at room temperature (RT) unless otherwise stated. Solutions 
which required sterilisation were filtered through a 0.22 µm Millex® syringe filter 
(Merck Millipore).  
 
2.1.2 Microbiology 
 
Bacterial growth media and antibiotics were obtained from Sigma-Aldrich. General 
sterilised plasticware and glassware were obtained from Greiner and Fisher.  
 
2.1.3 Molecular Biology 
 
2.1.3.1 General Lab reagents  
 
Deionised water (dH2O): Filter sterilised and autoclaved. 
70 % Ethanol: Stock solution 70 % ethanol (v/v).  
EDTA 0.5 M stock: 186.12 g/L EDTA, was adjusted to pH 10 with NaOH to dissolve 
EDTA. Once dissolved, pH was adjusted to 7.5 using HCl.  
Ampicillin: 100 mg/mL stock was prepared in bottled dH2O that was filter sterilised 
and stored at – 20 °C.  
 
2.1.4 Plasmid Vectors 
 
2.1.4.1 pcDNA3 Mammalian Expression Vector 
 
The pcDNA3 vector (5.446 kb) containing the full-length hRyR2 sequence and an 
N-terminal eGFP tag, termed pcDNA3-eGFP-hRyR2 (21.229 kb) shown in figure 
3.2A, was obtained from George et al., (2003). The full-length hRyR2 sequence 
encodes 4,967 amino acids (564,567 Da). Human RyR2 accession number: 
Q92736. 
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2.1.4.2 pSL1180 Intermediate Vector – Site-directed mutagenesis  
 
The pSL1180 vector (3.422 kb) containing the NheI/XhoI hRyR2 C-terminal DNA 
fragment, termed pSL1180-NX1-hRyR2 (8.597 kb) shown in figure 3.2B, was used 
for site-directed mutagenesis. The intermediate vector harbouring the desired point 
mutation, listed in table 3.1, was reinserted back into the full-length pcDNA3 vector 
for protein expression and subsequent biochemical and biophysical functional 
studies.  
 
2.1.5 Molecular biology reagents 
 
Restriction endonucleases: All enzymes (supplied with buffers) were acquired 
from New England Biolabs (BamHI, BglII, HinDIII, EcoRI, XhoI and FseI). Digestion 
of pSL1180 was performed using the fast EcoRI-HF® enzyme. All enzymes were 
stored at – 20 °C except for FseI that was stored at – 80 °C.  
1 kb DNA marker: 1 kb Plus DNA ladder (Invitrogen) was mixed with equal volume 
of 2 x DNA loading buffer stored at – 20 °C.  
TAE, 50 x stock: 2 M Tris, 2 M acetic acid and 50 mM EDTA. 
DNA loading buffer (2 x): 5 mL glycerol, 5 mL 1x TAE and 0.25 % (w/v) Orange G. 
Orange G was used as a tracking dye for nucleic acid electrophoresis to track the 
DNA front in agarose gels. 
 
2.1.5.1 Media 
 
Luria Bertani (LB) Lennox medium: 10 g/L tryptone, 5 g/L yeast extract and 5 g/L 
NaCl. Media were autoclaved and incubated at RT until < 50 °C before adding 
antibiotics (ampicillin 100 µg/mL). Stored at 4 °C. 
LB Lennox agar plates: 10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl and 15 g/L 
agar. Agar plates were autoclaved and incubated at RT until < 50 °C before adding 
antibiotics (ampicillin 100 µg/mL). Plates were poured in a Class 1 containment 
safety cabinet and allowed to set before parafilming individual plates and storing at 
4 °C. 
NZY broth: 5 g/L NaCl, 2 g/L MgSO4, 5 g/L yeast extract and 10 g/L NZ amine 
(casein hydrolysate) adjusted to pH 7.5 with NaOH. Broth was autoclaved before 
storing at 4 °C, antibiotic-free. 
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2.1.5.2 Mini/Maxiprep isolation reagents  
 
Qiagen reuspension buffer (P1): 50 mM Tris, adjusted to pH 8.0, 10 mM EDTA 
and 100 µg/mL RNase A/LyseBlue stored at 4 °C. 
Qiagen lysis buffer (P2): 200 mM NaOH and 1 % SDS (w/v). 
Qiagen neutralisation buffer (P3): 3 M potassium acetate, adjusted to pH 5.5. 
Qiagen column equilibration buffer (QBT): 750 mM NaCl, 50 mM MOPS, 
adjusted to pH 7.0, 15 % isopropanol (v/v) and 0.15 % Triton® X-100 (v/v). 
Qiagen column wash buffer (QC): 1 M NaCl, 50 mM MOPS and 15 % isopropanol 
(v/v), adjusted to pH 7.0. 
Qiagen elution buffer (QF): 1.25 M NaCl, 50 mM Tris and 15 % isopropanol (v/v) 
adjusted to pH 8.5. 
 
2.1.5.3 Mutant Oligonucleotide Primers 
 
Mutant hRyR2 primers were designed following the guidelines outlined in section 
3.2.1.1, and were ordered from Sigma-Aldrich. Primers were supplied as lyophilised 
pellets which were resuspended in 250 µL bottled dH2O to form a stock solution, 
and stored at – 20 °C. The stock solutions were diluted to form working 
concentrations (125 ng/µL) for site-directed mutagenesis PCR amplification. The list 
of primers is detailed in table 3.2. 
 
2.1.6 Protein biochemistry reagents 
 
Protease inhibitors:  Serine, cysteine and metalloprotease protease inhibitors 
were used during protein extraction and isolation. Complete EDTA-free protease 
inhibitor cocktail tablets were obtained from Roche, and stored at 4 °C. In addition, 
protease inhibitor cocktail solution for solubilisation buffer was obtained from Sigma-
Aldrich, and stored at – 20 °C. Both inhibited serine  
Hypo-osmotic cell lysis buffer: 20 mM Tris and 1 mM EDTA was adjusted to pH 
7.4 using HCl. One protease inhibitor tablet (Roche) per 50 mL buffer was prepared 
immediately before use. 
Microsomal resuspension ‘Solution C’ buffer: 0.4 M sucrose and 20 mM HEPES 
stored at – 20 °C. 
CHAPS/PC stock: 10 % (500 mg) 3-[(3-cholamidopropyl)-dimethylammonio] 1-
propane-sulphonate (CHAPS) and 5 % (250 mg) phosphatidylcholine (PC) in 5 mL 
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bottled dH2O was prepared on day of hRyR2 purification and incubated at 4 °C until 
required. 
KCl solution: 0.4 M KCl solution stored at 4 °C. 
Solubilisation buffer: 1 M NaCl, 0.15 mM CaCl2, 0.1 mM EGTA and 25 mM PIPES 
was adjusted to pH 7.4 and stored at – 20 °C. Protease inhibitor cocktail solution 
1:1000 (v/v) prepared immediately before use.  
Gradient buffer: 300 mM NaCl, 25 mM Tris, 50 mM HEPES, 0.3 mM EGTA, 0.3 % 
CHAPS/PC (from 10 % stock) and 82.24 mL bottled dH2O. One protease inhibitor 
tablet (Roche) per 25 mL buffer was prepared immediately before use. 
MicroBSA reagents: Obtained from Thermo Scientific.  
BSA standards: 2 mg/mL BSA stock diluted to 500, 200, 100, 50, 20 and 10 µg/mL 
in dH2O stored at – 20 °C.  
SDS-PAGE separating buffer: 1.5 M Tris stock solution, adjusted to pH 8.8 with 
HCl. 
SDS-PAGE stacking buffer: 0.5 M Tris stock solution, adjusted to pH 6.8 with HCl. 
Ammonium persulphate (APS): 10 % APS (w/v) solution. 
Sodium dodecyl sulfate (SDS): 10 % SDS (w/v) solution. 
SDS-running buffer 1x: 25 mM Tris, 250 mM glycine and 0.1 % (w/v) SDS. 
SDS-loading buffer 2x: 100 mM Tris pH 6.8, 20 % (v/v) glycerol, 4 % (w/v) SDS, 
10 % (v/v) β-mercaptoethanol and 0.2 % (w/v) bromophenol blue. 
Protein molecular weight ladder: Kaleidoscope prestained standard (Bio-Rad) 
stored at – 20 °C.  
Tris-buffered saline (TBS) 1x: 137 mM NaCl and 20 mM Tris, adjusted to pH 7.6 
with HCl. 
TBS-T 1x: 1x TBS and 0.1 % (v/v) Tween-20. 
Blocking solution: 5 % (w/v) non-fat dried milk (Marvel) dissolved in 1x TBS-T. 
Blocking Ab solution: 2.5 % (w/v) non-fat dried milk (Marvel) dissolved in 1x TBS-
T. Primary and secondary antibodies, stated in section 2.1.6.1, were applied to the 
membrane as a 1:5000 dilution.  
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2.1.6.1 Antibodies 
 
Primary Antibody: GFP (B-2) SC-9996 mouse monoclonal IgG2a, 200 µg/mL stock, 
raised against amino acids 1-236 of full length GFP was obtained from Santa Cruz 
Biotechnology.  
Secondary Antibody: Anti-mouse IgG (whole molecule)-Peroxidase antibody 
produced in goat was obtained from Sigma-Aldrich.  
 
2.1.7 Mammalian cell culture 
 
All growth media and reagents were supplied by Invitrogen and chemicals were 
obtained from Sigma unless otherwise stated. Sterile culture flasks and plates were 
supplied by Greiner.  
 
2.1.7.1 Mammalian cell culture reagents  
 
Dulbecco’s Modified Eagle Medium (DMEM): DMEM obtained from Gibco ® 
Invitrogen supplemented with 4.5 g/L glucose, 10 % (v/v) foetal calf serum and 4 
mM glutamine. For tissue culture media, complete DMEM (cDMEM) was 
supplemented with antibiotics, 100 µg/mL penicillin/streptomycin. For Ca2+ imaging, 
minimal DMEM (mDMEM) was antibiotic-free. All solutions were filtered sterilised 
and stored at 4 °C.  
Saline solution: 0.9 % (w/v) NaCl. 
HEPES buffered saline (HBS) 2x: Ready-made HBS 2x was obtained from Alfa 
Aesar containing 280 mM NaCl, 10 mM KCl, 1.5 mM NaPO4, 12 mM dextrose and 
50 mM HEPES, pH 7.0. 
Calcium chloride solution: 1 M CaCl2 stock solution filtered sterilised. 
Effectene transfection reagent: Effectene reagents were obtained from Qiagen 
and stored at 4 °C. 
Laminin: Mouse laminin (1 mg/mL) was obtained from Sigma. 
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2.1.8 Electrophysiology reagents  
 
All buffers and solutions were prepared in bottled dH2O (AnalaR NORMAPUR®, 
VWR Chemicals), produced by reversed osmosis and capacitive deionisation, that 
was subsequently filter sterilised before use.  
 
DOPE lipid: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, 18:1 (9-Cis), PE, was 
obtained from Avanti Polar Lipids Inc. PE lipid was supplied in powder form which 
was resuspended in chloroform (50 mg/mL) in a glass vial and stored at – 80 °C.  
n-decane: PE lipid was resuspended in n-decane to a working concentration of 33 
mg/mL. 
LiCl solution: 3 M LiCl stock solution was prepared and stored at 4 °C. 
KCl solutions: Various KCl solutions were prepared (15, 40, 90, 140, 200, 600, 800 
mM) with 20 mM HEPES and adjusted to pH 7.4 using KOH. The addition of 
hydroxide ions increased potassium concentration by 10 mM. Final KCl solutions 
concentrations were 25, 50, 100, 150, 210, 610, 810 mM. 
KCl gradient buffer: 3 M KCl and 20 mM HEPES solution was adjusted to pH 7.4. 
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2.2 – Methods 
 
Health and safety training and COSHH assessments were completed at the Wales 
Heart Research Institute (WHRI). Use of genetically modified organisms (GMO) was 
carried out in accordance with local GMO guidelines. Microbiology and cell culture 
procedures were performed in a Class I and Class II containment safety cabinet, 
respectively. Tritiated ryanodine radioisotope training was received from the WHRI 
safety officer and disposal of radioisotopes were documented using the IsoStock® 
software. 
 
2.2.1 Microbiology techniques  
 
2.2.1.1 Sterilisation procedures 
 
Flasks and bottles containing growth media or dH2O were sterilised by autoclaving 
at 121 °C, 15 psi for 30 min. Aseptic techniques were performed while working with 
bacterial cell cultures.  
 
2.2.1.2 Transformation of mutant hRyR2 DNA constructs following 
mutagenesis 
 
XL10-Gold Ultracompetent Epicurian coli cells were used during the cloning stages 
to transform full-length eGFP-hRyR2, as these cells are endonuclease deficient 
(endA), improving the quality of plasmid DNA, and recombination deficient (recA), 
increasing insert stability. In addition, these cells exhibit the Hte phenotype which 
increases the transformation efficiency of ligated and large DNA molecules suitable 
for RyR2 mutagenesis procedures, outlined in chapter 3. Prior to DNA 
transformation, the tube containing cells (50 µL) was thawed on ice, 2 µL of β-
Mercaptoethanol (β-ME) was mixed gently into incubating on ice for 5 min. 10 µL of 
the ligation reaction was added and swirled around the tube before incubating the 
mixture on ice for 30 min. XL10-Gold cells were transformed by incubating tubes at 
42 °C in a water bath for 45 s before incubating tubes on ice for 2.5 min. Pre-
warmed (30 °C) NZY broth (800 µL) was added to tubes which were incubated at 30 
°C, set at 225 rpm, for 1 h. Transformed XL10 cells were spread (50-100 µL) onto 
LB agar plates containing ampicillin (LBamp 100 µg/mL) and incubated for 16-18 h 
overnight at 30 °C. 
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2.2.1.3 Transformation of recombinant hRyR2 DNA constructs 
 
MAX Efficiency® Stbl2™ competent cells were routinely used to transform hRyR2 
DNA constructs, as these cells increased RyR2 plasmid yield and quality due to the 
endA1 mutation. Prior to DNA transformation, the tube containing Stbl2 cells (50 µL) 
was thawed on ice, 2 µL (1-10 ng) plasmid was subsequently added to the tube 
containing cells which was carefully mixed and incubated on ice for 30 min. Stbl2 
cells were transformed by incubating tubes at 42 °C in a water bath for 45 s before 
incubating tubes on ice for 2.5 min. 800 µL NZY broth (antibiotic-free) was added to 
tubes which were incubated at 30 °C, set at 225 rpm, for 1 h. Transformed Stbl2 
cells were spread (50-100 µL) onto LB agar plates containing ampicillin (LBamp 100 
µg/mL) and incubated for 16-18 h overnight at 30 °C (full-length pcDNA3-hRyR2) or 
37 °C (intermediate pSL1180-NX1).  
 
2.2.1.4 Propagation of recombinant hRyR2 DNA constructs 
 
2.2.1.4.1 Propagation of pSL1180-NX1 plasmids  
 
Transformed colonies were grown on LBamp plates and stored at 4 °C until required. 
For DNA cloning procedures using mutant NX1 plasmids, 10-20 bacterial colonies 
were picked and added in separate tubes containing 5 mL LBamp broth. Tubes were 
incubated in a 37 °C shaker, set to 225 rpm, for 16-18 h overnight.  
 
2.2.1.4.2 Propagation of pcDNA3-RyR2 plasmids 
 
For large-scale propagation of full-length hRyR2 plasmids, 5-10 colonies were 
picked and added in separate tubes containing 5 mL LBamp broth. Tubes were 
incubated in a 30 °C shaker, set to 225 rpm, for 16-18 h overnight. Plasmid DNA 
was isolated from 3 mL of the overnight culture and verified by EcoRI digest, 
described in sections 2.2.1.5 and 2.2.1.8. The remaining 2 mL was added into tubes 
containing 6 mL fresh LBamp broth and grown for a further 6-8 h at 30 °C, 225 rpm. 4 
mL of the bacterial culture was added to flasks containing 400 mL LBamp broth 
(1/100 ratio), these flasks were subsequently incubated overnight at 30 °C, 225 rpm 
for 16-18 h. Bacterial cultures were harvested by centrifugation Avanti® in a J-26 
XP centrifuge (Beckman Coulter) at 6000 x g for 20 min in 1 L centrifuge tubes (JLA 
8.1000 rotor Beckman). Pellets were taken straight through to DNA isolation 
(maxiprep see section 2.2.1.6) or, alternatively, were stored at – 20 °C. 
48 
 
2.2.1.5 Small-scale plasmid DNA isolation and purification – Miniprep  
 
Small-scale plasmid DNA isolation and purification was performed using the 
QIAprep Spin miniprep kit (Qiagen). A 3 mL bacterial culture, section 2.2.1.4, was 
harvested at 17,900 x g for 1 min at RT using a bench top minispin ‘plus’ Eppendorf 
centrifuge. The bacterial pellet was resuspended in 250 µL Buffer P1 (+RNase A 
(100 µg/mL) and LyseBlue) ensuring a homogenous solution containing no cellular 
clumps. The bacteria were lysed by the addition of 250 µL Buffer P2. Samples were 
inverted 4-6 times or until the cell suspension became viscous and changed to a 
blue colour. Cell lysis was neutralised by the addition of 350 µL Buffer N3 mixing 
immediately by inverting 4-6 times or until the cell debris and SDS from Buffer P2 
had precipitated to form a cloudy colourless solution. Precipitant material was 
removed by centrifugation at 17,900 x g for 10 min. The supernatant was carefully 
decanted into QIAprep spin columns and centrifuged for 1 min. The spin columns 
were washed by the addition of 500 µL Buffer PB and centrifuged again for 1 min. 
An additional wash step was performed by adding 750 µL Buffer PE (+ ethanol) into 
the columns which were centrifuged twice for 1 min to ensure that residual wash 
buffer had been completely removed. The DNA was eluted by adding 30 µL dH2O to 
the QIAprep columns which were placed in a 1.5 mL Eppendorf tube and incubated 
at RT for 1 min. Columns were then centrifuged for 1 min to isolate the DNA which 
was then stored at – 20 °C.  
 
2.2.1.6 Large-scale plasmid DNA isolation and purification – Maxiprep 
 
Large-scale plasmid DNA isolation and purification was performed using the Qiagen 
plasmid Maxi kit. As described in section 2.2.1.4.2, 800 mL of transformed Stbl2 cell 
culture containing plasmid DNA was harvested by centrifugation at 6000 x g for 20 
min at 4 °C. The bacterial pellet was resuspended in 30 mL Buffer P1 containing 
RNase A (100 µg/mL) and LyseBlue, before aliquoting the cell suspension in 3 x 50 
mL falcon tubes (3 x 10 mL). If the 30 mL bacterial pellet was frozen, the tubes were 
placed on a roller and allowed to thaw at RT before placing on ice. Cell lysis was 
completed by the addition of 10 mL Buffer P2 into tubes, inverting 4-6 times or until 
the cell suspension had turned blue. The 20 mL cell suspension was incubated for 5 
min at RT, before the addition of 10 mL neutralisation Buffer N3 to stopped further 
cell lysis/genomic shearing due to SDS. The samples were inverted 4-6 times or 
continued until the cell debris and SDS precipitated, forming a cloudy colourless 
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solution. The precipitated cell suspension was incubated on ice for 20 min, before 
centrifugation at 20,000 x g for 30 min at 4 °C (Avanti J-25 centrifuge Beckman) to 
remove unwanted cell debris, isolating the plasmid DNA in the supernatant. The 
supernatant was centrifuged again at 20,000 x g for 15 min at 4 °C to ensure that 
precipitated material was completely removed. Prior to the addition of supernatant 
to the QIAGEN-tip 500, the column was equilibrated by the addition of 10 mL Buffer 
QBT. The clear supernatant containing plasmid DNA was added to the QIAGEN-tip 
and left to pass through the resin by gravity flow. The QIAGEN-tip was washed 
twice with 30 mL Buffer QC. The DNA was eluted from the tip by the addition of 15 
mL buffer QF which was collected in a falcon tube. The addition of 10.5 mL 
isopropanol (stored at RT) to the eluate initiated DNA precipitation. The sample was 
mixed by inverting the tube 4-6 times before centrifugation at 15,000 x g for 30 min 
at 4 °C. The supernatant was carefully discarded leaving the DNA pellet which was 
washed with 5 mL of 70 % ethanol (stored at RT) and centrifuged at 15,000 x g for 
10 min. The ethanol supernatant was discarded and, the centrifuge tubes containing 
DNA were air-dried for 10 min to allow for remaining residual ethanol to evaporate. 
The DNA pellet was resuspended in 1 mL dH2O, followed by DNA quantification 
(section 2.2.1.7) and verification (section 2.2.1.8) by restriction digest.       
 
2.2.1.7 DNA spectrometry - Quantification of DNA concentration 
 
Spectrophotometric analysis of plasmid DNA, prepared from large-scale maxiprep, 
was performed to determine DNA concentration and purity. The spectrophotometer 
absorbance was set at 260 nm (Abs260), the wavelength at which DNA absorbs UV 
light, and a 1:50 dilution factor that enabled the calculation of DNA concentration 
according to the equation stated below: 
 
Abs260 x dilution factor x 50 = [DNA] (ng/μL) 
 
Plasmid DNA (20 µL) was mixed with 980 µL dH2O before calibrating (zeroing) the 
spectrophotometer using a cuvette containing 500 µL dH2O. 2 x 500 µL of the DNA 
dilution was added to the cuvette to assay concentration. A typical DNA yield from 
800 mL pellet ranged from 200-800 ng/µL. The sample purity was determined by 
the absorbance at 280 nm (Abs280) which measures aromatic residues such as 
tyrosine and tryptophan. The Abs280 is an indicator of protein contamination levels 
within samples, whereby an Abs260:280 ratio of > 1.8 was deemed to be of high DNA 
purity. 
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2.2.1.8 DNA restriction digest – Verification of DNA preparation  
 
Both intermediate (pSL1180) and full-length (pcDNA3) hRyR2 plasmids were 
verified by restriction digest to ensure that transformation and DNA propagation was 
successful. The recognition of specific nucleotide sequences and generation of 
correct digest patterns ensured that known DNA fragments with particular base pair 
length were generated and confirmed that plasmid rearrangements had not 
occurred (George et al., 2003). Four restriction endonucleases were used to digest 
the full-length pcDNA3-hRyR2 plasmid, described in chapter 3.2.2 with predicted 
DNA patterns depicted in figure 3.5B. EcoRI-HF® was used to digest the 
intermediate pSL1180-NX1 constructs, as the enzyme recognises two restriction 
sites, forming two distinct DNA fragments with identifiable base pair lengths (5370 
and 3227 bp), shown in figure 3.5A.  DNA plasmids were incubated at 37 °C for 1.5 
h (full-length plasmid) or 15 min (intermediate plasmid) with the reagents listed in 
table 2.1. The digested DNA fragments were loaded onto an agarose gel and 
electrophoresed to analyse DNA patterns described in section 2.2.1.9.   
 
Reagents Volume 
DNA (1-2 μg) 5 µL 
dH2O 2 µL 
Buffer 1 µL 
BSA (10 x) 1 µL 
Enzyme (5-10 U) 1 µL 
 
Table 2.1. Restriction DNA digest reagents. 
 
2.2.1.9 Agarose gel electrophoresis - DNA analysis 
 
DNA plasmids were digested using the restriction endonucleases listed in table 3.10 
and analysed by agarose gel electrophoresis. 1 % (w/v) agarose gels were 
prepared by dissolving an appropriate amount of agarose in TAE (1 x) buffer before 
heating in a microwave oven for (1-2 min). The dissolved agarose solution was 
cooled at RT for 5 min before the addition of 0.1 µg/mL ethidium bromide (EtBr). A 
gel tray was set up according to the instructions provided by the manufacturer (Bio-
Rad). The agarose EtBr solution was poured into the tray and allowed to cool at RT 
for the gel to set. The agarose gel tray was placed into a Bio-Rad tank filled with 1x 
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TAE to allow for the current to pass through. DNA samples were mixed with an 
equal volume of DNA loading buffer (2 x) and added to the wells alongside a 1 kb 
Plus DNA ladder (Invitrogen). Gels were electrophoresed for 30-45 min at 100 V or 
until the dye had migrated to the end of the gel. Agarose gels containing migrated 
DNA was visualised under UV light using a trans-illuminator Red™ SA – 1000 
(Alpha Innotech). DNA samples were compared with the known 1 kb Plus DNA 
ladder.  
 
2.2.2 Mammalian cell culture  
 
2.2.2.1 Human Embryonic Kidney (HEK) 293 cell culture 
 
Human Embryonic Kidney (HEK) 293 cells were routinely cultured in CellStar® cell 
culture 75 cm2 flasks containing complete Dulbecco’s Modified Eagles Medium 
(cDMEM) in a 37 °C, 5 % CO2 incubator (Thermo Scientific). HEK293 cells were 
passaged every 72-96 h or until cell density reached 80-95 % confluency. Cells 
were washed twice with 10 mL 0.9 % saline, before harvesting. The cell suspension 
was mixed to disrupt any cellular aggregates before counting the cells on a 
haemocytometer. A glass coverslip was fixed to the haemocytometer under 
determined counting chambers (4 x 4) with a volume of 1 x 10-4 mL. The average 
cell count was multiplied by 1 x 104 to determine cell density (cells / mL) before 
pelleting the known amount of cells at 1000 x g for 5 min. The HEK293 cell pellet 
was resuspended in a volume adjusted to 1 x 106 cells/mL and mixed with 20 mL 
pre-warmed (37 °C) cDMEM before incubating the flasks. 
 
2.2.2.2 Heterologous hRyR2 expression 
 
Two transfection methods were routinely used to express hRyR2 protein in HEK293 
cells which are discussed in detail in section 2.2.2.3. Briefly, the calcium phosphate 
(CaPO4) method generated increased protein expression valuable for protein 
biochemical and biophysical assays. However due to increased hRyR2 expression 
HEK293 cytotoxicity was high and was therefore not ideal for cellular assays. 
Alternatively, the Effectene transfection method was used in studying the function of 
hRyR2 in a cellular environment. The Effectene method provides increased 
transfection efficiency and reduces cell cytotoxicity, ideal for confocal microscopy 
fluorescent based imaging in HEK293 cells, described in chapter 4.2.2.1. 
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2.2.2.3 Calcium phosphate-mediated transfection  
 
HEK293 cells were seeded at a density of 1.5 x 106 cell/mL into CellStar® 100 x 20 
mm Greiner bio-one plates which were incubated for 24 h at 37 °C, 5 % CO2 prior to 
transfection. A DNA mix, containing full-length pcDNA3-eGFP-hRyR2 DNA 12 
µg/plate, 124 mM CaCl2 and bottled dH2O was prepared as stated in table 2.2 and 
ready-made 2x HEPES-buffered saline (HBS) was pre-warmed to 37 °C in a water 
bath.  
 
HEK293 transfection mixture  
  Reagents [Stock] Required amount Volume 
DNA mix 
DNA 500 ng/µL 12 µg/plate 24 µL 
CaCl2 1 M 124 mM 124 µL 
dH2O     up to 500 µL 
          
2x HBS Equal volumes 500 µL 
 
Table 2.2. Calcium-phosphate transfection mixture. An example of calcium-
phosphate reagents and quantities required to transfect HEK293 cells on a 100 mm 
plate.    
 
The DNA mix was added dropwise into the 2 x HBS solution while vortexing, 
followed by a 20 min incubation to initiate DNA precipitation. Fresh, pre-warmed 
cDMEM (20 mL) was added to each plate followed by the addition of the 
transfection mixture (1 mL added dropwise). Each plate was carefully mixed before 
returning the plates to the 37 °C, 5 % CO2 incubator, for 48 h. Protein expression 
was enhanced by the addition of 2 mM sodium butyrate (NaB), described in chapter 
3.3.3. The protocol was adjusted to replace the transfection media 24 h post-
transfection with pre-warmed 20 mL cDMEM supplemented with 2 mM NaB. Plates 
were incubated for a further 24 h before assessing transfection efficiency by eGFP 
imaging, described in section 2.2.2.4, and cell harvesting for mixed-membrane 
preparations, outlined in section 2.2.3.1. 
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2.2.2.4 Determining transfection efficiency using eGFP imaging  
 
The success and efficiency of hRyR2 transfection was determined by eGFP 
imaging. Plates were carefully mounted onto a 37 °C holding stage and were 
imaged using an Axiovert 200 microscope (Zeiss) with 10 x objective magnification. 
A field of view (FOV) was selected that contained a homogenous cell density using 
a bright-field (BF) light source. Subsequently, the same FOV was visualised using a 
xenon light source, applying peak excitation at ~ 488 nm, and a 520 ± 28 nm band 
pass filter to capture eGFP fluorescence, which confirmed hRyR2 protein 
expression. Image acquisition and processing were completed in AxioVision Rel. 
4.3 that were subsequently saved as .tiff files. Transfection efficiency was 
calculated by the total sum of fluorescent green cells by the total cell count per 
FOV. Transfected HEK293 cells containing hRyR2 proteins (efficiency > 30 %) were 
harvested for downstream applications as described in section 2.2.3.1.  
 
2.2.3 Protein Biochemistry 
 
2.2.3.1 Preparation of hRyR2 mixed-membranes from HEK293 cells 
 
HEK293 cells containing hRyR2 protein were harvested 48 h post-transfection. The 
transfection media was discarded and replaced with pre-heated (37 °C) fresh 
cDMEM (1 mL); cells were harvested by scraping each plate with a Fisherbrand™ 
cell scraper, collecting the cell suspension in a 50 mL falcon tube. The 
aforementioned process of collecting cells from plates was repeated twice to ensure 
maximal cell harvest. The cell suspension was pipetted to form a homogenous 
solution that contained no cellular clumps to improve cell count, described in section 
2.2.2.1. HEK293 cells were isolated by centrifugation at 1000 x g for 5 min RT, 
before incubating the pellet on ice. Cells were lysed by the addition of hypo-
osmostic buffer (1 mL/106 cells), containing one protease inhibitor tablet per 50 mL 
of buffer, which was stored at 4 °C. The lysed HEK293 cell suspension was 
homogenised in a 30 mL glass homogeniser on ice before aliquoting 15 mL into 50 
mL falcon tubes. The aliquots were further homogenised through a 23 G needle (10 
strokes) performed by a purpose built homogeniser constructed by Richard 
Montgomery (Montygeniser) to ensure complete cell lysis. Cell debris (organelles) 
was removed by centrifugation (2,700 rpm, 4 °C for 15 min) in an Allegra 6R 
centrifuge (Beckman Coulter). The supernatant containing the mixed-membrane 
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preparation was isolated by a further centrifugation step (28,000 rpm, 4 °C for 1 h) 
using a Optima XPN-100 ultracentrifuge (Beckman Coulter). The microsomal pellet 
was resuspended in solution C (0.4 M sucrose and 20 mM HEPES) at 20 µL/106 
cells and homogenised in a 3 mL glass homogeniser. The mixed-membrane 
preparation was quantified by microBCA protein assay, described in section 2.2.3.2 
before freezing 4 mg aliquots in liquid nitrogen and storing at – 80 °C.     
 
2.2.3.2 MicroBCA – Quantification of protein concentration  
 
The colourimetric BCA assay mix is a highly sensitive detection reagent that forms a 
purple-coloured reaction when Cu2+ are reduced by protein in an alkaline 
environment (Smith et al., 1985), which exhibits a strong linear absorbance directly 
proportional with increasing protein concentration. Mixed-membrane preparations 
were quantified by a Thermo Scientific™ Pierce™ Micro BCA™ protein assay kit 
(Fisher Scientific). Protein standards were prepared from a 2 mg/mL bovine serum 
albumin (BSA) stock (10, 20, 50, 100, 200, 500 µg/mL) and the BCA assay mix 
containing Reagent A, Reagent B and Reagent C combined in a 50:48:2 ratio, 
respectively. The mixed-membrane preparations were diluted in bottled dH2O (1:50, 
1:100, 1:200). The dilutions were added to 96-well plates in duplicates of 100 µL 
alongside BSA standards (100 µL). The BCA assay mix was added into all wells 
containing protein samples which were incubated for 20 min in a dark area. A 
multiskan EX spectrophotometer (Labsystems) was set at absorbance 595 nm 
(Abs595) to quantify protein concentration. A standard curve was generated from the 
known BSA protein concentrations and used to determine the mixed-membrane 
concentrations by linear regression, shown in figure 2.1. A typical mixed-membrane 
protein yield containing hRyR2 from 100-150 x 106 cells harvested 48 h post-
transfection was approximately 10-20 mg.    
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Figure 2.1. Linear regression analysis of the relationship between BSA 
concentration and absorbance at 595 nm. Diluted mixed-membrane protein 
samples (1:50, 1:100, 1:200) were estimated from the standard curve.  
 
2.2.3.3 Sodium dodecyl sulfate (SDS) - Polyacrylamide gel electrophoresis 
(PAGE) 
 
hRyR2 proteins were separated on a discontinuous SDS-PAGE to assess protein 
expression by western blot, described in sections 2.2.3.4 and 2.2.3.5. Dissociation 
of homotetremeric hRyR2 channels to monomers (molecular weight 565 kDa) by 
SDS ensured proteins were denatured and coated in negative charge for 
electrophoresis. A 5 % (v/v) acrylamide separating gel was prepared according to 
table 2.3 to resolve the high MW monomers. The polyacrylamide gel mixture was 
poured into the gel casing (Bio-Rad) and layered with bottled dH2O. The ammonium 
persulfate (APS) and TEMED initiated polymerisation, the polyacrylamide mixture 
was incubated at RT for 20 min to allow the gel to set. The dH2O was removed from 
the separating gel and replaced with 5 % stacking gel prepared as stated in table 
2.4, followed by the insertion of a pre-set 10 lane comb. The mixed-membrane 
preparation containing hRyR2 protein (100 µg) was prepared according to table 2.5, 
incubating the samples at 42 °C for 30 min.  
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 Reagent Volume 
dH2O 12.16 mL 
40 % bis-Acrylamide 2.5 mL 
Tris 1.5 M pH 8.8 5 mL 
SDS 10 % (w/v) 160 µL 
APS 10 % (w/v) 160 µL 
TEMED 20 µL 
Total 20 mL 
 
Table 2.3. 5 % SDS-PAGE separating gel reagents.  
 
Reagent Volume 
dH2O 4.73 mL 
40 % bis-Acrylamide 583 µL 
Tris 0.5 M pH 6.8 1.25 mL 
SDS 10 % (w/v) 50 µL 
APS 10 % (w/v) 50 µL 
TEMED 8.3 µL 
Total 6.67 mL 
 
Table 2.4. 5 % SDS-PAGE stacking gel reagents. 
 
Reagents  Volume  
MM Sample (100 µg) X µL 
6 x SDS sample buffer 6 µL 
dH2O up to 30 µL 
 
Table 2.5. Mixed-membrane SDS loading preparation for SDS-PAGE.  
 
Gels were loaded into gel tanks (Bio-Rad) and topped up with 1 x SDS running 
buffer. Samples (30 µL) were loaded in pre-cast lanes alongside a 20 µL 
kaleidoscope protein ladder (Bio-Rad). Electrophoresis was performed at constant 
current starting at 20 mA, for the first 30 min, before increasing to 30 mA until the 
myosin (pre-stained protein ladder 216 kDa) migrated to the bottom of the gel (~ 3-4 
h). The SDS-gel containing the separated proteins was transferred to a PVDF 
membrane for Western blot analysis, section 2.2.3.4.  
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2.2.3.4 Western blot – Transfer of proteins onto a PVDF membrane 
 
Western blotting was performed using the iBlot® Dry blotting system (Invitrogen). 
Proteins were separated on SDS-PAGE gels and transferred onto a ready-made 
iBlot Gel Transfer stack (regular or mini), containing the polyvinylidene difluoride 
(PVDF) membrane. The iBlot was set up as described in the manufacturer’s 
instructions. The anode stack (Bottom) was unsealed and placed into position, 
aligning with the gel barriers. The SDS-gel was transferred to the anode stack 
containing the PVDF membrane and a pre-soaked iBlot filter paper was placed on 
top of the SDS-gel. The cathode stack (Top) was unsealed and placed onto the filter 
paper with the electrode side facing up, air bubbles were removed using the blotting 
roller. A disposable sponge was aligned with the metal contact before the lid was 
secured shut. The proteins were transferred by selecting program 3, for 13 min at 
20 V. Once completed, the PVDF membrane containing transferred proteins was 
placed in blocking buffer overnight. 
 
2.2.3.5 Western blot – Enhanced Chemiluminsescence (ECL) detection   
 
hRyR2 proteins were transferred to a PVDF membrane using the method described 
in section 2.2.3.4 and were incubated in 5 % (w/v) non-fat dried milk protein 
(Marvel) in 0.01 % TBS-T buffer (blocking buffer) overnight at 4 °C. The PVDF 
membrane was washed three times using 20 mL TBS-T buffer for 5 min at RT. A 
GFP-specific (B-2) SC-9996 mouse monoclonal IgG2a primary antibody, section 
2.1.6.1, raised against the N-terminal RyR eGFP tag (amino acids 1-236), was 
diluted 1:5000 (v/v) in 2.5 % blocking buffer and applied to the membrane for 1.5 h 
at RT. The membrane was washed again three times using 20 mL TBS-T buffer for 
5 min at RT. A horseradish peroxidase (HRP)-conjugated anti-mouse secondary 
antibody (produced in goat) was diluted 1:5000 (v/v) in 2.5 % blocking buffer before 
applying to the membrane that was subsequently incubated for a further 1.5 h at 
RT. The membrane was washed (3 x 5 min RT) before being visualised by 
enhanced chemiluminsescence (ECL) detection (GE Healthcare). The HRP 
catalyses the oxidation of luminol into a reagent which emits light (428 nm), the ECL 
kit increases light emission more than 1000-fold from the presence of enhancer 
molecules, including phenols (Thorpe et al., 1985). Therefore the location and 
amount of light produced directly correlated with the amount of protein on the 
membrane. The PVDF membrane was placed into a cassette containing a plastic 
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folder, ECL reagent 1 and reagent 2 were mixed in equal volumes before applying 
to the cassette containing the membrane. An x-ray film (Hyperfilm, GE Healthcare) 
was aligned with the cassette in the dark room and was exposed for 2-5 min. The x-
ray film was developed using a Compact X4 X-OGraph imaging system. 
 
2.2.3.6 Quantification of protein expression by Western blot Densitometry  
 
WT and mutant RyR2 protein expression was determined by Western blot 
densitometry analysis (outlined in chapter 3) and was used to quantify the relative 
amounts of RyR2-membrane preparations for the [3H] ryanodine binding assay 
described in chapter 4. Western blots were scanned into a computer using a Canon 
CanoScan LiDE 100, achieving 300 dpi. ImageJ, an open source image processing 
program (http://imagej.net/Welcome), was used to perform densitometry 
measurements on exposed films. The integrated density tool (ROI area and mean 
grey value) was used to analyse bands, figure 2.2. A lower integrated density value, 
determined by a darker ROI, indicated greater protein expression. The area of ROIs 
remained constant for all band measurements with a working example outlined in 
section 2.2.3.6.1. To compensate for the differences in RyR2 expression levels, 
integrated densitometry values were calibrated to 100 µg WT hRyR2 mixed-
membrane to ensure that equivalent quantities of mutant and WT RyR2 were added 
for each [3H] ryanodine binding assay described in chapter 4.2.4.  
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2.2.3.6.1 Western blot densitometry analysis example 
 
           1         2        3                   4  
 
 
Figure 2.2. Representative Western blot densitometry analysis. (1) WT hRyR2 
and representative mutant RyR2 bands (2, 3 and 4). Region of interest (ROIs) are 
highlighted by red boxes. 
 
 
ROI IntDen 
Normalised   Relative  
IntDen  Volume (µL) 
1 WT hRyR2 51.23 51.23/51.23 1 10 
2 Mutant #1 86.83 86.83/51.23 1.694 16.94 
3 Mutant #2 45.51 45.51/51.23 0.888 8.88 
4 Mutant #3 45.74 45.74/51.23 0.892 8.92 
 
Table 2.6. Representative densitometry analysis of WT and mutant mixed-
membrane preparations. Mutant hRyR2 preparations were adjusted and 
normalised to compensate for the differences in hRyR2 expression levels as shown 
in figure 2.2. 
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2.2.3.7 Purification of hRyR2 from mixed-membrane preparations 
 
hRyR2 protein was purified from mixed-membrane preparation (12 mg) using 
continuous sucrose density centrifugation. Aliquots containing 4 mg hRyR2 mixed-
membrane (3 x 4 mg aliquots) were thawed on ice. A 10 % : 5 % CHAPS : PC stock 
was prepared in 5 mL bottled dH2O, and stirred for 2 h at 4 °C. The mixed-
membrane preparation was diluted at a 1 : 4 ratio with 0.4 M KCl and centrifuged at 
100,000 x g for 30 min at 4 °C using an Optima™ MAX-XP ultracentrifuge 
(Beckman Coulter). The mixed-membrane pellet (12 mg) was resuspended at 3 
mg/mL, adding 3756 µL solubilisation buffer containing 4 µL (1:1000 ratio) protease 
inhibitor cocktail through a 23 G needle (10 strokes). Once resuspended, the 10 % 
CHAPS/PC stock was added at a final detergent concentration of 0.6 % (240 µL) 
and the microsomal suspension was solubilised for 1 h at 4 °C with continuous 
stirring. The insoluble material from the lysate was removed by centrifugation 
(14,000 x g for 30 min at 4 °C) using an Eppendorf 5417R centrifuge. The 
supernatant containing the solubilised hRyR2 protein and other cellular components 
was carefully layered onto one sucrose gradient, described in section 2.2.3.7.1. 
Solubilised hRyR2 was purified from other membrane proteins and cellular 
components by continuous density gradient centrifugation using a SW 32.Ti swing 
out rotor at 100,000 x g for 16-18 h at 4 °C.    
 
2.2.3.7.1 Preparation of Sucrose gradient 
 
Gradient buffer was prepared as outlined in section 2.1.6, which was added to three 
prepared sucrose concentrations (40, 25 and 5 %) according to table 2.7.  
 
Sucrose 
Sucrose (g) Gradient buffer (g) 
Concentration % (w/w) 
40 7.2 10.8 
25 11.25 33.75 
5 2.25 42.75 
 
Table 2.7. Preparation of sucrose gradients. The stated amounts form two 
sucrose gradients. 
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Falcon tubes containing sucrose and gradient buffer were placed on rollers to mix 
for > 1 h at 4 °C. Sucrose gradients were prepared in Ultra-Clear™ centrifuge 25 x 
89 mm tubes fed from a two chamber pump shown in figure 2.3. The first layer, 
containing 5 mL 40 % sucrose buffer, acting as a cushion, was added manually. 
Before the addition of the 25 % sucrose (25 mL), the 5 % sucrose (40 mL) was 
passed through the inter-connecting chamber to ensure smooth transition and to 
prevent bubble formation. The stirrer was switched on and the inter-connecting tap 
was opened, which was immediately followed by switching the pump on to initiate 
mixing of the two sucrose buffers as detailed in figure 2.3. The buffers were loaded 
into the tubes layering the continuous sucrose gradient. To ensure sufficient 
capacity for the solubilised hRyR2 protein, 4-5 mL was left free on top of the 
gradient. Both gradients were carefully stored at 4 °C until required.     
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Figure 2.3. Schematic representation depicting the preparation of a sucrose 
gradient for hRyR2 purification. 40 mL of 5 % sucrose was added in chamber A, 
allowing sucrose to pass through the inter-connecting chambers to prevent bubble 
formation. The residual flow-through of 5 % sucrose in chamber B was transferred 
back into chamber A before adding 25 mL of 25 % sucrose into chamber B. The 
flow rate was set to 4, the inter-connecting tap was opened, the stirrer in chamber B 
and pump was turned on to allow the solutions to mix which were fed into the tubes 
forming a sucrose gradient.  
 
 
 
 
40 mL 
5 % sucrose 
25 mL 
25 % sucrose 
40 % 
40 % 
A B 
40 % 
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2.2.3.7.2 Fraction collection 
 
Following centrifugation, the gradient tube containing the solubilised hRyR2 protein 
was carefully placed in a fraction recovery system (Beckman) that was connected to 
a P-1 pump (Pharmacia Biotech), see figure 2.4. The fraction recovery system 
pierced the tube to allow the gradient to flow into 15 (~ 1.5 mL) fractions, performed 
at a flow rate setting of 4 (2 mL/min), for 45 s.  
 
 
 
 
 
 
 
 
  
 
 
 
 
   #    1      2      3      4      5      6      7       8      9    10    11     12    13    14    15    
  
 
 
 
 
Figure 2.4. Schematic diagram of sucrose gradient fraction collection. Tubes 
were placed in a fraction recovery system containing a pierced outlet. Fractions 1-
15 were manually collected in 45 s intervals using a flow rate setting of 4 (2 
mL/min).  
 
Sucrose concentration was measured by the addition of 10 µL fractions to a 0-50 % 
sugar refractometer obtained from Bellingham & Stanley Ltd. Early purification 
studies using [3H] ryanodine binding assays, described in chapter 4.1.3, determined 
the highest proportion of RyR protein in fractions containing 27-29 % sucrose 
(Campbell et al., 1987; Lai et al., 1988; Hymel et al., 1988). The total concentration 
of sucrose fractions (1 – 15) from hRyR2 purifications (n=29) are represented in 
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figure 2.5. Typically, fractions 4 (32.9 %), 5 (29.1 %) and 6 (25.8 %), highlighted in 
blue, containing purified hRyR2 were aliquoted (50 µL) and flash frozen in liquid 
nitrogen before storing at – 80 °C.    
 
 
 
Figure 2.5. Sucrose gradient fraction collections. The sucrose gradient fractions 
from 1 to 15 were collected, and the percentage of sucrose within fractions was 
measured by a refractometer. From the total hRyR2 purifications (n = 29) the 
highlighted sucrose fractions, 4, 5 and 6, corresponding to ~ 32 %, ~ 29 % and ~ 26 
% sucrose respectively, were routinely aliquoted (50 µL) and frozen in liquid 
nitrogen stored at – 80 °C and, used for single-channel bilayer experiments. 
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2.2.4 Electrophysiology - Single-channel Experiments  
 
2.2.4.1 Warner Instruments workstation 
 
All single-channel experiments were completed using the Planar Lipid Bilayer (BLM) 
workstation from Warner Instruments. Briefly, experiments were completed inside a 
FC series Faraday cage on a vibration isolation table (Kinetic Systems) to minimise 
environmental, mechanical and user noise. The components of the single-channel 
set up, including the cup and block described in section 2.2.4.1.1, were placed on a 
SPIN-2 bilayer stirplate integrated with a SUNStir rack-mount controller and a SUN-
1 halogen lamp.   
 
2.2.4.1.1 Planar lipid bilayer workstation set up 
 
The in vitro electrophysiology bilayer technique was first used to study ion channel 
properties by Miller and Racker, and Alvarez (Miller and Racker, 1976; Alvarez, 
1986). A cup and block, depicted in figure 2.6, are two important entities of the set 
up that allow the study of ion channels in a well-controlled environment. The cup, 
corresponding to the cis chamber, has a cylindrical 500 µL compartment with a 
centrally located 200 µm aperture. The cup mounted into a pre-casted block 
establishes a 1000 µL trans compartment. Together, the cup and block form two 
fluid filled chambers that are connected by a small aperture where a planar lipid 
bilayer was formed, illustrated in figure 2.7. Each chamber was connected via salt 
bridges which were thin 1 mm capillary tubes containing 3 M LiCl fixed in 2 % w/v 
agar. The end of each bridge was bathed in the experimental salt solution and a 
well containing 200 µL 3 M LiCl. These additional wells also contained Ag/AgCl 
coated electrodes that connected the remainder of the electronic circuit described in 
section 2.2.4.1.2.  
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(A)     (B) 
 
Figure 2.6. Schematic representation of (A) the styrene cup ‘cis’ chamber 
depicting the 200 µm aperture as a black dot and (B) the copolymer block 
‘trans’ chamber mounted with the cup.  
 
 
 
Figure 2.7. Schematic representation of the Planar Lipid Bilayer set up. The 
two fluid filled chambers, the cup (cis) and block (trans) are connected by a 200 µm 
aperture forming two fluid filled chambers. The stirring of the teflon coated magnetic 
stir-bar, placed at the bottom of the cis chamber, facilitated channel incorporation. A 
representative RyR2 channel is incorporated into a lipid bilayer membrane (not to 
scale), with the cytoplasmic domain facing the cis chamber. Salt bridges and 
Ag/AgCl electrodes connected the circuit with the head amplifier so that current 
flowing through the membrane via RyR2 was measured and recorded.  
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2.2.4.1.2 Electronic Bilayer set up  
 
The electrodes were connected to a head amplifier that held the trans chamber at 
ground relative to the cis chamber. The Warner Bilayer Clamp amplifier (BC-535) 
was used to voltage clamp the cis chamber that subsequently dictated the flow of 
cations. At positive holding potentials (+ mV) cations flowed in the non-physiological 
direction, from cis (cytosol)  trans (lumen), and at negative holding potentials (- 
mV) cations flowed in the physiological direction, from trans (lumen)  cis (cytosol), 
as RyR2 incorporates into the bilayer with a fixed orientation outlined in section 
2.2.4.4. The operational amplifier transduced the current flow through the bilayer 
into an analogue voltage signal that was passed through a 5 kHz and 1 kHz multi-
step low pass 8-pole Bessel filter (LPF-8). Single-channel data filtered at 5 kHz was 
used for analysis, whereas data passing through the 1 kHz filter was used for real-
time visualisation of current flow in an oscilloscope window. The signal was finally 
passed through an analog to digital converter (ADC), where the Bruxton software 
suite (Acquire and Review) was used to record and visualise the data. The QuB 
software, discussed in detail in chapters 5 and 6, was used for data analysis. 
 
2.2.4.2 Bilayer formation 
 
2.2.4.2.1 Phosphatidylethanolamine (PE) lipid preparation 
 
PE lipid (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, 18:1 (9-Cis), DOPE) was 
resuspended in chloroform at 50 mg/mL and stored at – 80 °C. The chloroform 
containing the dissolved PE lipid (10 µL) was evaporated using a stream of nitrogen 
gas under constant low pressure. The dried lipid was resuspended in 14.5 µL n-
decane at a final concentration of ~ 33 mg/mL for use in all experiments outlined in 
chapters 5 and 6.  
 
2.2.4.2.2 Priming the cis chamber aperture 
 
Prior to formation of a bilayer, the aperture was primed with excess PE lipid. A bolus 
of lipid was applied to the aperture and was forced through under pressure. Priming 
of the cis chamber was repeated twice, allowing the lipid to dry between each 
prime, which ensured that the hole had adequate lipid to facilitate bilayer formation.  
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2.2.4.2.3 Painting a bilayer and measuring lipid bilayer formation 
 
PE lipid was ‘painted’ across the hole by gentle upward strokes using a modified 3 
mL plastic Pasteur pipette as a painting stick shown in figure 2.8.  
 
(A) 
 
(B) 
 
 
Figure 2.8. A modified Pasteur pipette used as a ‘painting’ stick. A sharp 
scalpel was used to carve the decanting-end of the pipette to form a curved sharp 
tip. (A) The tip, highlighted by a black circle, was used to ‘paint’ the 200 µm aperture 
and (B) the convex outer end, indicated by a black line, was used to prime the 
aperture with excess lipid. 
 
Lipid was applied to the cis chamber side until a change in membrane capacitance 
was observed. Capacitance, measured in picofarads (pF), was used to assess 
bilayer formation as the capacity of the membrane to store charge correlated 
directly to the surface area and thickness of the lipid membrane. Plateau-Gibbs 
border suction and van der Waals attractions contributed to the spontaneous 
thinning of the lipid film (Williams, 1994). The spontaneous thinning of the lipid into 
a bilayer was characterised by an increased surface area that was observed by 
increased membrane capacitance, which was visualised on the oscilloscope 
depicted in figure 2.9.  
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Figure 2.9. Bilayer formation. Spontaneous thinning of lipid to form a bilayer, 
represented by an increase in membrane capacitance. The ‘CAP TEST’ function 
depicts the blue trace representing membrane capacitance in the oscilloscope 
window. Scale bar; 2 s/div and 50 pA/div.  
 
Using the Warner Instruments BLM set up and a styrene cup (200 µm aperture), 
bilayer formation was confirmed when membrane capacitance ranged from 160-220 
pF. High membrane capacitance (> 220 pF) corresponded to a bilayer with a large 
surface area that was fragile and prone to breaking, furthermore these membranes 
had a higher probability of multiple channel incorporations. Conversely, low 
membrane capacitance (< 160 pF) reduced the overall probability of channel 
incorporation. Thus, membranes with values outside of the preferred capacitance 
range were terminated to enhance experimental efficiency. 
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2.2.4.2.4 Bilayer integrity 
 
The success of a single-channel experiment was solely dependent on the stability 
and integrity of the bilayer. With experiments lasting up to one hour, forming a 
stable lipid membrane was essential for the long-term psychological and mental 
health of the user.  
 
 “Planar bilayers can be incredibly frustrating. All of us who have worked with them 
have, at one time or another, been reduced to irrational acts of anger.” 
 
Stephen H. White (Miller, 1986)  
 
Following bilayer formation (membrane capacitance 160-220 pF) a holding potential 
of ± 100 mV was applied to challenge the membrane. At high voltages the bilayers 
stability and integrity was assessed. The incorporation of ‘junk’, detailed in section 
2.2.4.3, or ‘leaky’ membranes were characterised by altered deflections in current 
baseline during membrane potential oscillation. A stable baseline ensured that a 
suitable bilayer was formed, establishing the foundation of a single-channel 
experiment.  
 
2.2.4.3 RyR2 channel incorporation 
 
Conditions were established to favour micelle fusion. An osmotic gradient was 
created between the cis and trans chambers by the addition of a 3 M KCl solution (2 
x 100 µL) into the cis chamber. The 500 µL volume of the chamber was maintained 
by removing 2 x 100 µL following each subsequent salt addition. Once the osmotic 
gradient was established, purified recombinant hRyR2 protein preparation, typically 
1-2 µL from fraction # 5, was added into the cis chamber. The cis solution and 
protein preparation were stirred, to facilitate micelle fusion, until a single channel 
was incorporated indicated by large fluctuations in current amplitude representative 
of channel gating depicted on the oscilloscope, illustrated in figure 2.10.  
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Figure 2.10. The incorporation of a single hRyR2 channel into a lipid bilayer. 
The oscilloscope depicts the inherent noise generated by stirring. RyR2 channel 
incorporation was indicated by large ~ 30 pA fluctuations from baseline (highlighted 
by the black arrow) with clear channel gating events observed when the stirrer was 
switched off (highlighted by the red arrow). The ‘Im’ function displays the current 
across the bilayer depicted by the blue trace in the oscilloscope window. Scale bar; 
500 ms/div and 20 pA/div.  
 
On occasion, damaged proteins from the purification process or unknown foreign 
objects, termed ‘junk’, incorporated into the bilayer, depicted in figure 2.11. All 
experiments with ‘junk’ were terminated by breaking the bilayer and starting again, 
repeating the bilayer procedure from section 2.2.4.2. 
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(A) 
 
(B) 
 
 
Figure 2.11. Incorporation of ‘junk’ into the bilayer. (A) Combination of junk and 
hRyR2 channel incorporated into the bilayer. (B) Junk represented by drastic 
spontaneous fluctuations in current flowing through the bilayer. Both (A) and (B) 
experiments resulted in bilayer termination.  
 
 
 
 
 
 
 
73 
 
2.2.4.4 RyR2 channel orientation 
 
An important consideration of channel incorporation was the orientation of RyR2. 
Due to the structural asymmetry of the RyR2 molecule shown in figure 1.6, it is 
physically improbable that the large hydrophilic, cytoplasmic domain would cross 
the membrane in preference to insertion of the relatively smaller, hydrophobic, TM 
domain into the membrane. Therefore, channel incorporation into the planar bilayer 
is in a fixed orientation (Bannister et al., 2015). When the purified hRyR2 protein is 
added to the cis compartment, the cytoplasmic side faces the cis chamber while the 
luminal side faces the trans chamber, as shown in figure 2.7. Evidence for RyR2 
orientation within the bilayer has been established through cytosolic (cis) RyR2 
activation and that interaction of blocking molecules with RyR2, such as, but not 
limited to, ryanodine, flecainide and large tetraalkylammonium (TAA) cations that 
are side-specific (Lindsay et al., 1991; Tinker and Williams, 1993a; Tinker and 
Williams, 1993b; Mason et al., 2012; Mukherjee et al., 2012; Bannister et al., 2015).  
 
2.2.4.5 Chamber Perfusion 
 
Upon channel incorporation, the cis chamber was immediately perfused using a 
dual perfusing manipulator, figure 2.12, set at a rate of 2.5 mL/min for 2 min. 
Perfusion ensured that the cis chamber solution was replaced 10 times (5000 µL 
exchange) with the experimental salt solution. Chamber perfusion ensured that the 
osmotic gradient and protein suspension was removed preventing further channel 
incorporation.  
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Figure 2.12. Dual perfusion manipulator. An input and output tube, set at different 
levels, was lowered to a specific point within the chamber. The addition of 
experimental salt solution occurred through the input while instantaneously excess 
‘waste’ was removed from the output ensuring constant chamber volume. A 
magnet, indicated by a red rectangle, was placed over the reed switch to isolate the 
bilayer from the circuit.  
 
2.2.4.6 Single-channel Experiments  
 
Following successful channel perfusion, a range of experiments were completed 
detailed in chapters 5 and 6. All experiments were completed at room temperature, 
20 ± 2 ˚C. 
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Construction and Expression of Selectivity Filter and Pore Helix mutant 
human RyR2 (hRyR2) channels 
 
Chapter Three – Aims  
 
A mechanism of hRyR2 gating is proposed to arise from interactions between the 
selectivity filter and pore helix, controlled by a potential hydrogen-bonding network. 
Before exploring molecular mechanisms occurring at the selectivity filter of hRyR2, 
structural components formed by residue interactions predicted to be important in 
channel gating were altered. This chapter describes molecular DNA mutagenesis 
and cellular biology techniques used to construct and express the proposed single-
point hRyR2 mutations. The aims of this chapter were as follows: 
 
 To construct six full-length hRyR2 mutants by site-directed mutagenesis 
(SDM) using a cassette based method detailed in section 3.2.1. 
  
 To generate three alanine hRyR2 cDNAs, Y4813A, D4829A and Y4839A, to 
disrupt a proposed hydrogen-bonding network that is hypothesised to 
stabilise the selectivity filter during channel gating.  
 
 To construct three conservative hRyR2 mutants, Y4813W, D4829E and 
Y4839W, to introduce residues with similar physicochemical properties that 
have the potential of forming a hydrogen-bonding network.   
 
 To transfect the six mutant hRyR2 constructs in human embryonic kidney 
(HEK) 293 cells to ensure that the introduced missense point mutation did 
not affect protein expression.  
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3.1 - Introduction  
 
3.1.1 A cassette-based strategy for constructing mutant hRyR2 channels – 
Site-directed mutagenesis 
 
The manipulation of genetic code, i.e. targeting particular alterations such as 
mutation, insertion or deletion within DNA sequences has considerably improved, 
attributed to advances in molecular biology techniques. For example, site-directed 
mutagenesis (SDM), an in vitro procedure, is a common tool utilised to introduce 
point mutations within DNA templates in order to express desired mutant proteins 
for structure-function relationships, protein-protein interactions and binding domains 
of protein/active sites of enzymes for the last three decades (Carrigan et al., 2011). 
 
The full-length pcDNA3-eGFP-hRyR2 plasmid is approximately 21 kb, depicted in 
figure 3.2, however is unsuitable for polymerase chain reaction (PCR) amplification 
due to stochastic effects such as premature termination of DNA polymerase 
affecting product yield and efficiency of PCR. To overcome this challenge, George 
et al and Thomas et al constructed five hRyR2 DNA fragments spanning the entire 
length of the DNA sequence (George et al., 2003; Thomas et al., 2004). These DNA 
fragments were cloned into intermediate vectors, pSL1180 (Amersham Biosciences, 
UK), ultimately decreasing the base pair (bp) length of the new plasmid, enabling 
PCR amplification of the chosen region. These mutagenic cassettes have simplified 
and permitted the generation of point mutations along the hRyR2 sequence for 
structural and functional studies (George et al., 2003; Thomas et al., 2004). 
 
3.1.2 Alteration of hRyR2 residues to test a proposed hydrogen-bonding 
network  
 
The lack of detailed structural hRyR2 information, prompted the generation of the 
PFR hRyR2 analogy model based on KcsA (Welch et al., 2004), whereby known 
gating mechanisms in KcsA (and other K+ channels) can be used to test and refine 
the model. Comparing residues in KcsA involved in a network with those present at 
similar positions in the hRyR2 PFR model highlights the potential for a similar 
mechanism, as discussed in chapter 1.6. Residue D4829 in hRyR2 occupies an 
equivalent position in the selectivity filter signature sequence to D80 in KcsA and is 
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located at an ideal position to form hydrogen bonds with Y4839 and Y4813 
analogous to W67 and E71 in KcsA, respectively. In further support, the Welch et al 
PFR hRyR2 analogy model indicates distances between Y4813-D4829 of ~ 2.5 and 
Y4839-D4829 of ~ 3.7 Å, illustrated in figure 3.1B, which are within the ideal range 
for hydrogen bond formation (Welch et al., 2004; Hubbard and Haider, 2010).  
 
(A)      (B) 
                      
 
Figure 3.1. Measuring the distances of residues in the analogy PFR RyR2 
model. Structure of the Welch et al PFR RyR2 analogy model (Welch et al., 2004), 
highlighted residues are colour coded; Y4813 (blue), D4829 (red) and Y4839 
(green). (A) Two monomers of the PFR shown for clarity. (B) Labelled distances 
(Ångström) were measured and constructed in PyMol, one monomer is shown for 
clarity.  
 
3.1.3 Amino acid selection - Alanine mutations  
 
To test the hypothesis it was important to select amino acids which would abolish 
any potential hydrogen-bonding interactions between the selectivity filter and pore 
helix. Alanine mutations have historically been a popular choice, offering a non-
bulky, no charge, chemically inert, methyl side chain (Morrison and Weiss, 2001). In 
addition, alanine residues form alpha helices to preserve secondary structure and 
for these reasons, alanine substitution was selected for all three residues listed in 
table 3.1.  
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Tyrosine residues are key in providing structural stability in proteins (Hamill et al., 
2000), therefore removing a hydrogen-bonding component by alanine substitution is 
proposed to disrupt local interactions and alter a stabilising conformation of the 
selectivity filter that is hypothesised to affect hRyR2 channel gating.  
 
3.1.4 Amino acid selection - Conservative mutations  
 
To thoroughly examine channel gating around the proposed selectivity filter region, 
three conservative mutations at identical positions were constructed, serving as 
positive controls. Amino acid selection was essential; the chosen residue (side 
chain) would require aromatic characteristics and physicochemical properties 
similar to WT to retain hydrogen-bonding interactions. 
 
Tyrosine, with an aromatic phenol side group at Y4813 and Y4839 was substituted 
by tryptophan. Tryptophan, an aromatic heterocyclic organic compound contains an 
indole functional group capable of hydrogen-bonding (Cordero-Morales et al., 
2011), generating ideal conservative substitutions (Y4813W and Y4839W). The 
aspartic acid at position D4829, a hydrogen-bonding acceptor, was substituted by 
glutamic acid (D4829E). Selection of glutamic acid was consistent with the 
properties of aspartic acid, extending the side chain by one methyl group however 
retaining the negative charge, acid carboxyl group.  
 
This study focused on constructing six full-length mutant hRyR2 to investigate the 
role of a proposed hydrogen-bonding network between the selectivity filter and pore 
helix in hRyR2. The construction and expression of all hRyR2 mutants permitted 
cellular and electrophysiological characterisation to assess the involvement of 
residue substitution on channel gating as discussed in chapters 4, 5, 6 and 7. 
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3.2 – Materials and Methods 
 
3.2.1 Generation of mutant pSL1180-NX1-hRyR2 plasmids 
 
The SDM method was adopted to construct the point mutations listed in table 3.1. 
The hRyR2 residues Y4813, D4829 and Y4839 are located in the C-terminal of 
hRyR2, spanning the TM domain. The pSL1180 vector containing the cloned 
NheI/XhoI C-terminus DNA fragment, figure 3.2, was utilised for the generation of all 
six full-length mutant pcDNA3-eGFP-hRyR2 cDNA constructs. Unlike the NheI site, 
the XhoI site is not part of the coding sequence of hRyR2 and is found in the three 
prime untranslated region (3’-UTR), therefore an XhoI digestion preserves the 
native stop codon of hRyR2. The pSL1180-NX1-hRyR2 mutagenic cassette, 8597 
bp, was a suitable length for PCR amplification. Prior to SDM, 2 µL WT NX1 DNA 
was transformed into MAX Efficiency® Stbl2™ competent cells, as described in 
chapter 2.2.1.2, to produce 30 µL template DNA for cloning.  
 
The WT pSL1180-NX1-hRyR2 plasmid was constructed by George et al., (2003), 
and was made available by Professor Alan Williams’ lab.  
 
 
hRyR2 residue  Amino acid Substitution Codon change 
Y4813 
Alanine (A) TAT  GCT 
Tryptophan (W) TAT  TGG 
D4829 
Alanine (A) GAT  GCT 
Glutamic acid (E)  GAT  GAG 
Y4839 
Alanine (A) TAT  GCT 
Tryptophan (W) TAT  TGG 
 
Table 3.1. Full-length selectivity filter (D4829) and pore helix (Y4813 and 
Y4839) hRyR2 point mutations.  
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(A) 
 
 
 
 
(B) 
 
 
 
 
 
Figure 3.2. Schematic representation of the pcDNA3-eGFP-hRyR2 and 
pSL1180-NX1-hRyR2 vectors. (A) The pcDNA3 vector containing the N-terminal 
eGFP tag (green) and the hRyR2 sequence (grey) including the NheI and XhoI 
(NX1) DNA sequence (red), encoding the C-terminus pore-forming region. (B) The 
intermediate pSL1180 vector containing the NX1-hRyR2 DNA sequence highlighted 
in red was used for site-directed mutagenesis. The restriction endonuclease 
recognition sites for NheI, FseI and XhoI are shown. The sequence encoding the 
pcDNA3 (5.446 kb) and pSL1180 (3.422 kb) vectors are shaded in black.  
 
3.2.1.1 Primer design 
 
The design of oligonucleotide primers containing a codon substitution and reagents 
including a DNA polymerase, listed in table 3.3, has enabled the introduction of 
nucleotide substitution within DNA sequences using PCR amplification. Several 
factors must be considered when designing primers for SDM. To increase efficiency 
of mutagenesis the primers should follow certain characteristics: The mutagenic 
forward and reverse oligonucleotide primers must contain the desired codon 
substitution, preferably at the centre of the 20-45 nucleotide bases. It is important 
that primers contain 40-60 % guanine and cytosine (GC) to ensure high melting 
temperatures (Tm), ideally Tm > 78 °C for efficient annealing and elongation. It is also 
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essential that they anneal to their complementary sequence on opposite strands of 
the template and to avoid any possible secondary priming sites. In addition, 
avoiding primer self-complementarities and direct repeats ensures that primer 
dimerisation and hairpin formation was prevented (Hyndman and Mitsuhashi, 2003). 
These guidelines were applied when designing the six hRyR2 mutant primers listed 
in table 3.2. 
 
Mutation 
Direction  
Primer nucleotide sequence  
Length 
(bp) 
GC 
% 
Tm 
°C 5' - 3'  
Y4813A 
Forward CGATATGCTAACATGCGCTATGTTCCACATGTATGTTGG 
 39 43.6 79 
Reverse  CCAACATACATGTGGAACATAGCGCATGTTAGCATATCG 
            
Y4813W 
Forward CGATATGCTAACATGCTGGATGTTCCACATGTATGTTGG 
 39 43.6 79.3 
Reverse  CCAACATACATGTGGAACATCCAGCATGTTAGCATATCG 
            
D4829A 
Forward GGAGGAGGGATCGGGGCTGAAATCGAAGACCCAGC 
35 62.9 85.8 
Reverse  GCTGGGTCTTCGATTTCAGCCCCGATCCCTCCTCC 
            
D4829E 
Forward GGAGGAGGGATCGGGGAGGAAATCGAAGACCCAGC 
35 62.9 85.2 
Reverse  GCTGGGTCTTCGATTTCCTCCCCGATCCCTCCTCC 
            
Y4839A 
Forward CCAGCAGGAGATGAAGCTGAGATCTATCGAATCATC 
36 47.2 77.6 
Reverse  GATGATTCGATAGATCTCAGCTTCATCTCCTGCTGG 
            
Y4839W 
Forward CCCAGCAGGAGATGAATGGGAGATCTATCGAATC 
34 50 78.2 
Reverse  GATTCGATAGATCTCCCATTCATCTCCTGCTGGG 
 
Table 3.2. Mutagenic oligonucleotide forward and reverse primers designed 
for the generation of selectivity filter and pore helix mutants in hRyR2. 
‘Mutation’ codon substitutions are highlighted in red, ‘GCT’ alanine, ‘TGG’ 
tryptophan and ‘GAG’ glutamic acid. Table includes primer nucleotide base length, 
guanine and cytosine content percentage and melting temperature. The JustBio 
‘Oligocalc’ web-hosting software was used to calculate Tm, 
(http://www.justbio.com/index.php?page=oligocalc). 
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Three main thermal steps were performed with specific time and temperature, 
repeating in cycles, to ensure the amplification of desired synthesised DNA strands, 
listed in table 3.4 and depicted in figure 3.3. Optimisation of reagents, such as DNA 
polymerase, has enhanced proofreading and yield quality ensuring high-fidelity PCR 
amplification for SDM (Xia et al., 2014).  
 
 
 
Figure 3.3. Schematic representation of the QuikChange PCR procedure. 
Figure adapted from QuikChange XL SDM kit instruction manual (Agilent 
Technologies). 
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3.2.1.2 Site-directed Mutagenesis 
 
SDM PCR amplifications of pSL1180-NX1-hRyR2 were performed using a 
GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems). The reaction 
mixture stated in table 3.3 contains PfuTurbo DNA polymerase which is a mixture of 
Pfu DNA polymerase and a thermostable ArchaeMaxx polymerase-enhancing 
factor. In combination, PfuTurbo can amplify vector targets up to 15 kb in length, 
with increased proofreading activity providing a robust and enhanced high-fidelity 
PCR product (Cline et al., 1996). The thermal cycling protocol is listed in table 3.4. 
 
Reagent Volume Final Concentration 
Reaction buffer 5 µL 1 x 
dsDNA template* 1 µL 10 ng 
Forward Primer** 1 µL 125 ng 
Reverse Primer** 1 µL 125 ng 
dNTP mix (10 mM) 1 µL 0.2 mM 
QuikSolution 3 µL 1x 
dH2O 38 µL up to 50 µL 
PfuTurbo DNA Polymerase 1 µL 2.5 U 
 
Table 3.3. QuikChange XL PCR reagents. *dsDNA template is WT pSL1180-NX1-
hRyR2 plasmid. **Forward and reverse primers are listed in table 3.2. 
 
Step Cycles Temperature Time 
Initial Denaturation 1 95 °C 1 min 
Denaturation 
18 
95 °C 50 s 
Annealing 60 °C 50 s 
Elongation 68 °C 8 min (1 min/kb) 
Final Elongation 1 68 °C 7 min 
Hold 1 4 °C Indefinite  
 
Table 3.4. QuikChange XL site-directed mutagenesis PCR thermal cycle 
protocol. 
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3.2.1.3 DpnI Digest 
 
Following PCR, 1 µl of DpnI, a restriction endonuclease, was added to the reaction 
product and incubated at 37 °C for 1 h. DpnI digests methylated ‘parental’ DNA, 
leaving the non-methylated, newly synthesised, mutant plasmid DNA. The single-
stranded DNA was subsequently transformed into XL10-Gold Ultracompetent cells 
to generate the double-stranded plasmid as described in section 2.2.1.2.  
 
3.2.1.4 DNA Sequencing  
 
The BigDye Terminator v3.1 Cycle sequencing kit (Applied Biosystems) provides a 
method of performing fluorescence-based cycle sequencing on DNA templates to 
verify nucleotide sequence, confirming that SDM codon substitution had been 
completed. The SDM reaction was prepared according to table 3.5 and tubes were 
placed in the cycle sequencing ABI Veriti 96 well thermal cycler set to BigDye 
standard program, listed in table 3.6. 
 
Reagent Quantity 
Better Base (Microzone Ltd) 5 µl 
ABI BigDye terminator Ready Reaction mix 1 µl 
Mutant template 150-300 ng 
Primer* 3.2 pmol 
dH2O to 15 µl 
 
Table 3.5. BigDye Terminator v3.1 reagents. Sequencing reaction primers 
flanking boundary sites are stated in section 3.3.2. *Primers stated in section 3.3.2. 
 
Step Cycle Temperature Time 
Initial Denaturation 1 96 °C 1 min 
Denaturation 
25 
96 °C 10 s 
Annealing 50 °C 5 s 
Elongation 60 °C 4 min 
Hold 1 4 °C Indefinite 
 
Table 3.6. BigDye Terminator PCR sequencing thermal cycling protocol. 
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Unincorporated dye terminators, enzymes and salts were removed from the 
reaction using the DyeEx 2.0 spin kit (Qiagen). This ensured that sequencing 
products were eluted in distilled deionised water free from nuclease and ready for 
DNA sequencing. DNA samples were sequenced using an ABI Prism Genetic 
Analyser 3130xl sequencer. Confirmation of mutant hRyR2 constructs were 
analysed by importing sequencing data from Four Peaks 
(http://nucleobytes.com/index.php/4peaks), a visual sequencing software, to 
generate chromotagrams. Nucleotide sequences were then exported into JustBio 
aligner web-hosted software (http://www.justbio.com/index.php?page=aligner) to 
compare WT and mutant hRyR2 sequences. The intermediate mutant pSL1180-
NX1-hRyR2 constructs were further verified by gel agarose electrophoresis using 
EcoRI to digest 1 µg of plasmid DNA, shown in figure 3.5A.  
 
3.2.1.5 DNA cloning of mutant hRyR2 fragments into WT pcDNA3 vector  
 
WT pcDNA3-eGFP-hRyR2 and mutant pSL1180-NX1-hRyR2 plasmids (1 µg) were 
digested for 2 h at 37 °C as listed in table 3.7. Following digestion, samples were 
electrophoresed in a 1 % agarose gel for 1.5 h to allow for maximum DNA band 
separation.  
 
  
Vector Insert  
WT pcDNA3-eGFP-hRyR2  Mutant NX1 cassette  
cDNA 2 µL 10 µL 
XhoI (10 U) 0.5 µL 0.5 µL 
FseI (3 U) 1.5 µL 1.5 µL 
BSA (10 x) 2 µL 2 µL 
Buffer 4 (10 x) 2 µL 2 µL 
dH2O 12 µL 4 µL 
 
Table 3.7. Cloning of full-length pcDNA3-eGFP-hRyR2 vector and mutant 
pSL1180-NX1-hRyR2 insert. Reagents used for restriction endonuclease digest of 
vector and insert.  
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3.2.1.6 Gel Extraction  
 
The QIAEX II® Gel Extraction Kit (QIAGEN) was used to excise DNA fragments 
from the agarose gel following digestion. Two 1.5 mL Eppendorf tubes were 
weighed and a water bath was pre-heated to 50 °C. The correct DNA fragments 
were extracted from the agarose gel using a clean, sharp scalpel, illustrated in 
figure 3.8. The DNA gel slice from pcDNA3-eGFP-hRyR2 and pSL1180-NX1-
hRyR2 were weighed in separate tubes. The weight of the DNA gel fragment 
determined the volume of Buffer QX1 (3 x w/v), and dH2O (2 x w/v) including 30 µl 
QIAEXII suspension silica particles. Tubes were incubated at 50 °C for 10 min to 
solubilse the agarose gel with gentle inversion every 2 min to assist agarose 
solubilisation and binding of DNA to the QIAEXII silica particles. Samples were 
centrifuged at 17,900 x g for 30 s, the supernatant was carefully discarded and the 
DNA-QIAEXII pellet was washed by resuspending in 500 µL Buffer QX1. 
Centrifugation was repeated, the supernatant was discarded and samples were 
resuspended in 500 µL Buffer PE. The supernatant was carefully discarded 
following another centrifugation step where the pellet was air-dried for 30 min until 
the DNA-QIAEXII pellet became white. The DNA was eluted by resuspending the 
pellet in 20 µL dH2O, incubating for 5 min at 50 °C and then centrifuging for 30 s to 
separate the DNA from the QIAEXII beads. The purified sample was transferred to 
a fresh tube. 
 
3.2.1.7 Ligation of mutant hRyR2 fragments into the WT pcDNA3 vector  
 
The DNA nanodrop Nanovue Plus (GE Lifesciences) was used to determine DNA 
concentration following gel extraction prior to ligation of the purified NX1 fragment 
and vector DNA. The ligation reaction was set up at a vector:insert ratio of 1 : 3 as 
stated in table 3.8. The T4 DNA ligase (Roche) was added to catalyse the formation 
of phosphodiester bonds between 3’hydroxyl and 5’-phosphate ends of double-
stranded DNA, joining mutant pSL1180-NX1 insert and pcDNA3-hRyR2 vector 
‘sticky’-end DNA fragments together. Reagents were incubated for 16-18 h 
overnight at 4 °C, allowing for the T4 ligase to join boundary sites to form full length 
mutant pcDNA3-eGFP-hRyR2 constructs.  
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Reagents Quantity  
Vector 50 ng 
Insert 33 ng 
Buffer 2 2 µL 
dH2O up to 35 µL  
Buffer 1 15 µL 
T4 Ligase 1.5 µL 
 
Table 3.8. Ligation of full-length mutant hRyR2 mutations using T4 ligase.  
 
3.2.2 Verification of full-length mutant pcDNA3-eGFP-hRyR2 constructs 
 
Following the overnight incubation, 10 µL of the ligation reaction was transformed 
into XL10-Gold Ultracompetent cells as described in chapter 2.2.1.3. Propagation of 
mutant full-length pcDNA3-eGFP-hRyR2 constructs was carried out as stated in 
chapter 2.2.1.4, to generate 30 µL of purified DNA. Full-length constructs were 
verified by gel agarose electrophoresis using a complement of four restriction 
endonucleases listed in table 3.10 and illustrated in figure 3.4. Restriction digest 
reactions were set up as stated in table 3.9 and incubated for 1.5 h at 37 °C. 10 µL 
of digest reaction was mixed with 10 µL sample buffer and loaded onto a 1 % 
agarose gel, and was electrophoresed for 30-40 min. The hRyR2 DNA fragments 
following restriction digest are shown in figure 3.5. 
 
Reagents Volume 
DNA (1-2 μg) 5 µL 
dH2O 2 µL 
Buffer 1 µL 
BSA (10x) 1 µL 
Enzyme (5-10 U) 1 µL 
 
Table 3.9. Restriction digest reaction of full-length WT or mutant pcDNA3-
eGFP-hRyR2. Restriction enzymes are listed in table 3.10 and hRyR2 DNA 
fragments following digestion are illustrated in figure 3.5. 
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Enzyme Specificity Cuts 
pcDNA3-eGFP-hRyR2  
BamHI G●GATC●C 5 
BglII A●GATC●T 8 
HindIII A●AGCT●T 3 
EcoRI G●AATT●C 5 
pSL1180-NX1-hRyR2 
EcoRI G●AATT●C 2 
 
Table 3.10. Restriction endonuclease recognition sites used for construct 
verification for full-length pcDNA3-eGFP-hRyR2 and intermediate pSL1180-
NX1-hRyR2 vectors.  
 
 
Figure 3.4. A circular sequence vector map of full-length pcDNA3-eGFP-
hRyR2. Restriction endonucleases used (A) BamHI, (B) BglII, (C) HindIII and (D) 
EcoRI. Figure obtained from New England BioLabs 
(http://tools.neb.com/NEBcutter2). 
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(A)  (B)    (C) 
 
 
Figure 3.5. A template of hRyR2 DNA fragments following restriction digest. A 
representation of DNA fragments from (A) pSL1180-NX1-hRyR2 and (B) pcDNA3-
eGFP-hRyR2 on a 1 % agarose gel (electrophoresed for 30 min), following 
restriction digest. (C) Restriction enzymes, plasmid coordinate sites and DNA 
fragment length (bp) are stated. pcDNA3- eGFP-hRyR2 DNA fragments digested by 
BglII, 2632 bp, 2610 bp and 2573 bp, and also 1905 bp and 1873 bp were not 
resolved on the agarose gel and migrated as a single band, respectively. The DNA 
fragments were created using NEBcutter V2.0 (http://tools.neb.com/NEBcutter2). 
 
3.2.3 Propagation of WT and Mutant hRyR2 DNA 
 
Following full-length mutant pcDNA3-eGFP-hRyR2 DNA sequencing and 
verification, transformed MAX Efficiency® Stbl2™ cells were propagated containing 
mutant DNA as outlined in chapter 2.2.1.4. Mutant constructs were isolated from 
Stbl2 cells by MAXIprep as described chapter 2.2.1.6 and were verified by 
restriction digest mapping using the enzymes described in section 3.2.2. DNA was 
used for mammalian HEK293 cell transfection and protein expression.  
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3.2.4 Protein expression of WT and Mutant hRyR2  
 
The calcium-phosphate (CaPO4) precipitant transfection method was used to 
transiently introduce WT and mutant pcDNA3-eGFP-hRyR2 constructs into 
mammalian HEK293 cells, as described in chapter 2.2.2.3. An optimisation trial of 
WT and mutant protein expression was completed by supplementing the cDMEM 
media with 2 mM sodium butyrate (NaB). While the exact mechanism of increased 
hRyR2 expression by NaB remains unknown, NaB is an inhibitor of histone 
deacetylation, and possibly increases gene transcription by enhancing gene 
accessibility to transcription factors (Jiang and Sharfstein, 2008). Previous studies 
have used NaB to improve expression levels of ion channels including voltage 
gated Na+ channels (Baines et al., 1992), inward rectifier K+ channels (Panama et 
al., 2007) and the cystic fibrosis transmembrane regulator (CFTR) Cl- channel 
(Gerçeker et al., 2000). In addition, a study assessed the proposed transcriptional 
upregulatory properties of NaB for hRyR2 expression and reported that the effect of 
NaB was both time and concentration dependent (Guzadhur, 2009). The 
optimisation trial by Guzadhur identified that using 2-5 mM NaB and harvesting cells 
24-48 h post-transfection was optimal for hRyR2 protein expression, and was 
therefore employed in this thesis. Subsequently, RyR2 protein expression was 
quantified by Western blot as outlined in sections 2.2.3.5 and 2.2.3.6.    
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3.3 – Results 
 
3.3.1 Production of selectivity filter and pore helix mutant hRyR2 plasmids  
 
Full length, eGFP tagged, hRyR2 cDNA was modified to incorporate the desired 
selectivity filter and pore helix mutations using Quikchange® XL SDM kit. Primers 
were designed to incorporate the correct codon missense mutation (alanine (GCT), 
tryptophan (TGG), glutamic acid (GAG)) following primer guidelines discussed in 
section 3.2.1.1 and listed in tables 3.1 and 3.2. The PCR protocol stated in section 
3.2.1 (tables 3.3 and 3.4) was used to perform SDM on the pSL1180-NX1-hRyR2 
template at the desired nucleotide position. Following PCR DpnI digestion, newly 
synthesised mutant DNA was transformed into XL-10 competent cells and 
propagated to yield 30 µL mutant DNA. The mutant pSL1180-NX1-hRyR2 plasmid 
was initially verified by DNA digest using EcoRI. The DNA fragments, depicted in 
figure 3.6, were in accordance to the predicted DNA patterns shown in figure 3.5.   
 
                       M        1         2        3         4         5 
 
 
Figure 3.6. Representative mutant pSL1180-NX1-hRyR2 plasmid digested with 
EcoRI, lanes 1-5. (M) 1 kB DNA ladder. DNA fragments were in accordance with 
the predicted DNA patterns shown in figure 3.5A.  
 
Utilising the BigDye terminator protocol described in section 3.2.1.4, mutant 
pSL1180-NX1-hRyR2 DNA was sequenced using the SPFOR 14357-79 (3.2 pmol) 
oligonucleotide primer targeted to the site of mutation. All six intermediate NX1-
hRyR2 plasmids successfully contained the desired point mutation, as indicated by 
the chromatograms in figure 3.7, highlighting the codon substitution to either alanine 
(GCT), tryptophan (TGG) or glutamic acid (GAG).  
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(A)    (B)    (C) 
 
 
(D)    (E)    (F) 
 
 
Figure 3.7. Mutant pSL1180-NX1-hRyR2 chromatograms. (A) Y4813A, (B) 
D4829A, (C) Y4839A, (D) Y4813W, (E) D4829E and (F) Y4839W. DNA sequencing 
was successful, desired point mutations to alanine (GCT), tryptophan (TGG) or 
glutamic acid (GAG) were verified, highlighting codon substitution in blue. 
 
3.3.1.1 Ligation of mutant hRyR2 fragments into WT pcDNA3 vector  
 
Full-length hRyR2 mutants were created by reinserting mutant NX1 DNA cassettes 
into full-length vector using XhoI and FseI restriction enzymes, outlined in section 
3.2.1.5. Full-length WT pcDNA3-eGFP-hRyR2 vector and mutant NX1-hRyR2 insert 
were digested using reagents listed in table 3.7. The double digest was 
electrophoresed for > 2 h to ensure maximum DNA fragment separation for DNA 
cloning, shown in figure 3.8.   
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                 1                                2                              M 
 
 
Figure 3.8. Restriction digest of full-length pcDNA3-hRyR2 vector (1) and 
mutant pSL1180-NX1 insert (2). (M) 1 kb Plus DNA ladder. DNA-gel fragments 
(red boxes) were excised under UV light using a clean, sharp scalpel and purified 
using the QIAEXII as described in sections 3.2.1.5 and 3.2.1.6. 
 
3.3.2 Verification of full-length mutant pcDNA3-eGFP-hRyR2 constructs 
 
Mutant NX1-hRyR2 insert and WT pcDNA3-eGFP-hRyR2 vector were ligated using 
the protocol listed in table 3.8. Transformed MAX Efficiency ® Stbl2™ cells 
containing mutant pcDNA3-hRyR2 constructs were propagated, yielding 200-800 
ng/µl DNA. Full-length hRyR2 constructs were verified by gel agarose 
electrophoresis using the restriction endonucleases listed in table 3.10. WT hRyR2 
(figure 3.9) and the six full-length digested mutant hRyR2 DNA fragments (figure 
3.10 A-E) were correct and in accordance to the predicted DNA patterns shown in 
figure 3.5B when electrophoresed for 30-45 min on a 1 % agarose gel. Mutant 
constructs were finalised by verifying ligation boundary sites using automated 
sequencing, described in section 3.2.1.4, using primers SPREV 11923-42 (FseI 
recognition region), BF 14622-640 (XhoI recognition region) and SPFOR 14357-79 
(mutation recognition region). However, in the absence of sequencing the entire 
reading frame, it was not possible to be entirely certain that the only sequence 
alteration in the hRyR2 plasmid was the intended point mutation.   
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                                       M        1        2        3         4  
 
 
Figure 3.9. DNA digest mapping of full-length WT hRyR2 DNA. Restriction 
endonucleases (1) BamHI, (2) BglII, (3) HinDIII and (4) EcoRI. (M) 1 kB DNA ladder. 
WT hRyR2 DNA fragments were in accordance to the predicted DNA patterns 
shown in figure 3.5B. 
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Figure 3.10. Verification of ligated full-length mutant pcDNA3-eGFP-hRyR2 
constructs. DNA digest mapping of (A) Y4813A, (B) Y4813W, (C) D4829A, (D) 
D4829E, (E) Y4839A and (F) Y4839W using restriction endonucleases (1) BamHI, 
(2) BglII, (3) HinDIII and (4) EcoRI. (M) 1 kB DNA ladder. Mutant DNA fragments 
were in accordance to the predicted DNA patterns shown in figure 3.5B. 
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3.3.3 Heterologous expression of WT and mutant hRyR2 plasmids – eGFP 
imaging  
 
To achieve appropriate levels of hRyR2 protein expression for downstream assays 
([3H] ryanodine binding (chapter 4) and single-channel experiments (chapters 5 and 
6)), the transfection of both WT and mutant hRyR2 DNA into mammalian HEK293 
cells was optimised by the addition of 2 mM NaB, as described in chapter 2.2.2.3. 
Figure 3.11 depicts the increase in WT hRyR2 protein expression indicated by 
enhanced ‘green’ fluorescent cells following the addition of 2 mM NaB compared to 
control (figure 3.11A).  
 
eGFP imaging 48 h post-transfection indicated that all six full-length mutant 
pcDNA3-eGFP-hRyR2 constructs were able to express hRyR2 protein verified by 
green fluorescent HEK293 cells. Transfection efficiencies of the six mutant hRyR2 
constructs were comparable to WT hRyR2 shown in figures 3.11B, 3.12 and 3.13.  
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(A) 
      
 
(B) 
      
 
Figure 3.11. WT hRyR2 transfection trial using sodium butyrate. (A) 
Representative control field of view (FOV) without the addition of 2 mM NaB. (B) 
Representative FOV with the addition of 2 mM NaB. (left) eGFP imaging FOV 
visualised using a xenon light source (peak excitation ~ 488 nm), and a 520 ± 28 
nm band pass filter, outlined in section 2.2.2.4. The green fluorescent cells indicated 
hRyR2 protein expression. (right) Bright field imaging displays the total cell density. 
Scale: 10 x objective magnification.  
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(A) 
   
(B)      
   
(C)      
   
 
Figure 3.12. Transfection of alanine hRyR2 mutation constructs into HEK293 
cells. (A) Y4813A, (B) D4829A and (C) Y4839A. (left) eGFP imaging of HEK293 
cells outlined in section 2.2.2.4. The green fluorescent cells confirmed hRyR2 
protein expression. Transfection media was supplemented with 2 mM NaB 24 h 
post-transfection. (right) A bright field light source applied to the same FOV displays 
the total cell density. Scale: 10 x objective magnification.  
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(B)      
   
(C)      
    
 
Figure 3.13. Transfection of conservative hRyR2 mutation constructs into 
HEK293 cells. (A) Y4813W, (B) D4829E and (C) Y4839W. (left) eGFP imaging of 
HEK293 cells outlined in section 2.2.2.4. The green fluorescent cells confirmed 
hRyR2 protein expression. Transfection media was supplemented with 2 mM NaB 
24 h post-transfection. (right) A bright field light source applied to the same FOV 
displays the total cell density. Scale: 10 x objective magnification. 
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3.3.4 Quantification of WT and Mutant hRyR2 protein expression  
 
Quantification of WT and mutant hRyR2 protein expression was achieved by 
Western blot densitometry analysis, described in chapter 2.2.3.6. Following 
microBCA protein assay, 100 µg of mixed-membrane preparations, containing 
hRyR2 protein, were loaded onto SDS-PAGE gels and subsequently verified by 
Western blot, shown in figure 3.14. The distinctive upper band highlighted by a 
black arrow in figure 3.14A and B, represents the monomers of WT and mutant 
hRyR2 protein (~ 565 kDa) due to dissociation of the tetrameric protein by SDS-
PAGE. 
 
Figure 3.15A shows protein expression of hRyR2 channels from control 
experiments without the addition of 2 mM NaB. In contrast, figure 3.15B represents 
protein expression performed using a modified transfection protocol that included 2 
mM NaB 24 h post-transfection. Comparing figure 3.15A and B, the addition of NaB 
almost doubled protein expression of WT and mutant hRyR2 channels by 1.82 ± 0.2 
fold (n=5, p=0.0085), listed in table 3.11. In addition, mutant protein expression 
shown in lanes 2-5 in figure 3.15B were comparable to WT hRyR2 in lane 1, 
demonstrated by relative protein expression (compared to WT hRyR2) of D4829A 
0.84, Y4813A 0.82, Y4839A 1.1 and Y4839W 1.02. The two conservative hRyR2 
mutations, Y4813W and D4829E, were not used in the protein expression NaB trial. 
Their expression was subsequently verified by Western blot shown in figures 4.11 
and 4.12.   
 
 
 
 
 
 
 
 
 
 
 
 
102 
 
     (A)        1        2      3      4      5       6 
           
 
     (B)           1       2      3       4       5 
           
 
Figure 3.14. Western blot comparing protein expression of WT and mutant 
hRyR2 mixed-membrane preparations between control and the addition of 
sodium butyrate. Western blot of hRyR2-eGFP tagged channels, labelled on 
figure, from (A) control, without the addition of 2 mM NaB, except for lane 1, and (B) 
with the addition of 2 mM NaB. The hRyR2 monomers detected by eGFP-Ab, as 
outlined in chapter 2.2.3.4, are indicated by a black arrow. (M) The Kaleidoscope™ 
prestained markers of myosin, molecular weight (MW) of 216 kDa (top band), and 
β-galactosidase, MW of 132 kDa (lower band), are depicted by a black bar. 
Integrated densitometry analysis is shown in figure 3.15. 
 
 
M 
M 
1. WT (+ NaB) 
2. WT (- NaB) 
3. D4829A 
4. Y4813A 
5. Y4839A 
6. Y4839W 
1. WT (+ NaB) 
2. D4829A 
3. Y4813A 
4. Y4839A 
5. Y4839W 
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3.3.4.1 Western blot protein expression – Densitometry analysis  
 
(A)               1       2       3       4       5 
 
 
Lane ROI Area IntDen 
1 WT hRyR2 756 131.34 
2 D4829A 756 93.398 
3 Y4813A 756 97.086 
4 Y4839A 756 74.360 
5 Y4839W 756 64.016 
 
 
 
  (B)          1       2       3       4       5 
 
 
Lane ROI Area IntDen 
1 WT hRyR2 756 48.052 
2 D4829A 756 56.934 
3 Y4813A 756 58.512 
4 Y4839A 756 43.566 
5 Y4839W 756 46.716 
 
Figure 3.15. Integrated densitometry analysis to measure hRyR2 protein 
expression. Western blot of (A) control and (B) with the addition of 2 mM NaB. A 
lower integrated density value, determined by a darker area, indicated greater 
protein expression. A 1.82 fold increase in hRyR2 protein expression occurred with 
the addition of NaB listed in table 3.11. Densitometry was assessed as described in 
chapter 2.2.3.6.  
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Lane 
Control NaB Factor 
IntDen IntDen increase 
1 131.34 48.05 2.73 
2 93.40 56.93 1.64 
3 97.09 58.51 1.65 
4 74.36 43.57 1.70 
5 64.02 46.72 1.37 
Mean  ± SEM 1.82 ± 0.2 
 
Table 3.11. Comparing the difference in hRyR2 protein expression between 
control and addition of sodium butyrate using integrated density 
measurements. A low integrated density value represents a darker area. The 
addition of NaB increased hRyR2 protein expression by 1.82 ± 0.2 fold (p=0.0085, 
n=5). Integrated densitometry values are from figure 3.15. 
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3.4 – Discussion  
 
In order to understand processes of hRyR2 channel gating and how it is regulated 
during normal and pathogenic states, further information is required on structural 
mechanisms involved in conformational changes occurring at the proposed 
selectivity filter. Three residues located in the selectivity filter and pore helix of PFR 
hRyR2 are predicted to form a hydrogen-bonding network that form a defined 
structural element within the pore region acting to regulate channel gating 
analogous to known mechanisms occurring in K+ channels (Cuello et al., 2010a; 
McCoy and Nimigean, 2012). The development and introduction of subtle 
differences in chemical properties of amino acids are invaluable for pinpointing 
speciﬁc traits of side chain function, especially when detailed structural gating 
elements for hRyR2 remain unknown (Welch et al., 2004; Euden et al., 2013b; 
Ramachandran et al., 2013; Mei et al., 2015).  
 
The selection of residues for substitution at positions Y4813, D4829 and Y4839 
were carefully considered as every amino acid side chain has multiple chemical and 
physical attributes (valence, hydrophobicity, polarity, hydrogen bonding ability, and 
size), meaning that point mutation, in particular side chain exchange, would result in 
numerous chemical and steric alterations in the local protein environment (Pless 
and Ahern, 2013). The selection process discussed in sections 3.1.3 and 3.1.4 was 
employed to eliminate a proposed network of interactions by three alanine residues 
around the pore region. In addition, to comprehensively assess the importance of 
residue interaction on the stabilisation of the proposed selectivity filter, that is 
predicted to act as a defined structural element in hRyR2 channel gating (regulated 
by a network of interactions), three residues with particular side chain chemical and 
physical attributes (hydrogen-bonding properties) were selected. Tyrosine was 
replaced by tryptophan at positions Y4813W and Y4839W, and the conserved 
aspartic acid was replaced by a glutamic acid residue (D4829E) at the proposed 
selectivity filter. 
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3.4.1 Construction and Expression of mutant hRyR2 channels   
 
Construction of recombinant mutant hRyR2 cDNA was followed by verification of 
protein expression. It was necessary to assess whether the introduction of a 
missense point mutation altered protein expression. A reduced, or absence of, 
mutant hRyR2 expression would have deleterious consequences on downstream 
functional assays. It was confirmed that point mutations occurring within the 
proposed pore region did not alter protein expression when compared to WT 
hRyR2, shown in figure 3.14. The addition of NaB in this study augmented hRyR2 
protein expression, depicted in figure 3.15, supporting previous reports by 
Guzadhur, (2009). The use of NaB within the transfection protocol was therefore 
continued throughout future transfections. 
 
This chapter has described molecular and cellular biology techniques used to 
generate the hRyR2 mutations to test the proposed hypotheses outlined in chapter 
1.6. In summary, the successful construction and expression of all six hRyR2 
mutants permitted the continuation of the PhD project, whereby cellular and 
electrophysiological approaches were utilised to fully characterise the effect of point 
mutations on hRyR2 channel gating, discussed in chapters 4, 5, 6 and 7. 
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Chapter Four:  
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Functional Assessment of mutant Selectivity Filter and Pore Helix 
hRyR2 channels 
 
Chapter Four – Aims  
 
This chapter describes functional qualitative and quantitative assays that were used 
as an initial screen to examine the consequence of generating point mutations in 
the proposed selectivity filter and pore helix of hRyR2 on protein expression, 
tetrameric stability and function. The aims of this chapter were as follows: 
 
 To confirm the functional homotetrameric status of a population of mutant 
selectivity filter and pore helix hRyR2 channels in a cellular context utilising 
intracellular Ca2+ imaging.  
 
 To assess the activity of mutant hRyR2 channels by measuring equilibrium 
binding of [3H] ryanodine. 
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4.1 – Introduction 
 
4.1.1 Techniques to investigate mutant RyR2 functional status 
 
The emphasis of this study was to elucidate the consequence of constructing point 
mutations occurring in critical regions lining the PFR on channel tetramerisation and 
function. Due to their intracellular location, specific techniques have been developed 
to study RyR2. A method of investigating RyR2 function has been based on 
visualising Ca2+ signalling in cells. Characterisation of mutant hRyR2 channels has 
been achieved using fluorescent based markers as tools to examine the functional 
status of a population of mutant channels, outlined in section 4.1.2. In addition, a 
subcellular approach, utilising tritiated ([3H]) ryanodine, was used to investigate the 
activity of mutant hRyR2 channels, detailed in section 4.1.3.  
 
4.1.2 Caffeine-induced calcium release assay  
 
A cellular based assay, termed caffeine-induced calcium release, has been 
developed to examine the consequences of point mutations in hRyR2 on 
intracellular Ca2+ handling (Thomas et al., 2004). HEK293 cells have been 
extensively used as a heterologous cellular model for studying hRyR2 function, 
described in chapter 2.2.2.2, as importantly, these cells lack endogenous RyRs, 
therefore Ca2+ signals from ER stores can confirm channel function (Du et al., 2001; 
Kong et al., 2008; MacLennan and Chen, 2009; Viero et al., 2012). The elevation of 
cytosolic Ca2+ concentration [Ca2+]cyt as a consequence of RyR2 activation can be 
used as a biomarker for determining the functional status of wild-type and mutant 
channels expressed in HEK293 cells. The use of confocal laser scanning 
microscopy (CLSM) has enabled high resolution imaging of membrane-permeable 
Ca2+ sensitive fluorescent dyes (fluorescent Ca2+ indicators) such as Fluo3, to 
measure overall intracellular Ca2+ changes as outlined in section 4.1.2.1.  
 
Activating channels by caffeine, an RyR agonist, provokes a Ca2+ response 
inducing a fluorescent intensity change that can be measured, therefore caffeine 
has been regularly used to examine Ca2+ dynamics in whole cell experimental 
models that express RyR channels (Mead-Savery et al., 2009; Euden et al., 2013b; 
Ramachandran et al., 2013; Mei et al., 2015). Although the exact mechanism of 
RyR2 activation by caffeine is unknown, it is considered to occur through an indirect 
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action, sensitising RyR2 to activating Ca2+ and lowering the luminal Ca2+ threshold 
(Sitsapesan and Williams, 1990; Kong et al., 2008).  
 
4.1.2.1 Fluorescent Ca2+ indicator – Fluo3   
 
Fluo3 molecules exhibit an increase in fluorescence upon binding Ca2+ revealing 
spatial dynamics of many elementary processes in Ca2+ signalling (Clapham, 1995; 
Cheng et al., 1996; Bootman et al., 1997). Fluo3 has an absorption spectrum 
compatible with excitation at 488 nm by Argon-ion laser and emissions when bound 
to Ca2+ from 506 to 526 nm (Rijkers et al., 1990). The Fluo3 molecule shares similar 
properties with Ca2+ chelators such as EGTA (ethylene glycol tetraacetic acid) and 
BAPTA (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) binding Ca2+ 
with high affinity (KD 325 nM) (Grynkiewicz et al., 1985;  Paredes et al., 2008). Its 
high specificity for Ca2+, and sensitivity over an appropriate concentration range with 
linear output (calcium concentration proportional to fluorescence intensity), ensure 
that Fluo3 has a large signal-to-noise ratio for imaging analysis.  
 
4.1.2.2 Fluo3-acetoxymethyl permeation – HEK293 cell loading 
 
Efficiency of fluorescent indicator cell loading has improved with the attachment of a 
modified uncharged acetoxymethyl (AM) ester to Fluo3 (Fluo3-AM), enabling the 
indicator to permeate cell membranes (Paredes et al., 2008). In addition, the 
permeation of the fluorescent indicator involves a dispersing agent (Pluronic ® F-
127) as AM esters are relatively insoluble in aqueous solutions, therefore Pluronic ® 
F-127 facilitates the solubilisation of water-insoluble dyes, assisting cell loading. 
Once passively loaded inside the cell cytosol, nonspecific esterases cleave the 
Fluo3-AM resulting in a charged Fluo3 fluorescent molecule that decreases the 
probability rate of indicator leakage from the cell.  
 
4.1.2.3 Confocal Laser Scanning Microscopy 
 
As described above, Ca2+ is used as a biomarker for studying the function of RyR2 
channels when expressed in fluorescent Fluo3-loaded HEK293 cells by CLSM. 
CLSM offers many advantages over conventional light microscopy, in particular, it 
utilises a pair of pinhole apertures to limit the specimen focal plane, removing 
extraneous light originating in out-of-focus regions, increasing the optical resolution 
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and contrast (Webb, 1996). Fluorescent based images are prone to photo-bleaching 
from exposure to light, decreasing the signal-to-noise ratio and image resolution 
(Bernas et al., 2004). To overcome this, excitation light (488 nm) from a high-
powered laser passes through a pinhole filter and is directed towards a series of 
horizontally and vertically rotating mirrors by the acousto-optical beam splitter 
(AOBS), shown in figure 4.1. These mirrors allow the excitation light to 
systematically scan across the sample in a point-by-point fashion preventing global 
photo-bleaching. For these reasons, and the availability of a SP5 CLSM (Leica), 
visualisation of Ca2+ signalling to functionally characterise mutant RyR2 channels 
were completed using fluorescent based CLSM.  
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Figure 4.1. Fundamental principles of confocal optics. Schematic representation 
of confocal microscopy showing excitation (red) and emitted (blue) light in the focal 
plane. The AOBS directs light from the focal plane through a pinhole filter 
generating a high-resolution optical image while excluding extraneous light reflected 
from above the focal plane (grey dotted line). Diagram adapted from Mongan et al., 
(1999). 
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4.1.3 [3H] ryanodine binding assay measuring mutant RyR2 activity 
 
Among the macroscopic techniques established to investigate the function of large 
numbers of RyR channels (section 4.1.1), an approach involving the isolation of 
mixed-membrane vesicles to monitor mutant channel activity was developed (Chu 
et al., 1990). The advent of [3H] ryanodine has provided an indispensable tool that 
was initially used in the identification and isolation of RyR2 (Campbell et al., 1987; 
Lai et al., 1988; Hymel et al., 1988) and more recently used to assess the activity of 
RyR channels under particular conditions. The ryanodine molecule can only access 
its high affinity binding site when the channel is in an open conformation (Lai and 
Meissner, 1989; Chu et al., 1990; Sutko et al., 1997; Tanna et al., 1998), therefore 
hRyR2 activity can be assessed by specific radioactive binding measurements.  
 
In previous studies, [3H] ryanodine binding assays have been used to investigate 
the effect on RyR function of various compounds known to modulate channel 
activity, including physiological ligands such as Ca2+, Mg2+, ATP, calmodulin and 
PKA (Holmberg and Williams, 1989; Imredy and MacLennan, 1998; Balshaw et al., 
2001; Swan et al., 2003), non-physiological ligands such as caffeine, JTV-519 
(K201), dantrolene (Holmberg and Williams, 1989; Jones et al., 2005; Hunt et al., 
2007; Seidel et al., 2014), and accessory proteins such as FKBP12.6 (Yano et al., 
2003; Zissimopoulos et al., 2012), as binding of ryanodine is enhanced by 
compounds which activate the channel, and is reduced by other agents that inhibit 
RyR activity.  
 
While the exact binding site is unknown, proteolytic digestion (Callaway et al., 
1994), photo-affinity labelling (Witcher et al., 1994) and observations that ryanodine 
can only access its site when the channel is in an open confirmation has led to the 
suggestion that the binding site is located in the C-terminal pore region of the 
channel (Witcher et al., 1994; Callaway et al., 1994; Wang et al., 2003; Mukherjee 
et al., 2014). In addition, numerous studies have investigated alanine scanning 
within the PFR and have identified several residues that effect or even abolish [3H] 
ryanodine binding, discussed in section 4.4.2 (Zhao et al., 1999; Gao et al., 2000; 
Du et al., 2001; Li et al., 2002a; Wang et al., 2003; Du et al., 2004; Wang et al., 
2004; Ranatunga et al., 2005).  
 
The three residues located in the selectivity filter, D4829, and pore helix, Y4813 and 
Y4839 depicted in figure 4.2, are in similar positions within the RyR PFR to residues 
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investigated in previous studies (section 4.4.2) (Gao et al., 2000; Wang et al., 2003; 
Euden et al., 2013b). Measurements of equilibrium [3H] ryanodine binding were 
important to assess the consequence of alanine and conservative mutations on 
channel activity, in particular to assess if the mutations affected channel gating or 
altered the access to, or affinity of, the ryanodine binding site. 
 
(A)      (B) 
            
 
Figure 4.2. The pore-forming region RyR2 analogy model. Highlighted residues 
correspond to Y4813 (blue), D4829 (red) and Y4839 (green). (A) Side view of the 
PFR RyR2 highlighting the proposed region of the ryanodine binding site, boxed 
“Ry” (Witcher et al., 1994; Callaway et al., 1994; Wang et al., 2003), two monomers 
shown for clarity. (B) Luminal view of the PFR RyR2 channel with central aligned 
pore. Highlighted residues are at ideal distances to form a hydrogen-bonding 
network that may support and stabilise selectivity filter regulated channel gating akin 
to known mechanisms in K+ channels outlined in chapter 1.5. 
 
 
 
 
 
 
 
Ry 
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4.2 – Materials and Methods 
 
4.2.1 Materials – Ca2+ imaging reagents and agonists 
 
20 % Pluronic acid stock: 50 µg pluronic acid was dissolved in 250 µL DMSO to 
form a 20 % stock.    
Fluo3-AM solution: 50 µg Fluo3-AM was added to 44 µL of 20 % pluronic stock to 
obtain a stock concentration of 1 mM Fluo3-AM.                         
Fluo3-AM mDMEM solution: 10 µL Fluo3-AM pluronic acid stock was added to 1 
mL mDMEM to obtain a 10 µM working concentration.               
100 mM caffeine stock: 20 mg caffeine was added to 1 mL mDMEM pre-heated to 
37 °C to facilitate solubilisation. 
 
4.2.2 Methods – Caffeine-induced calcium release assay 
 
4.2.2.1 Effectene transfection 
 
RyR2-HEK293 cell transfections for Ca2+ imaging was performed using the non-
liposomal, lipid-based Effectene kit (Qiagen) due to its high transfection efficiencies 
and low cell cytotoxicity requiring low DNA concentrations (0.8 µg per experiment). 
HEK293 cells were seeded at 1 x 105 cells/mL in 200 µL menisci onto coverslips 
(MatTek) coated with 5 µL mouse laminin (1 mg/mL) obtained from Sigma. Laminin 
was evenly coated onto coverslips using the decanting-end of a 200 μL pipette tip 
prior to the addition of cells. The coverslips were incubated for 2-3 h at 37 °C, 5 % 
CO2, to allow for cell adhesion prior to transfection. A transfection mixture was 
prepared containing plasmid DNA (0.8 µg for 7 coverslips) made up to 100 µL using 
buffer EC. A DNA-condensing enhancer was added (6.4 µL) to the mixture before 
vortexing and incubating at RT for 5 min. 20 µL Effectene was added to the reaction 
which was further vortexed and incubated at RT for 10 min to produce condensed 
Effectene-DNA complexes. 600 µL of pre-warmed cDMEM was added to the 
reaction, mixing twice, before adding 100 µL Effectene-transfection mixture to each 
coverslip (x 7). The coverslips were returned to the incubator for 24 h. Each 
coverslip was flooded with 2 mL cDMEM the following day before returning to the 
incubator for a further 24 h (total 48 h post-transfection). HEK293 cells expressing 
hRyR2 protein were verified by eGFP imaging prior to determining channel function 
using light microscopy, described in section 2.2.2.4. For a control, plates were 
116 
 
seeded with untransfected HEK293 cells and were subsequently assessed as 
described in the following sections.  
 
4.2.2.2 Cellular Ca2+ imaging – Caffeine-induced calcium release assay 
 
Cellular Ca2+ imaging studies of HEK293 cells expressing hRyR2 channel proteins 
were performed using a SP5 confocal microscope (Leica). Coverslips containing 2 
mL media were removed 48 h post-transfection (Effectene) and dried using tissue. 
A 10 µM Fluo3-AM working stock was prepared by adding 10 µL Fluo3-AM pluronic 
acid mix (section 4.2.1) to 1 mL mDMEM. HEK293 cells were loaded (150 µL) with 
the 10 µM Fluo3-AM mDMEM and then incubated at 30 °C, 5 % CO2 for 1 h. 
Coverslips were flooded with 1.2 mL mDMEM to stop Fluo3-AM loading and to 
initiate de-esterification (20 min). The medium was removed and replaced with 200 
µL mDMEM immediately prior to imaging the coverslips using an oil-immersed, 63 x 
magnification objective and Argon laser (20 %). The Leica LAS AF Lite software 
was used for confocal imaging and was set up as stated; excitation of Fluo3-AM 
488 nm, Argon laser set to 20 %, format 512 x 512 pixels, zoom factor 1.7, time 
interval 70 ms and frames set to 1000 (1 min recording). A field of view (FOV) 
containing 10 or more well loaded fluorescent HEK293 cells was chosen for each 
experiment shown in figure 4.4. Channel function was assessed by the addition of 
20 µL caffeine stock (100 mM) to the 200 µL meniscus (final concentration 10 mM) 
20-30 s into the recording. Large data files (~ 0.5 GB/1 min recording) were saved 
onto an external hard drive immediately after use which were analysed as described 
in section 4.2.2.3.  
 
4.2.2.3 Caffeine-induced calcium release assay – Analysis  
 
Ca2+ imaging analysis was performed using the Leica LAS AF Lite software before 
exporting the raw data into Excel. The change in fluorescent intensity (∆F) was 
measured by selecting regions of interest (ROI) within the FOV containing cells 
loaded with Fluo3 Ca2+ indicator that responded to the addition of 10 mM caffeine. 
∆F was background corrected by subtracting selected ROI containing background 
fluorescence. The basal Fluo3 signal intensity (F0) was calculated as the mean 
average fluorescence before caffeine addition (first 20 s). Fluorescent transient 
plots were generated by normalising the data, dividing the background corrected 
change in fluorescence by the average basal fluorescence (∆F/F0) as shown in 
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figure 4.3. An increase in Fluo3 fluorescent intensity upon caffeine addition 
corresponded to functional hRyR2 channels. 
 
4.2.2.3.1 Measuring the maximum Ca2+ release from HEK293 cells 
expressing hRyR2 channels 
 
The caffeine-induced Ca2+-transient amplitude was measured in HEK293 cells 
expressing WT and mutant hRyR2 channels. The maximum Ca2+ release was 
determined by measuring the height of the peak Fluo3 signal (F), shown in figure 
4.3, and subtracting the value by the average basal F0. Due to differences in basal 
F0 the maximum Ca
2+ release peak was normalised and determined by the equation 
stated; (F-F0)/F0.  
 
 
 
Figure 4.3. Measurement of maximum Ca2+ release in HEK293 cells expressing 
WT and mutant hRyR2 channels. The average basal Fluo3 signal intensity (F0) 
was determined over a period of 20 s prior to 10 mM caffeine addition. The 
maximum Ca2+ release was determined by measuring the height of the peak Fluo3 
signal (F) and subtracting the basal F0; (F-F0)/F0.  
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4.2.3 Materials – Ryanodine binding reagents 
 
Ryanodine binding buffer: 1 M KCl, 25 mM PIPES and 100 µM CaCl2 adjusted to 
pH 7.4 with KOH. 
[3H] ryanodine: 1 µM stock obtained from Perkin Elmer (95 Ci/mmol). 
‘Cold’ unlabelled ryanodine: 1 mM stock prepared in dH2O obtained from Abcam. 
Ryanodine binding buffer (CaCl2 and caffeine): 1 M KCl, 25 mM PIPES, 100 µM 
CaCl2 and 10 mM caffeine adjusted to pH 7.4 with KOH. 
Ryanodine binding buffer (Caffeine): 1 M KCl, 25 mM PIPES and 10 mM caffeine 
adjusted to pH 7.4 with KOH. 
 
4.2.4 Methods – [3H] Ryanodine binding assay 
 
To minimise local radioisotope contamination all [3H] ryanodine binding experiments 
were completed inside a 1 m2 plastic tray. Assays were prepared as stated in table 
4.1, to a total reaction volume of 500 µL in triplicate (3 x hot and 3 x cold reactions). 
For valid comparison, relative contents of WT and mutant RyR2 protein in 
membrane preparation fractions were determined by Western blot densitometry 
analysis described in chapter 2.2.3.6. Mutant hRyR2 bands were calibrated to 100 
µg WT protein, adjusting mutant mixed-membrane (MM) volumes accordingly. Cold 
ryanodine (10 µM) was added into cold reactions and 2 µL (10 nM) of the [3H] 
ryanodine stock, stored at – 20 °C, was diluted 1 : 10 ratio (v/v) with binding buffer 
(total 20 µL) to reduce pipetting error. Reaction tubes were vortexed and incubated 
for 1.5 h at 37 °C in a water bath while Whatman GF-F filter pads were pre-soaked 
in binding buffer. 
 
  
[3H] Ryanodine 
reaction 
Cold Ryanodine 
reaction 
Reagent [Working] Volume 
MM Sample 100 µg X µL X µL 
Binding buffer   up to 500 µL up to 500 µL 
Cold ryanodine  10 µM N/A  5 µL 
[3H] ryanodine 10 nM 20 µL 20 µL 
 
Table 4.1. Representative ryanodine binding reaction. MM samples, completed 
in triplicate, were calculated by densitometry analysis described in section 2.2.3.6. 
Volumes were adjusted according to WT hRyR2.  
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Once the incubation period was complete, the reactions were stopped by the 
addition of 5 mL binding buffer. The pre-soaked GF-F filter pads were placed onto 
columns of a vacuum manifold (Hoeffer). Each reaction (5.5 mL) was passed 
through the filter pads by a vacuum created using a Heto Master Jet pump. The 
tubes were washed twice with binding buffer (5 mL) and passed through the column 
by vacuum to remove any unbound radioactive ryanodine. The GF-F filter pads 
were placed in scintillation vials with 10 mL scintisafe liquid and incubated for 24 h 
before counting radioactivity (disintegrations per minute - dpm) on a scintillation 
counter (Packard Tricarb 2100TR Liquid Scintillation Analyser). Specific binding 
was measured by subtracting ‘cold’ ryanodine with ‘hot’ [3H] ryanodine binding 
results. 
 
4.2.4.1 Effects of caffeine on [3H] Ryanodine binding assay 
 
Ryanodine binding assays were repeated as outlined in the protocol stated above 
with modification of binding buffers. Two binding buffers were prepared with either 
100 µM CaCl2 and 10 mM caffeine, or only 10 mM caffeine as stated in section 
4.2.3. 
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4.3 – Results  
 
4.3.1 Caffeine-induced calcium release assay 
 
An initial qualitative assessment of the functional state of WT and mutant hRyR2 
channels was performed by monitoring the release of Ca2+ from intracellular stores 
in response to the application of 10 mM extracellular caffeine. Figure 4.4 shows a 
representative FOV of transfected HEK293 cells expressing WT hRyR2 before (A) 
and after (B) caffeine addition. Figure 4.4A depicts the basal F0 before agonist 
addition. Upon caffeine addition to the menisci, induction of Ca2+ release through 
activated WT hRyR2 channels was observed as a fluorescence intensity increase 
shown in figure 4.4B.  
 
(A)                  (B)  
   
 
Figure 4.4. Caffeine-induced calcium release assay. Representative FOV of 
fluorescent Ca2+ imaging showing HEK293 cells, loaded with Ca2+ indicator Fluo3, 
expressing WT hRyR2 examined by CLSM. (A) FOV depicts basal F0 of 10 or more 
HEK293 cells prior to caffeine addition. (B) Identical FOV following caffeine (10 mM) 
challenge. Ca2+ release through activated WT RyR2 channels is represented by a 
fluorescent intensity increase, highlighted by regions of interest (ROI). Scale: 63 x 
objective magnification. 
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Figure 4.5A represents a typical trace depicting changes in fluorescence intensity of 
ten HEK293 cells expressing WT hRyR2 channels following caffeine addition. The 
addition of caffeine, 20-30 s into the experiment, evoked a rapid 3-8 fold increase in 
fluorescence. The mean maximum Ca2+ release of HEK293 cells expressing WT 
hRyR2 was 5.11 ± 0.28, acquiring data from 55 cells from six separate transfection 
experiments, shown in figure 4.10. In addition, a control caffeine-induced calcium 
release experiment of untransfected HEK293 cells was completed. The addition of 
caffeine did not illicit a fluorescence change 20-30 s into the experiment (figure 
4.5B). 
 
 (A)  
 
(B) 
 
 
Figure 4.5. Caffeine-induced calcium release assay examining changes in 
fluorescence intensity upon addition of caffeine. (A) Ten representative ROIs 
containing Fluo3-loaded HEK293 cells expressing WT hRyR2 channels were 
monitored. Caffeine stimulation (20-30 s) induced a 3-8 fold increase in 
fluorescence intensity. (B) Untransfected RyR-deficient HEK293 cells did not illicit a 
fluorescence change upon caffeine stimulation. The addition of caffeine is indicated 
by a black arrow. 
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(A)     
      
 
(B) 
      
 
(C) 
      
 
Figure 4.6. Expression of hRyR2 alanine mutations using the Effectene 
transfection method. Confocal microscopy eGFP imaging demonstrated high 
transfection efficiency using the Effectene method. (A) Y4813A, (B) D4829A and (C) 
Y4839A. (left) Bright field imaging displays the total cell density and (right) eGFP 
imaging, outlined in section 2.2.2.4, of green fluorescent HEK293 cells confirmed 
hRyR2 protein expression. Scale: 10 x objective magnification. 
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(A)   
      
 
(B) 
      
 
(C)  
      
 
Figure 4.7. Expression of hRyR2 conservative mutations using the Effectene 
transfection method. Confocal microscopy eGFP imaging demonstrated high 
transfection efficiency using the Effectene method. (A) Y4813W, (B) D4829E and 
(C) Y4839W. (left) Bright field imaging displays the total cell density and (right) 
eGFP imaging, outlined in section 2.2.2.4, of green fluorescent HEK293 cells 
confirmed hRyR2 protein expression.  Scale: 10 x objective magnification. 
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4.3.1.1 Mutant hRyR2 caffeine-induced calcium release assay 
 
Protein expression of hRyR2 mutants was confirmed by eGFP imaging shown in 
figures 4.6 and 4.7. Transfection efficiencies observed were high using the 
Effectene method (> 40 %), ideal for Ca2+ imaging using CLSM. All alanine mutants 
(Y4813A, D4829A and Y4839A) and conservative mutants (Y4813W, D4829E and 
Y4839W) were sensitive to caffeine stimulation and evoked a rapid increase of 
fluorescence. Figures 4.8 and 4.9 depict representative responses from ten different 
HEK293 cells expressing mutant channels. The change in ∆F indicated that all 
hRyR2 mutations formed functional homotetrameric channels that could release 
Ca2+ from the HEK293 ER stores upon 10 mM caffeine addition.  
 
The maximum Ca2+ release in Fluo3-loaded HEK293 cells expressing mutant 
channels was compared with cells expressing WT hRyR2 channels. Interestingly, 
the mean maximum Ca2+ release, determined by measuring the height of the Fluo3 
signal peak (section 4.2.3.3.1), from cells expressing Y4813A (3.81 ± 0.26, 
p=0.0009) and D4829A (3.95 ± 0.24, p=0.0022) channels were significantly reduced 
compared to WT hRyR2 (5.11 ± 0.28) by 25.6 % and 22.7 %, respectively, shown in 
figure 4.10. There were no differences in maximum release between WT and the 
conservative mutants (Y4813W, D4829E and Y4839W) and Y4839A mutant hRyR2 
channels (figure 4.10). The data from mutant channels were acquired from three 
separate transfection experiments and from a minimum of 39 cells, listed in table I 
(appendix I). 
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(A) 
 
(B) 
 
(C)  
 
 
Figure 4.8. Caffeine-induced calcium release assay examining HEK293 cells 
transfected with alanine hRyR2 mutations. (A) Y4813A, (B) D4829A and (C) 
Y4839A. Caffeine stimulation induced a rapid increase in fluorescence intensity 
indicating that alanine mutations formed functional homotetrameric channels. 
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(A) 
 
(B) 
 
(C)  
 
 
 
Figure 4.9. Caffeine-induced calcium release assay examining HEK293 cells 
transfected with conservative hRyR2 mutations. (A) Y4813W, (B) D4829E and 
(C) Y4839W. Caffeine stimulation induced a rapid increase in fluorescence intensity 
indicating that conservative mutations formed functional homotetrameric channels. 
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Figure 4.10. Measurement of maximum Ca2+ release in HEK293 cells 
expressing WT and mutant hRyR2 channels. Data are presented as the mean 
maximum Ca2+ release (error bars ± SEM) from at least three separate transfection 
experiments, acquiring data from a minimum of 39 cells. The total number of 
experiments and cells (ROIs) are listed in table I (appendix I). Differences between 
maximum Ca2+ release for WT and mutant channels were compared using an 
unpaired two-tailed t-test, p values < 0.05 were deemed significant, described in 
section 4.3.1.1.  
 
 
4.3.2 Protein expression of hRyR2 mutants – Densitometry analysis 
 
The relative expression of WT and mutant RyR2 channels in membrane preparation 
fractions was determined by Western blot densitometry analysis, adjusting 
equivalent quantities of mutant to WT RyR2 membrane fractions in [3H] ryanodine 
binding assays for valid comparison. RyR2-HEK293 cell transfections were 
completed on three separate occasions and were subsequently labelled mixed-
membrane # 1, 2 and 3. Mutant protein expression was comparable for all six 
mutations represented in figures 4.11, 4.12 and 4.13 and tables 4.2, 4.3 and 4.4.   
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(A)   WT       1          2         3    (B)   WT       1         2        3       
       
 
Figure 4.11. Quantification of (A) Y4813A and (B) Y4813W protein expression 
compared to WT hRyR2 using densitometry analysis. Figure numbering (1, 2 
and 3) denotes separate mutant hRyR2 mixed-membrane preparations from 
HEK293 cell transfections. 
 
 
 
 
Y4813A   Y4813W 
  
IntDen 
Normalised    
IntDen 
Normalised  
  expression (%)   expression (%) 
WT 40.685 100   89.208 100 
MM #1 40.644 100.1   71.741 124.3 
MM #2 41.586 97.8   52.376 170.3 
MM #3 41.241 98.7   54.205 164.6 
 
 
Table 4.2. Normalised Y4813A and Y4813W protein expression levels relative 
to WT hRyR2.     
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(A)   WT       1         2        3    (B)   WT       1        2         3       
  
 
Figure 4.12. Quantification of (A) D4929A and (B) D4829E protein expression 
compared to WT hRyR2 using Western blot densitometry analysis. Figure 
numbering (1, 2 and 3) denotes separate mutant hRyR2 mixed-membrane 
preparations from HEK293 cell transfections. 
 
 
 
D4829A   D4829E 
  
IntDen 
Normalised    
IntDen 
Normalised  
  expression (%)   expression (%) 
WT 42.43 100   60.288 100 
MM #1 39.899 106.3   57.177 105.4 
MM #2 43.721 97.0   57.678 104.5 
MM #3 43.155 98.3   44.13 136.6 
 
 
Table 4.3. Normalised D4929A and D4829E protein expression levels relative 
to WT hRyR2. 
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(A)  WT      1         2         3    (B)   WT       1        2         3        
  
 
Figure 4.13. Quantification of (A) Y4839A and (B) Y4839W protein expression 
compared to WT hRyR2 using Western blot densitometry analysis. Figure 
numbering (1, 2 and 3) denotes separate mutant hRyR2 mixed-membrane 
preparations from HEK293 cell transfections. 
 
 
 
Y4839A   Y4839W 
  
IntDen 
Normalised    
IntDen 
Normalised  
  expression (%)   expression (%) 
WT 63.335 100   70.882 100 
MM #1 72.598 87.2   95.106 74.5 
MM #2 82.294 77.0   54.842 129.2 
MM #3 74.644 84.8   61.843 114.6 
 
Table 4.4. Normalised Y4839A and Y4839W protein expression levels relative 
to WT hRyR2.  
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4.3.3 [3H] ryanodine binding assay 
 
Mutant RyR2 channel activity was assessed and compared quantitatively by 
determining the ability of mixed-membrane vesicles containing hRyR2 to bind [3H] 
ryanodine, as the high-affinity binding site is only accessible when the channel is in 
an open conformation. Figure 4.14 shows an overview of the total values of specific 
Ca2+-stimulated ryanodine binding to mutant RyR2, expressed as a proportion of the 
binding to WT hRyR2 protein. Point mutations at the proposed selectivity filter and 
pore region demonstrated a marked alteration in the ability to bind ryanodine 
described in sections 4.3.3.1/2/3/4 and listed in table 4.5. 
 
 
 
Figure 4.14. An overview of normalised [3H] ryanodine binding of mutant 
relative to WT hRyR2 mixed-membrane fractions. Normalised binding values are 
listed in table 4.5. 
 
 
 
 
 
 
 
 
132 
 
        
Normalised binding (%) p < 0.05 
WT hRyR2 100   
 Y4813A 1.03 ± 0.27 < 0.0001 
Y4813W 30.12 ± 5.80 < 0.0001 
D4829A 45.63 ± 8.36 < 0.0001 
D4829E 7.18 ± 1.18 < 0.0001 
Y4839A 37.59 ± 9.52 < 0.0001 
Y4839W 107.1 ± 5.63 ns 
 
Table 4.5. Normalised [3H] ryanodine binding results of mutant relative to WT 
hRyR2 mixed-membrane fractions. Normalised binding values are means from at 
least n=9 (± SEM), expressed as a percentage. [3H] ryanodine binding results 
between WT and mutant hRyR2 channels were compared using a one-way 
ANOVA, Tukey’s multiple comparison test, p values < 0.05 were deemed 
significant. Specific [3H] ryanodine binding values, measured in disintegrations per 
minute (dpm), are listed in table II (appendix II).  
 
4.3.3.1 [3H] ryanodine binding - Y4813A vs Y4813W hRyR2 mutations 
 
As can be seen in figure 4.14, the replacement of Y4813 with alanine produced a 
significant reduction in the level of ryanodine binding (1.03 %, compared to WT 
fractions). In contrast, the introduction of a tryptophan at Y4813, a conservative 
mutation with the ability to form hydrogen-bonding network, partially restored the 
binding of [3H] ryanodine (30.12 %) compared to WT fractions. The increased 
binding of ryanodine observed for the conservative Y4813W mutation was 
significant compared to Y4813A (p<0.0001). However, Y4813W did not restore 
binding to the equivalent level of WT hRyR2. 
 
4.3.3.2 [3H] ryanodine binding - D4829A vs D4829E hRyR2 mutations 
 
D4829A showed a marked reduction in ryanodine binding, 45.6 %, compared to WT 
channels shown in figure 4.14. Unlike the tryptophan residue substitution at 
Y4813W, the conservative mutation D4829E did not improve ryanodine binding 
(7.18 % compared to WT hRyR2). In fact, the replacement of glutamic acid at 
D4829E showed a large decrease in [3H] ryanodine binding compared to the alanine 
hRyR2 mutation at D4829.  
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4.3.3.3 [3H] ryanodine binding - Y4839A vs Y4839W hRyR2 mutations 
 
Mutating a residue proposed to eliminate a hydrogen-bonding network, Y4839A, 
reduced ryanodine binding to 37.6 % compared to WT fractions. In contrast to the 
other two residues at positions Y4813 and D4829, reintroducing similar 
physicochemical interactions by tryptophan substitution (Y4839W) fully restored 
ryanodine-RyR2 binding interaction (107.1 %) compared to the WT channel, figure 
4.14.  
 
4.3.3.4 [3H] ryanodine binding assay – Y4813A caffeine experiment  
 
An additional assay was performed to examine the observed reduction of Y4813A 
[3H] ryanodine binding (1.03 %) as described in section 4.3.3.1. Observations from 
intracellular Ca2+ imaging (section 4.3.1.1) confirmed that Y4813A was caffeine-
sensitive and formed functional homotetrameric channels, albeit the maximum Ca2+ 
release was reduced by 25.6 % compared to WT hRyR2. [3H] ryanodine binding 
assays were repeated on three separate occasions using modified buffers, outlined 
in section 4.2.4, containing caffeine to activate Y4813A channels. Binding buffers 
supplemented with 10 mM caffeine, the equivalent concentration used for mutant 
activation during caffeine-induced calcium release assays, did not restore Y4813A 
ryanodine binding, 1.15 % (caffeine buffer) and 2.03 % (caffeine and CaCl2 buffer) 
when compared to WT hRyR2, shown in figure 4.15.  
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Figure 4.15. Y4813A caffeine [3H] ryanodine binding experiment. Y4813A 
incubated in (A) CaCl2 buffer, (B) caffeine buffer and (C) caffeine and CaCl2 buffer. 
The addition of 10 mM caffeine, and or 10 mM caffeine and 100 µM CaCl2 did not 
significantly increase [3H] ryanodine binding to Y4813A. Buffers are listed in section 
4.2.3. 
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4.4 – Discussion 
 
This study elucidated the effects of point mutations occurring in the PFR on hRyR2 
channel function. The constructed selectivity filter and pore helix mutants were 
examined to assess whether these channels were able to release Ca2+ upon 
caffeine addition, discussed in section 4.4.1, suggesting that mutant channels 
formed functional homotetramers. In addition to in situ function, mutant channel 
activity was examined by [3H] ryanodine binding to isolated membrane populations, 
discussed in section 4.4.2.  
 
4.4.1 Caffeine-induced calcium release assay 
 
The process of RyR2 activation, where Ca2+ is released from intracellular stores 
through open channels into the cytosol, was measured using fluorescent Ca2+ 
indicators. Recording changes in fluorescent intensities, upon agonist addition, 
correlated to the functional status of channels and examined the stability of 
channels in a cellular context. Previous studies have reported non-functional 
channels arising from residue substitution in close proximity to the point mutations 
described in this thesis, such as inner helix mutations outlined in figure 4.16 (Wang 
et al., 2003) and more recently, G4864V (Euden et al., 2013b). It was therefore 
important to validate the structural stability of channels harbouring residue 
substitutions before investigating single-channel gating mechanisms as described in 
chapters 5 and 6.  
 
The caffeine-induced calcium release assay, using a heterologous RyR-deficient 
HEK293 cell model, established that all six mutants were able to form functional 
homotetrameric channels that could release Ca2+ from ER stores into the cytoplasm 
upon activation by caffeine (figures 4.8 and 4.9). Interestingly, point mutations 
proposed to be in close proximity to the ion permeation pathway, Y4813A in the 
pore helix and D4829A in the selectivity filter, affected the maximum Ca2+ release 
from HEK293 cells compared to WT hRyR2 channels shown in figure 4.10. The 
reduction in Ca2+ release determined by a reduced ∆F suggested that Y4813A and 
D4829A had either affected the channel’s caffeine sensitivity (and/or channel’s Ca2+ 
sensitivity) thereby fewer mutant channels were activated, or alternatively that these 
mutations physically affected the ability to translocate Ca2+ ions through the pore. 
Determining the maximum Ca2+ release provided the first insight into functional 
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differences resulting from point mutation within the pore that was subsequently 
useful for evaluating altered [3H] ryanodine binding, discussed in section 4.4.2.  
 
4.4.2 [3H] ryanodine binding assay 
 
The impact of residue mutation on the ryanodine-hRyR2 interaction was assessed 
by monitoring equilibrium [3H] ryanodine binding to mixed-membrane fractions 
containing either alanine, or conservative, mutant channels. Binding experiments 
were carried out in the presence of 100 µM CaCl2, a condition under which hRyR2 
has a high open probability (Mukherjee et al., 2012). Using a high Ca2+ 
concentration was optimal for the detection of radioactive binding as access to the 
ryanodine binding site is limited to when the channel is in an open conformation 
(Tanna et al., 1998).  
 
Previous studies have demonstrated that mutating residues located in the PFR of 
RyR modifies the ability of the receptor to bind ryanodine (Zhao et al., 1999; Gao et 
al., 2000; Du et al., 2001; Li et al., 2002a; Wang et al., 2003; Du et al., 2004; Wang 
et al., 2004; Ranatunga et al., 2005). These previous investigations are consistent 
with the proposal that ryanodine binds within the ion conduction pathway of RyR2 
within a wide vestibule, as mutations in the S6 region abolish or markedly reduce 
[3H] ryanodine binding to RyR2 as depicted in figure 4.16 (Wang et al., 2003; 
Ranatunga et al., 2005). This suggests that the pore region constitutes an essential 
determinant of ryanodine-RyR2 interaction. Consistent with this proposal, the data 
presented in this chapter demonstrate that mutation of residues located in the 
proposed selectivity filter and pore region of hRyR2 reduced the binding of 
ryanodine, except for the conservative Y4839W channel, shown in figure 4.14. 
Western blot analysis established that all hRyR2 mutants were expressed at a 
comparable level to WT hRyR2 in HEK293 cells (figures 4.11, 4.12 and 4.13). 
Equivalent amounts of WT and mutant protein were used for the binding assays, 
determined by densitometry analysis, therefore reduced [3H] ryanodine binding to 
mutant channels was not due to low or altered expression.   
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(A)       (B) 
 
 
Figure 4.16. Investigating [3H] ryanodine binding and caffeine response of 
inner (S6) helix RyR2 mutants. (A) The relative percentages of mutant [3H] 
ryanodine binding were compared to WT RyR2. Caffeine-induced Ca2+ response in 
mutant hRyR2 channels were indicated by “+ or -”. Figure adapted from (Wang et 
al., 2003). (B) The Welch et al PFR hRyR2 analogy model highlighting the S6 helix 
mutations in red relative to the selectivity filter and pore helix mutations in this 
project, Y4813 (blue), D4829 (red) and Y4839 (green) (Welch et al., 2004).   
 
Once bound to WT hRyR2, the rate of ryanodine dissociation is very slow and binds 
almost irreversibly to its high affinity site stabilising the channel in an open, reduced 
conductance, conformation (Lindsay et al., 1994; Needleman and Hamilton, 1997; 
Mukherjee et al., 2014). Mutation-dependent alterations in ryanodine binding to 
hRyR2 may occur through several factors such as; the generation of unstable or 
closed channels, modification of structural components important in the ryanodine-
hRyR2 interaction altering the access to, or affinity of, the binding site, or by altering 
the mutant channel’s sensitivity to calcium. Consequently, these considerations 
were accounted for when interpreting the mutant hRyR2 [3H] ryanodine results and 
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were assessed in combination with complementary assays such as Ca2+ imaging 
and single-channel bilayers discussed in chapters 5 and 6. 
 
The reduction of [3H] ryanodine binding to Y4813A hRyR2, 1.03 % of that seen in 
WT, indicated that alanine substitution modified the ryanodine-Y4813A interaction 
either by altering the properties of the binding site or by affecting the stability of the 
protein when isolated from whole-cell environment. The functional studies confirmed 
that Y4813A was caffeine sensitive, i.e. the channel opened in response to agonist, 
but caffeine failed to increase ryanodine binding to the isolated mixed-membrane 
preparation as described in section 4.3.3.4. Interestingly, the conservative 
tryptophan mutation, Y4813W, improved [3H] ryanodine binding in comparison to 
the alanine mutation Y4813A. This significant increase was however only 30.12 % 
compared to WT hRyR2. The partial restoration of ryanodine binding by the 
replacement of tyrosine with tryptophan, a residue with similar aromatic bulk, steric 
occupancy and physicochemical hydrogen-bonding capabilities, highlights the 
importance of residue 4813 in this aspect of RyR2 function and provides an 
interesting insight into a potential hydrogen-bonding network originating from the 
pore helix to the selectivity filter. 
 
The aspartic acid at position 4829, located at the luminal end of the selectivity filter 
is highly conserved throughout the RyR isoforms (GGGIGD), IP3R (GGGVGD) 
(Taylor and Tovey, 2010) and K+ channels (TVGYGD) (Heginbotham et al., 1994; 
McCoy and Nimigean, 2012). Replacing this conserved residue with alanine, 
D4829A, reduced ryanodine binding to 45.63 % of the level seen in WT hRyR2. In 
contrast, the extension of the side chain by a methyl group, generating the 
conserved glutamic acid, reduced the ryanodine-D4829E interaction to 7.18 % 
compared to WT hRyR2. This observation suggested that the bulk of the residue at 
4829 is much more important than its charge in maintaining a conformation that 
supports ryanodine binding. The reduced ryanodine binding resulting from the 
substitution of D4829 with either alanine or glutamic acid could be explained if 
conformational changes resulting from the substitutions either limited the access of 
ryanodine to its binding site, increased the rate at which bound ryanodine 
dissociates from its site, or altered the channel’s Ca2+ sensitivity.  
 
The alanine substitution at Y4839 produced hRyR2 channels that bound 37.59 % of 
the ryanodine bound to WT hRyR2. This confirmed that the reduction of hydrogen 
bonding capacity, by alanine substitutions, of all three residues examined in this 
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thesis reduces the capacity of hRyR2 to bind ryanodine. In addition, unlike the pore 
helix mutation Y4813W, the conservative mutation at Y4839W fully restored binding 
to 107.1 % of the WT hRyR2 level.  
 
While all hRyR2 mutations investigated in this thesis reduced the ryanodine binding 
interaction to hRyR2 (except for Y4839W), only two mutations (Y4813A and 
D4829A) affected the maximum release of Ca2+ from HEK293 cells. This suggests 
that altered [3H] ryanodine binding to hRyR2 does not exclusively determine 
channel function as the remaining mutations (Y4813W, D4829E and Y4839A) that 
reduced binding maintained the functional maximum Ca2+ release compared to WT 
hRyR2 channels. This highlights a limitation of the [3H] ryanodine binding assay, as 
it can produce misleading results. Previous studies have shown that mutations 
affect the ability of the channel to bind ryanodine, however without affecting channel 
gating (Zhao et al., 1999; Gao et al., 2000; Chen et al., 2002). Therefore it is 
essential to examine the mechanisms underlying altered ryanodine binding and 
maximum Ca2+ release, as a consequence of point mutation, by using the single-
channel bilayer technique described in chapter 5.     
 
In summary, two assays were used as an initial screen to examine the effect of 
point mutations at the selectivity filter and pore helix on channel function. The 
investigations reported in this chapter demonstrate that all six mutant hRyR2 
channels were successfully expressed in HEK293 cells and formed functional Ca2+ 
release channels in situ that were able to translocate Ca2+ upon stimulation. In 
accordance to previous studies, [3H] ryanodine binding to alanine substituted 
channels was altered suggesting that point mutations located in the PFR in this 
investigation had either affected the sensitivity to activating Ca2+ or modified the 
ryanodine binding site (Gao et al., 2000; Wang et al., 2003; Euden et al., 2013b). 
The binding results highlighted the significance of side chain interaction properties 
(valence, hydrophobicity, polarity, hydrogen-bonding ability, and size) in the 
surrounding PFR environment, as engineering point mutations within PFR resulted 
in diverse and altered ryanodine-mutant hRyR2 interactions. The stability and gating 
behaviour of these mutants when purified and incorporated into planar bilayers was 
determined by single-channel experiments discussed in chapters 5 and 6.   
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Initial Single-Channel Characterisation of Mutant human Cardiac 
Ryanodine Receptor (hRyR2) channels 
 
Chapter Five – Aims 
 
To understand the involvement of a gating component in RyR2, formed by a 
potential hydrogen-bonding network between the selectivity filter and surrounding 
area, it was essential to characterise mutant hRyR2 proteins at the single-channel 
level. This chapter discusses the importance of the single-channel electrophysiology 
technique, and how it was used to determine general biophysical properties of 
mutant hRyR2 channel conduction, discrimination and permeability. The initial 
characterisation and ion handling properties established in this chapter set the 
foundation for investigating single-channel gating mechanisms discussed in chapter 
6. The aims of this chapter were as follows: 
 
 To initially screen purified selectivity filter and pore helix mutant hRyR2 
channels assessing their stability when isolated, solubilised and 
incorporated into a planar lipid bilayer. 
 
 To evaluate ryanodine modification and ion conduction of mutant hRyR2 
compared to WT hRyR2 channels.  
 
 To assess altered ion conduction properties in mutant hRyR2 channels by a 
series of ion handling experiments to probe potential mechanistic differences 
in ion channel discrimination, relative permeability and pore dimensions.   
 
 To examine differences between previous and new structural modelling data 
in regard to residue positioning around the selectivity filter region.  
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5.1 – Introduction 
 
5.1.1 The Single-Channel Electrophysiology technique 
 
Ion channels possess three fundamental properties; (1) they translocate ions across 
the cell membrane, (2) they selectively discriminate between ions and (3) they 
regulate gating (opening and closing) in response to specific stimuli. These 
biophysical properties can be quantified by electrophysiological techniques to 
understand protein function such as mechanisms of channel gating. Conventional 
electrophysiology techniques such as whole-cell voltage clamp or patch-clamping 
cannot be used to study the biophysical properties of RyR2 channels due to their 
inaccessible intracellular SR location (Zhao et al., 2009). The only method to gain 
biophysical information governing the function of RyR2 and its PFR is to study the 
behaviour of individual channels using the single-channel planar lipid bilayer 
technique. 
 
The study of ion channel properties were first demonstrated using the bilayer 
technique by Miller and Racker, and Alvarez, described in chapter 2.2.4, and 
enables the investigation of single molecules in a well-controlled in vitro 
environment (Miller and Racker, 1976; Alvarez, 1986; Miller, 1986). The advantage 
of this technique is that the behaviour of single protein channels can be monitored 
under defined conditions. The ionic composition of the solutions bathing both faces 
of the channel can be manipulated either in the presence or absence of particular 
accessory proteins, modulators and permeant ions thus enabling comprehensive 
characterisation of channel gating, selectivity and conduction properties.  
 
The single-channel technique is established by an electrical circuit that is formed by 
two ionic fluid filled chambers separated by an artificial lipid membrane in which a 
single ion channel is incorporated. Current flowing through the channel from one 
side of the membrane to another can be measured, depicted in figure 5.1, and 
interpreted using sophisticated data analysis software, discussed in section 5.2.3.5 
and chapter 6.2.2. Idealised raw single-channel data details important 
measurements such as current amplitudes, frequency of events, dwell time intervals 
and open probability, revealing fundamental molecular kinetics of ion channel 
function.  
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Figure 5.1. Single-channel recording of unitary current fluctuations from a 
single hRyR2 channel.  Single-channel trace depicts clear gating transitions 
between open and closed states at + 40 mV in symmetrical 210 mM KCl conditions. 
The purple line denotes the closed state with upward deflections observed as 
channel openings. 
 
5.1.2 The role of K+ as the permeant ion for studying hRyR2  
 
Although Ca2+ is the physiological permeant ion, single-channel bilayer experiments 
have been optimised by using K+ ion as the charge-carrying species (Mukherjee et 
al., 2012; Euden et al., 2013b; Ramachandran et al., 2013; Mukherjee et al., 2014; 
Mei et al., 2015; Bannister et al., 2015). RyR2 has a very high unitary conductance 
when K+ is the permeant ion, reaching a maximum of ~ 1 nS (Lindsay et al., 1991). 
Under typical experimental condition (symmetrical 210 mM KCl) the conductance of 
RyR2 is approximately 789 pS outlined in section 5.3.4. Due to the large 
conductance of RyR2, K+ ions offer the greatest signal-to-noise ratio (SNR), 
improving data accuracy when acquiring current amplitudes, frequency and dwell 
time interval measurements. The SNR ensures that even brief events are detected 
and prevents identifying noise as false gating events or disregarding a true event as 
background noise (Mukherjee et al, 2012). K+ ions are therefore the most favourable 
cations to use for single-channel bilayer recording of RyR2 activity (Lindsay et al., 
1991). 
 
5.1.3 Single-channel characterisation of mutant hRyR2  
 
At present, identifying and altering residues or regions of interest within RyR2 by 
mutagenesis is the only method of investigating the contribution of these entities to 
single-channel gating mechanisms. In the absence of accurate structural data the 
Welch et al analogy model of the hRyR2 PFR, discussed in chapter 1.5.2, provides 
a framework that can be used to predict the involvement of domains and individual 
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residues in the processes of ion translocation and gating (Welch et al., 2004). 
Predictions based on known mechanisms in K+ channels such as a hydrogen-
bonding network that regulates channel inactivation are tested by monitoring the 
function of mutant channels assessing their biophysical characteristics such as 
conductance, open probability, open and closed times in planar lipid bilayers.  
 
Previous RyR2 studies utilising single-channel planar bilayers have focused on 
structural gating components and the process of cation discrimination and 
translocation in the RyR2 PFR. Such studies include investigating the contribution 
of a putative glycine hinge to RyR2 gating (Euden et al., 2013b), the contribution of 
hydrophobic residues predicted to line the cytosolic vestibule of the RyR2 PFR 
(Mason et al., 2012) and identifying acidic residues expected to coat the face both 
the luminal and cytosolic entrances of the RyR2 PFR (Mead-Savery et al., 2009). 
The approach of studying the behaviour of single-channels has yielded novel 
information on the mechanisms underlying ion movement through RyR2.  
 
To understand the involvement of a gating component in RyR2, formed by a 
potential hydrogen-bonding network between the selectivity filter and surrounding 
area proposed in chapter 1.5, it was essential to initially characterise mutant hRyR2 
proteins at the single-channel level. To study the function of recombinant single 
hRyR2 channels at the molecular level the protein must be generated in a 
heterologous cell expression system, isolated and purified to be incorporated into a 
planar phospholipid bilayer, detailed in chapter 2.2.3. Previous investigation of 
channel function was confirmed in chapter 4 using Ca2+ fluorescent-based imaging. 
This important assay verified cellular channel function, thus the next logical step 
was to remove the membrane protein from a cellular environment and, in the 
absence of accessory proteins, to assess fundamental biophysical properties such 
as ion conduction and modification of function by ryanodine at the single-channel 
level. 
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5.2 – Methods and Materials 
 
5.2.1 Electrophysiology reagents  
 
All buffers and solutions were prepared in bottled dH2O (AnalaR NORMAPUR®, 
VWR Chemicals) that were filter sterilised before use. General reagents are listed in 
chapter 2.1.8. All experiments were completed at RT 20 ± 2 °C. 
 
5.2.2 Ion handling reagents  
 
BaCl2 solution: 205 mM BaCl2 with 20 mM HEPES was prepared and adjusted to 
pH 7.4 using Ba(OH)2. The addition of hydroxide ions increased the barium 
concentration by 5 mM. The final BaCl2 concentration was 210 mM. 
 
Monovalent organic cations: 210 mM X+ (‘X’ represents monovalent organic 
cation) and 20 mM HEPES, pH 7.4.  
Ethanolamine: 12.68 mL/L (v/v) ≥ 98 % ethanolamine (16.56 M) stock was 
prepared to obtain a 210 mM working solution, adjusting to pH 7.4 with HCl. 
Diethanolamine: 20.19 mL/L (v/v) ≥ 99.5 % diethanolamine (10.4 M) stock was 
prepared to obtain a 210 mM working solution, adjusting to pH 7.4 with HCl. 
Triethanolamine: 28 mL/L (v/v) ≥ 99 % triethanolamine (7.5 M) stock was prepared 
to obtain a 210 mM working solution, adjusting to pH 7.4 with HCl. 
 
5.2.3 Methods – Single-channel bilayer experiments  
 
5.2.3.1 Initial characterisation of mutant hRyR2 
 
Single-channel bilayer experiments were set up as described in chapter 2.2.4. Upon 
channel incorporation, symmetrical 210 mM KCl conditions were established. WT 
and mutant hRyR2 channels were recorded in contaminant Ca2+ (~ 1 µM) for 5 min 
at + 40 mV. Single mutant hRyR2 channels were assessed by the addition of 1 µM 
ryanodine to the cis chamber.  
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5.2.3.2 Mutant hRyR2 channel conductance - Current-Voltage relationship 
 
Mutant hRyR2 channels were recorded for a minimum of 30 s at each holding 
potential from ± 10 – 70 mV, in 10 mV increments, with symmetrical 210 mM KCl, 
unless stated otherwise. On occasion, to increase channel open probability for 
reliable amplitude idealisation, a caffeine analog, EMD41000, was added (1 µL) 
from a 50 mM stock to the cis chamber at a final concentration of 100 µM (McGarry 
and Williams, 1994). A minimum of five experiments were completed from each 
channel. Channel conductance, measured in pico Siemens (pS), was calculated 
from the slope of the current/voltage (I/V) relationship using linear regression. 
 
5.2.3.3 Ion handling experiments  
 
A series of ion handling experiments were completed to assess altered channel 
conduction properties in Y4839A hRyR2 channels. Single channels were activated 
by solutions containing ~ 1 µM Ca2+, measured using a calcium probe (Orion; 
Thermo Fisher Scientific) (Mukherjee et al., 2012) as outlined in section 6.2.2.1. 
 
5.2.3.3.1 Investigating mutant hRyR2 cation-anion discrimination 
 
Mutant channel discrimination between cation-anions was assessed by establishing 
asymmetric conditions with 810 mM KCl in the cis chamber and 210 mM KCl in the 
trans chamber. A current-voltage relationship, section 5.2.3.2, was completed and 
reversal potential (Erev) was measured at which no current (0 pA) passed through 
the channel, determined by the x-intercept.  
 
5.2.3.3.2 Examining mutant hRyR2 monovalent-divalent permeability  
 
The permeability of divalent Ba2+ ions relative to monovalent K+ ions was 
determined by monitoring reversal potentials under bi-ionic conditions. Conditions 
were initially established in symmetrical 210 mM KCl before the perfusion of the 
trans chamber with 210 mM BaCl2. Relative permeability (PX
2+/PY
+) between 
monovalent (Y+) and divalent (X2+) was calculated using the equation given by Fatt 
and Ginsborg stated below (Fatt and Ginsborg, 1958): 
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PX
2+/PY
+ = [Y+]/(4.[X2+]).exp(ErevF/RT)
.[exp(ErevF/RT) + 1] 
 
RT/F (room temperature/Faraday constant) was 25.2 mV at 20 °C. All reversal 
potentials were corrected for junction potentials arising between the two solutions 
using the ‘AutoZero’ function on the bilayer clamp amplifier BC-535, nullifying any 
offset.  
 
5.2.3.3.3 Investigating mutant hRyR2 ion conduction with changes in K+ 
activity  
 
The effects of mutant hRyR2 ion conduction with varying K+ concentrations were 
assessed using symmetrical 25 mM, 50 mM, 100 mM, 150 mM, 210 mM and 610 
mM KCl conditions. KCl concentrations that corresponded to K+ activities of 21.5 
mM, 40.8 mM, 76.8 mM, 111.3 mM 149.9 mM and 385.5 mM respectively, were 
calculated using the activity co-efficient taken from Hamer and Wu as given in Lobo 
(Hamer and Wu, 1972; Lobo, 1989). Mutant hRyR2 conductance under varying K+ 
activities was calculated from current-voltage relationships that were assessed by 
nonlinear regression derived by Michaelis-Menten-type kinetics. The nonlinear 
regression determined the maximum saturating conductance (Bmax) and half 
maximal conductance (KD).  
 
5.2.3.3.4 Assessing the dimensions of the pore using monovalent organic 
cations 
 
Three monovalent organic cations, ethanolamine, diethanolamine and 
triethanolamine, with varying minimal radii, 2.3 Å, 2.8 Å and 3.6 Å, respectively, 
determined using a molecular modelling software package (HyperChem Release 2, 
Autodesk InC, Sausalito, CA) (Tinker and Williams, 1993a), were selected to assess 
ion conduction and relative permeability to provide information on the dimensions of 
the mutant hRyR2 pore. Symmetrical 210 mM KCl conditions were initially 
established for channel incorporation, before perfusing the cis chamber with 210 
mM of the appropriate organic cation. The reversal potential was measured at which 
no current passed through the channel in order to determine the relative 
permeability ratio (PX
+/PK
+) between the monovalent organic cation (X+) and K+ 
using the Goldman-Hodgkin-Katz equation (Hodgkin and Katz, 1949) stated below:  
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PX
+/PK
+ = [K+]/[X+].e-ErevF/RT 
 
The trans chamber was subsequently perfused with the appropriate test cation to 
create symmetrical conditions to assess channel conductance, section 5.2.3.2. 
 
5.2.3.4 Western blot analysis assessing Y4813A hRyR2 tetramerisation  
 
Western blot analysis assessing Y4813A hRyR2 tetramerisation was completed as 
no single channel events were seen for this channel as described in section 5.3.3.1. 
Purified Y4813A (200 µL) fractions from 28 – 30 % sucrose, detailed in chapter 
2.2.3.7.2, were concentrated in a vivaspin 500 (Sartorius Stedim Biotech) 100,000 
MWCO column at 15,000 x g. The purified protein was concentrated 10 x, 
centrifuging to a final volume of 20 µL. Prior to protein concentration, dH2O was 
eluted through the column to remove residual glycerin. Concentrated samples were 
loaded onto SDS-PAGE and analysed by Western blot, described in chapter 2.2.3. 
 
5.2.3.5 Single-channel data acquisition and analysis  
 
The Acquire 5.0.1 (Bruxton) oscilloscope was used to visualise the data and the 
current transitions were saved as .acquire files. The QuB suite, version 2.0.0.9, from 
the Department of Physiology and Biophysics, State University of New York at 
Buffalo, was used to analyse single-channel data. QuB is a free-access software 
package with a user-friendly graphical interface, enabling scientists to import, 
process, analyse and simulate single-channel data. QuB was used to construct 
multi-state models to describe single-channel kinetics outlined in chapter 6.2.2. 
Acquire files were imported into QuB, selected data of interest were extracted in the 
pre-processing window and saved as .qdf files for subsequent data analysis. An 
initial two state model, closed ⇌ open, was used for data idealisation, generating 
key results such as open probability (Po), open and closed amplitudes (Amp1 and 
Amp2) and mean open and closed times (To and Tc). For current-voltage 
relationships, 30-60 s (> 1000 events) of single-channel data were extracted over a 
range of holding potentials, typically from – 70 mV to + 70 mV in 10 mV increments. 
Channel conductance was assessed as described in section 5.2.3.2.  
 
For presenting single-channel representative traces, current transition data were 
low-pass 1 kHz filtered in QuB, unless otherwise stated. Traces were presented 
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with purple line as baseline (closed state) with channel openings determined by 
upward current deflections at positive holding potentials and downward current 
deflections at negative holding potentials.   
 
5.2.3.5.1 Statistical analysis 
 
Single-channel data were imported into GraphPad (Prism version 5.01) for figure 
construction and statistical analysis. Unitary conductance between WT and mutant 
hRyR2 channels were compared using a one-way ANOVA, Tukey’s multiple 
comparison test, p values < 0.05 were deemed significant. Differences between 
channel conductance and relative permeability for WT and Y4839A were compared 
using an unpaired two-tailed t test, p values < 0.05 were deemed significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
150 
 
5.3 – Results 
 
5.3.1 Initial single-channel characterisation of mutant hRyR2 channels 
 
The functional stability of mutant hRyR2 channels was assessed in chapter 4 by 
whole cell fluorescent based imaging, which confirmed that all six hRyR2 mutations 
formed homotetrameric Ca2+-release channels. Mutant hRyR2 channels were next 
generated in a recombinant cell expression system and were further isolated and 
purified as described in chapters 2.2.2 and 2.2.3. The initial characterisation of 
mutant hRyR2 channels evaluated the stability and integrity of single-channels upon 
removing these membrane proteins from a whole-cell environment and solubilising 
in a detergent/lipid mix before incorporation into an artificial planar lipid bilayer. A 
comprehensive single-channel investigation of mutant channels was completed to 
assess the effect of constructing point mutations at and around the surrounding 
area of the selectivity filter on the biophysical function of the channel.  
 
Mutant hRyR2 single-channel traces, shown in figure 5.2, are representative 5 s 
recordings observing current fluctuations with the primary activating cytosolic ligand 
as contaminant Ca2+ (~ 1 µM) at + 40 mV in symmetrical 210 mM KCl. From initial 
observations, three hRyR2 mutants, Y4813W, Y4839A and Y4839W formed 
channels that were comparable to WT hRyR2. These channels were able to 
incorporate into the bilayer and were therefore suitable for further single-channel 
analysis, discussed in chapter 6. In contrast, the pore helix mutation Y4813A 
depicted in figure 5.2B, was non-functional and was further investigated in section 
5.3.3.1. The mutations proposed at the luminal mouth of the selectivity filter, 
D4829A and D4829E, were characterised by drastically altered gating and 
conductance shown in figures 5.2D and 5.2E that were described in sections 5.3.3.2 
and 5.3.3.3, respectively.  
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Figure 5.2. Initial characterisation of recombinant purified single WT and 
mutant hRyR2 channels incorporated into a planar lipid bilayer. Single-channel 
recording at + 40 mV with baseline (closed) represented as a purple line with 
upward deflections as channel openings. (A) WT hRyR2, (B) Y4813A, (C) Y4813W, 
(D) D4829A, (E) D4829E, (F) Y4839A and (G) Y4839W.  
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5.3.2 Ryanodine modification of mutant hRyR2 channels  
 
The plant alkaloid, ryanodine, which binds with high affinity to hRyR2 was used to 
assess channel modification to verify mutant hRyR2 channels. Figure 5.3 shows 
single-channel WT and mutant hRyR2 gating transitions indicating ryanodine 
binding, illustrated by a red arrow, with channel modification characterised by 
increased open probability and reduced unitary conductance. Ryanodine 
modification was confirmed in all mutant channels except Y4813A, detailed in 
section 5.3.3.1. Gating transitions upon proposed ryanodine modification for 
D4829A and D4829E were both drastically altered and were uniquely different to 
modified WT hRyR2 channels, discussed in section 5.4.4. 
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Figure 5.3. Ryanodine modification of mutant hRyR2 channels. Single-channel 
traces depicting gating transitions prior to ryanodine binding with channel 
modification, illustrated by a red arrow, were characterised by increased open 
probability and reduced unitary conductance, except for (E) and (D) respectively. 
(A) WT hRyR2, (B) Y4813A, (C) Y4813W, (D) D4829A, (E) D4829E, (F) Y4839A 
and (G) Y4839W. The baseline (closed) is represented by the purple line with 
upward deflections as channel openings. Traces are 5 s recording at + 40 mV in 
symmetrical 210 mM KCl.  
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5.3.3 Investigating altered mutant hRyR2 single-channel function 
 
The initial single-channel characterisation of mutant hRyR2 channels indicated that 
point mutations at Y4813A, D4829A and D4829E either altered channel stability, 
gating or conductance while Y4813W, Y4839A and Y4839W were qualitatively 
comparable to WT hRyR2 channels.  
 
5.3.3.1 Investigating altered mutant hRyR2 single-channel function - Y4813A  
 
From over 100 channel incorporation attempts and from three separate purified 
preparations, Y4813A, depicted in figure 5.2B, was not detected in bilayers. The 
stability of Y4813A was assessed by concentrating purified ~ 28 – 30 % sucrose 
fractions, corresponding to tetramer density, by Western blot analysis. Figure 5.4 
demonstrated that Y4813A was present in the concentrated fractions and confirmed 
that the protein assembled to a tetrameric channel following the purification 
procedure that was observed as monomers by Western blot following protein 
dissociation by SDS-PAGE. While the channel tetramer density was confirmed, the 
absence of channel function in bilayers suggested the alanine point mutation within 
the pore helix, either prevented channel incorporation or remained permanently 
closed. Thus, single Y4813A channels were unable to bind ryanodine, figure 5.3B, 
which supported previous loss of high-affinity [3H] ryanodine binding reported in 
chapter 4.3.3. 
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Figure 5.4. Assessing the presence and tetrameric density of Y4813A hRyR2 
channels in purified fractions. Concentrated purified sucrose fractions from three 
separate Y4813A preparations were examined by Western blot analysis. Control 
samples of (1) WT hRyR2 mixed-membrane and (2) purified WT hRyR2 were 
compared to Y4813A sucrose fractions containing either ~ 28 or 30 %, left or right 
lanes, respectively. Purified Y4813A samples were analysed from preparation #1 
(Lane 3), preparation #2 (Lane 4) and preparation #3 (Lane 5). Western blot 
analysis confirmed the presence of Y4813A in sucrose fractions and that the protein 
maintained the ability to form a channel corresponding to the RyR2 tetramer density 
following the purification procedure. Y4813A RyR2 monomers (~ 565 kDa) were 
observed by Western blot, represented by a black arrow, following protein 
dissociation by SDS-PAGE. Bio-markers corresponding to myosin (216 kDa) and β-
galactosidase (132 kDa).   
 
 
 
 
 
Lanes    1   2             3         4                     5 
216 kDa 
132 kDa 
~ 565 kDa 
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5.3.3.2 Investigating altered mutant hRyR2 single-channel function - D4829A  
 
Single-channel characterisation of D4829A revealed multiple unique channels with 
altered gating and reduced conductance properties depicted in figure 5.5. When 
incorporated into a bilayer, purified D4829A did not form channels comparable to 
WT RyR2, figure 5.2. Abolishing the negative charge and hydrogen-bonding 
capabilities of the aspartic acid by alanine mutation, proposed to be located at the 
luminal end of the selectivity filter induced channels with high functional variability. 
From 85 recorded incorporation attempts, 20 D4829A channels were observed and 
were confirmed by ryanodine modification, figure 5.3D. Although channels were 
variable and difficult to quantify, a typically observed D4829A channel depicted in 
figures 5.5A and 5.5B (n=7) had a reduced unitary conductance at + 40 mV, 195.5 
pS, 75 % less than WT hRyR2 (p<0.0001) shown in figure 5.9.  
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Figure 5.5. Single-channel characterisation of D4829A hRyR2 channels. 
Single-channel traces of purified D4829A channels (A – F) incorporated into a 
planar lipid bilayer had high channel-to-channel variability. Alanine point mutation at 
position D4829 induced multiple unique channels characterised by altered channel 
gating and conductance. Channels typically observed (A) and (B) were confirmed 
by ryanodine modification, depicted in figure 5.3D. Differences in current amplitude 
indicated by scale bar depicted top right. 
(A) 
(B) 
(C) 
(D) 
(E) 
(F) 
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5.3.3.3 Investigating altered mutant hRyR2 single-channel function - D4829E  
 
From 30 incorporation attempts, 12 single D4829E channel recordings were 
observed. Similar to D4829A, the conservative D4829E substituted channels were 
characterised by high channel-to-channel variability shown in figure 5.6. Multiple 
unique defined sub-conductance states were observed when channels were 
monitored at + 40 mV in symmetrical 210 mM KCl. Measuring the closed to fully 
open level at ± 40 mV revealed that D4829E had a reduced unitary full conductance 
of 627.6 pS that was 20.5 % lower compared to WT hRyR2, depicted in figure 5.9. 
Introducing a conservative residue substitution with negative charge, D4829E, 
however had a 68.9 % larger unitary conductance compared to the alanine mutation 
D4829A, highlighting the importance of residue interactions at the selectivity filter 
within the proposed luminal mouth of the pore.    
 
Increased open probability and reduced unitary conductance, seen typically in WT 
hRyR2 following ryanodine interaction, were not observed in D4829E, depicted in 
figure 5.3E. Prior to the addition of ryanodine, defined sub-conductance states were 
observed in D4829E channels. The change in D4829E gating, highlighted by the 
arrow in figure 5.3E, was only seen in the presence of ryanodine suggesting that the 
observed state was induced by channel modification of ryanodine. Upon this 
proposed modification, two of the intermediate sub-conductance states were 
replaced with a defined reduced conductance state. The dissociation of the 
ryanodine molecule from the channel was observed by changes in gating kinetics 
and sub-conductance states, shown in figure 5.7. The dissociation of the ryanodine 
from the proposed modified channels supported previous [3H] ryanodine results that 
reported reduced binding, 7.18 % compared to WT hRyR2. This indicated that point 
mutation at D4829E either altered access to, or altered the conformation of the 
binding site affecting the affinity of ryanodine within the pore.   
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Figure 5.6. Single-channel characterisation of D4829E hRyR2 channels. 
Observed single-channel recordings of purified D4829E channels (A – F) at + 40 
mV in symmetrical 210 mM KCl. The conservative glutamic acid substitution at 
position D4829E induced high channel-to-channel variability characterised by 
defined sub-conductance states with altered channel gating and conductance. 
Differences in current amplitude indicated by scale bar depicted top right. 
(A) 
(B) 
(C) 
(D) 
(E) 
(F) 
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Figure 5.7. Single-channel ryanodine modification of D4829E hRyR2. Single-
channel gating events prior to and following the addition of 1 µM ryanodine. 
Highlighted section in red represents distinct and unique channel modification. 
Dissociation of ryanodine was observed in the time-scale of a single-channel 
experiment.  
 
Channel function was drastically altered highlighting the importance of residue 
properties and their interactions within the proposed selectivity filter region. The 
initial mutant single-channel characterisation revealed that Y4813A was non-
functional for bilayer experiments, and due to the high variability seen in both D4829 
mutations it was decided that these three hRyR2 mutations, Y4813A, D4829A and 
D4829E, were not examined further, however the consequences of these mutations 
are discussed in sections 5.4.3 and 5.4.4, and in chapter 7.  
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5.3.4 Ion handling – Assessing mutant hRyR2 channel conductance 
 
Three channels, Y4813W, Y4839A and Y4839W, from the six hRyR2 mutations 
constructed were suitable for in depth single-channel analysis, detailed in chapter 6. 
Chapter 6 investigates potential subtle alterations in channel gating kinetics, as a 
consequence of residue substitution, that are not considered in this chapter. These 
hRyR2 point mutations produced channels that were qualitatively comparable to WT 
hRyR2 with similar observable gating transitions as shown in figure 5.2. As a 
general overview, K+ conductance was examined in the three hRyR2 mutants and 
compared with the conductance measured in WT channels. Unitary channel 
conductance was assessed by monitoring the relationship between current 
amplitude and holding potential in symmetrical 210 mM KCl. These current/voltage 
(I/V) relationships shown in figure 5.8 measured slope conductance of WT and 
mutant hRyR2 channels that were calculated using linear regression, listed in table 
5.1.   
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(A)      (B)  
   
(C)      (D) 
   
 
Figure 5.8. Current-Voltage (I/V) relationships of WT and Mutant hRyR2 
channels. I/V plots (A) WT hRyR2, (B) Y4813W, (C) Y4839A and (D) Y4839W. 
Channel conductance was assessed in symmetrical 210 mM KCl recording current 
amplitude from ± 70 mV in 10 mV increments. Each point is the mean ± SEM from a 
minimum of five experiments. When no error bars are visible, the SEM is included 
within the symbol. Slope conductance was calculated by linear regression, listed in 
table 5.1. Due to high D4829A and D4829E channel-to-channel variability, 
conductance was calculated from a single holding potential (+ 40 mV). Therefore, 
D4829A and D4829E were not included in this figure.   
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Figure 5.9. Comparing channel conductance between WT and mutant hRyR2. 
The conductance of D4829A, D4829E and Y4839A were significantly reduced 
compared to WT by 75 %, 20.5 % and 16.8 %, respectively. Y4813W and Y4839W 
were comparable to WT hRyR2. Individual channel experiments are plotted with 
overall mean conductance listed in table 5.1. Bars (where visible) indicate SEMs.  
 
        
  n G (pS) p < 0.05 
WT hRyR2 9 789.4 ± 16.42 
 Y4813W 7 769.4 ±   8.49 ns 
D4829A 7 195.5 ± 33.59  < 0.0001 
D4829E 5 627.6 ± 56.84        0.0046  
Y4839A 14 656.6 ± 15.98 < 0.0001 
Y4839W 5 765.1 ± 15.97 ns 
 
Table 5.1. Assessing WT and mutant hRyR2 channel conductance in 
symmetrical 210 mM KCl. Mean conductance (± SEM) between WT and mutant 
hRyR2 channels were compared using a one-way ANOVA, Tukey’s multiple 
comparison test, p values < 0.05 were deemed significant. Channel conductance 
was calculated as described in section 5.2.3.2. 
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Unitary conductance of the two conservative mutations Y4813W, 769.4 ± 8 pS, and 
Y4839W, 765.1 ± 15 pS, were comparable to WT hRyR2, 789.4 ± 16 pS. Figure 5.9 
compares individual WT and mutant hRyR2 unitary channel conductance revealing 
that the alanine mutation, Y4839A, conductance was significant reduced by 16.8 % 
compared to WT hRyR2.  
 
5.3.5 Ion handling – Assessing altered Y4839A ion conduction properties 
 
The reduced unitary conductance in Y4839A compared to WT hRyR2 prompted a 
series of four additional ion handling investigations to assess potential mechanisms 
responsible for altered conductance in this channel. These experiments included; 
channel discrimination between cation and anions, relative permeability of 
monovalent and divalent cations, examining channel conductance in response to 
varying K+ activity and to probing the dimensions and conduction properties of the 
Y4839A pore using monovalent organic cations.  
 
5.3.5.1 Assessing Y4839A hRyR2 cation-anion discrimination  
 
Purified WT RyR2 is impermeable to anions such as Cl- (Lindsay and Williams, 
1991). An initial ion handling experiment was completed to assess Y4839A cation 
vs anion discrimination under asymmetric conditions using 810 mM KCl in the cis 
chamber and 210 mM KCl in the trans chamber. An I/V plot was completed to 
measure the reversal potential (Erev), determined by the x-intercept, at which no 
current passed through the channel (0 pA). Under these conditions using the Nernst 
equation a selective cation channel (K+) over anions (Cl-) had an Erev of - 34 mV 
(Mead-Savery et al., 2009). The reversal potential value was comparable to both 
WT - 30 mV and Y4839A - 29 mV shown in figure 5.10 and listed in table 5.2. These 
experiments demonstrated that alanine mutation at Y4839 did not change the ability 
of RyR2 to discriminate between cations and anions.     
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Figure 5.10. Cation-anion discrimination in Y4839A hRyR2. Current/Voltage 
(I/V) relationship assessing cation-anion discrimination between WT (black) and 
Y4839A (red) under asymmetric 810 mM KCl (cis) and 210 mM KCl (trans). Each 
point is the mean ± SEM from a minimum of five experiments. When no error bars 
are visible, the SEM is included within the symbol. 
 
 
n G (pS) Erev (mV) 
WT hRyR2 5 898.8 ± 14.28 - 30.13 ± 1.21 
Y4839A 5 906.9 ± 22.97 - 29.01 ± 1.12 
 
Table 5.2. Cation-anion discrimination of Y4839A hRyR2. Assessing channel 
conductance (G) and Erev between WT and Y4839A hRyR2 in asymmetrical KCl 
conditions confirmed that alanine mutation retained the ability to discriminate 
between cations over anions.  
 
5.3.5.2 Examining Y4839A hRyR2 divalent-monovalent cation permeability 
 
Relative permeability between divalent and monovalent cations (PBa
2+/PK
+) for 
Y4839A hRyR2 was assessed under bi-ionic conditions using 210 mM KCl in the cis 
chamber and 210 mM BaCl2 in the trans chamber. The permeability of Ba
2+ ions 
relative to K+ ions was calculated using the relationship derived by Fatt and 
Ginsborg with the equation stated in section 5.2.3.3.2 (Fatt and Ginsborg, 1958). 
Reversal potentials were manually recorded, filtering at 500 Hz to detect any small 
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current fluctuations.  Previous ion handling experiments on purified sheep RyR2 
demonstrated that divalent cations (Ba2+, Sr2+ Ca2+ and Mg2+) were on average 6.2 
times more permeable (5.8 times for Ba2+) than monovalent K+ ions (Tinker and 
Williams, 1992). The relative permeability of Ba2+ ions, in this study, was 5.3 times 
more than that of monovalent K+ ions in recombinant WT hRyR2 channels. For 
Y4839A hRyR2 however, the relative permeability of Ba2+ ions was 4.5 times 
greater than that of K+ ions. Relative permeability between divalent and monovalent 
cations was significantly reduced by 15.1 % in Y4839A compared to WT hRyR2 
(p=0.0038), depicted in figure 5.11 and listed in table 5.3.  
 
 
 
Figure 5.11. Assessing monovalent-divalent permeability between WT and 
Y4839A hRyR2 channels. Current/Voltage (I/V) relationship showing the response 
of Y4839A compared to WT hRyR2 in bi-ionic conditions of monovalent 210 mM K+ 
(cis) and divalent 210 mM Ba2+ (trans). The Erev and permeability ratios (PBa
2+/PK
+) 
are detailed in table 5.3. All points are mean ± SEM derived from a minimum of four 
experiments. When no error bars are visible, the SEM is included within the symbol. 
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  n Erev Ba
2+ vs K+ (mV) PBa
2+/PK
+ 
WT hRyR2 6 + 35.67 ± 0.38 5.3 
Y4839A 7  + 33.57 ± 0.42 4.5 
 
Table 5.3. Assessing the reversal potential and permeability ratios of WT and 
Y4839A hRyR2 channels under bi-ionic conditions using 210 mM KCl in the 
cis chamber and 210 mM BaCl2 in the trans chamber. 
 
5.3.5.3 Assessing Y4839A hRyR2 ion conduction with changes in K+ activity 
 
To investigate the effects of altered Y4839A hRyR2 function, ion conduction was 
measured under six varying K+ activities (stated in section 5.2.3.3.3) that were used 
to determine the maximum saturating conductance (Bmax) and the activity of K
+ 
(mM) that yielded half-maximal conductance (KD) by nonlinear regression derived 
by Michaelis-Menten-type kinetics, as depicted in figure 5.12. While the KD was 
similar for Y4839A compared to WT hRyR2, ~ 23 mM, the Bmax was reduced by 8.6 
%, listed in table 5.4. Differences in Bmax between the alanine mutation and WT 
hRyR2 channels was due to reduced unitary conductance at 21.50 mM, 111.3 mM 
and 149.9 mM K+ activities in Y4839A, corresponding to symmetrical 25 mM, 150 
mM and 210 mM KCl concentrations, respectively.  
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Figure 5.12. Assessing channel conductance between WT and Y4839A hRyR2 
in response to increasing K+ activity. Nonlinear regression derived by Michaelis-
Menten-type kinetics determined Bmax and KD listed in table 5.4. Each point is the 
mean conductance ± SEM derived from at least four experiments. When no error 
bars are visible, the SEM is included within the symbol. 
 
  
 
Bmax (pS) KD (mM) 
WT hRyR2 
 
906.5 ± 15.2 23.59 ± 1.9 
Y4839A 
 
829.2 ± 37.4 23.10 ± 5.9 
 
Table 5.4. Comparing Bmax and KD between WT and Y4839A in response to 
increasing K+ activity. Each point is the mean conductance ± SEM derived from at 
least four experiments. 
 
5.3.5.4 Measuring the pore dimensions and ion conduction properties of 
Y4839A hRyR2 using monovalent organic cations 
  
Previous investigations demonstrated that RyR2 is permeable to a wide range of 
monovalent organic cations (Tinker and Williams, 1993a). To assess the 
dimensions and conduction properties of Y4839A, three monovalent organic 
cations, ethanolamine, diethanolamine and triethanolamine with similar chemical 
properties but varying minimal radii were selected. Table 5.5 lists the reversal 
potential and relative permeability comparing WT and Y4839A. Both Y4839A and 
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WT hRyR2 channels were impermeable to triethanolamine, with a minimal radius of 
3.6 Å. Triethanolamine was unable to pass through the channels at high holding 
potentials, ≥ + 80 mV, as depicted in figure 5.13. This supported previous studies 
that established that the narrowest portion of RyR2, proposed to be the selectivity 
filter, had a minimal radius of ~ 3.5 Å (Tinker and Williams, 1993a). The 
consequence of reducing the side chain length and interactions at position Y4839A 
within the PFR did not alter the dimensions of the pore. In addition, the relative 
permeability and unitary channel conductance for ethanolamine and diethanolamine 
were comparable to WT hRyR2 channels.  
 
Organic 
cation 
RxA Erev (mV) Px/PK G (pS) 
  
WT Y4839A WT Y4839A WT Y4839A 
Ethanolamine 2.3 23.4 ± 0.6 25.5 ± 1.1 0.40 0.36 133.6 ± 1.1 131.7 ± 2.0 
Diethanolamine 2.8 43.8 ± 0.4 41.7 ± 0.5 0.18 0.19 33.6 ± 1.4 33.6 ± 1.1 
Triethanolamine 3.6 ≥ 80  ≥ 80  ≤0.04 ≤0.04 - - 
 
Table 5.5. Probing the dimensions and conduction properties of WT and 
Y4839A hRyR2 channels using monovalent organic cations. Reversal potentials 
and single channel conductance were derived from four or more experiments. 
 
(A)
 
 
(B) 
 
 
Figure 5.13. Measuring reversal potential for monovalent organic cations. 
Representative single-channel traces of WT hRyR2 in asymmetric conditions, 210 
mM KCl (cis) and 210 mM triethanolamine (trans) at holding potentials (A) 0 mV and 
(B) + 80 mV. Both WT and Y4839A were impermeable to triethanolamine (minimum 
radius 3.6 Å), indicating that reducing the side-chain length with alanine mutation 
did not alter the pore dimensions in a way that increased aperture radius or 
permeability of the tertiary amine. Single-channel data were filtered at 500 Hz to 
visualise small currents. 
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5.4 – Discussion 
 
5.4.1 Initial single-channel characterisation of mutant hRyR2 channels 
 
The purpose of this investigation was to characterise the single-channel properties 
of purified hRyR2 channels in which residues in the proposed selectivity filter and 
pore helix, and hypothesised to play important roles in channel function, have been 
mutated. Mutant hRyR2 channels were generated recombinantly in a heterologous 
cell expression system and were isolated and solubilised in conditions that have 
been used in previous studies to investigate single-channel RyR2 function (Mead-
Savery et al., 2009; Mason et al., 2012; Euden et al., 2013b). It was essential to 
initially screen the novel hRyR2 mutants to assess their single-channel stability and 
general biophysical properties such as ion conduction.  
 
Constructing single point mutations within hRyR2 revealed that residue interactions 
in the proposed selectivity filter and pore helix are essential for maintaining typical 
gating and ion conduction discussed in section 5.4.3, 5.4.4 and 5.4.5. Altered 
single-channel function was assessed by examining structural models of the pore-
forming region, in particular, the position and distances of mutated residues in the 
proposed pore, detailed in sections 5.4.2 and 5.4.6.  
 
5.4.2 Structural models of the RyR pore-forming region   
 
Models of the pore-forming region of RyR1 based on structures obtained by cryo-
EM have superseded the original PFR RyR2 model based on the K+ channel KcsA 
that was used to make predictions of gating mechanisms stated in the hypotheses 
(Welch et al., 2004; Zalk et al., 2014; Efremov et al., 2014; Yan et al., 2015). In the 
absence of high resolution crystal structures of the PFR region resolved in varies 
conformations, these structural models have been used to predict mechanisms of 
channel gating that arise from interactions between residues and domains (Welch et 
al., 2004; Euden et al., 2013b; Ramachandran et al., 2013; Mei et al., 2015). The 
continual evolution of protein preparation, instrumentation and image processing 
techniques has improved the accuracy of structural data, and currently the 3.8 Å 
PFR RyR1 model in a closed conformation is the most accurate structural model 
shown in figure 5.14A (Yan et al., 2015).  
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The initial and most striking difference comparing the two models are the 
dimensions of the selectivity filter and the conformation and length of the S6 and 
pore helices. Comparing the side and luminal view between models, shown in figure 
5.14, the altered conformation of the helices has changed the location and 
distances between the three residues highlighted in red. A hydrogen-bonding 
network in the current Yan et al model between the three residues would not be 
possible, discussed in section 5.4.6. 
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(A)       
            
(B) 
        
 
Figure 5.14. Pore-Forming Region models of the ryanodine receptor channel. 
(A) RyR1 PFR model (Yan et al., 2015) and (B) the analogy PFR RyR2 model 
(Welch et al., 2004). (Left) Side view highlighting the S5 helix (green), pore helix 
(blue), selectivity filter (red) and S6 helix (purple). (Right) Luminal view highlighting 
the three residues, Y4813, D4829 and Y4839 in red, which depicts the changes in 
residue position and distance between models. (A) The model of Yan et al is unable 
to support a proposed hydrogen-bonding network. PDB file 3J8H used with 
permission from Chang-cheng Yin (Yan et al., 2015). 
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The structural differences between the models are highlighted when aligning the 
primary sequence of the proposed helix boundary sites depicited in figure 5.15. Of 
importance, residue Y4839 in the Yan et al RyR1 model is located at the start of the 
S6 helix, in contrast to the analogy model where it is located in a loop-forming 
region thus explaining potential differences in ion handling and ion conduction, 
discussed in section 5.4.5.  
 
 
 
Figure 5.15. Proposed boundary sites of pore-forming region RyR helices. 
Human RyR1 and RyR2 helice boundary sites based on (Yan et al., 2015) and 
(Welch et al., 2004), respectively. Highlighted residues form S5 helix (green), pore 
helix (blue), selectivity filter (red) and S6 helix (purple). Point mutations are 
underlined. Figure obtained from a web-based software, uniprot, aligning entry 
codes P21817 (RyR1) and Q92736 (RyR2) (http://www.uniprot.org/align).  
 
In the absense of crystal structures, these models provide a useful structural 
framework to predict the involvement of residue interactions when assessing the 
structural-functional relationship. The initial single-channel characterisation of 
hRyR2 containing point mutations in the proposed selectivity filter and pore helix 
regions of the channel revealed interesting insights into the importance of residues 
within the pore. Evaluting the differences in residue distances and orientation, in 
regard to the orginial Welch et al analogy model, with the data obtained by single-
channel analysis is explored in the following sections.  
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5.4.3 Initial single-channel characterisation of mutant hRyR2 channels – 
Y4813 
 
hRyR2 containing the alanine mutation at residue Y4813A was confirmed to form 
functional tetramer channels, in a cellular environment, albeit with a 25.6 % 
reduction in the maximum Ca2+ release compared to cells expressing WT hRyR2 
channels. The [3H] ryanodine binding assay on mixed-membranes expressing 
Y4813A, isolated from HEK293 cells, reported 1.03 % binding compared to WT 
hRyR2 in conditions that favoured high channel open probability that included high 
Ca2+ (100 µM) and caffeine (10 mM) concentrations. While the mutant channels 
maintained the ability to form tetrameric proteins, confirmed by Western blot 
following solubilisation and the purification procedure, substituting the tyrosine with 
an alanine within the pore helix resulted in a channel that was either unable to 
incorporate into the planar lipid bilayer or remained permanently closed upon 
incorporation. From over 100 unsuccessful incorporation attempts, from three 
separate purification preparations, the channel was deemed non-functional at the 
single-channel level. It was therefore not possible to characterise the mechanism for 
reduced maximum Ca2+ release reported in chapter 4.3.1.1. 
 
Figure 5.16 compares the location of residues between the monomers of both the 
Yan et al, figure 5.16A and Welch et al PFR, figure 5.16B, models highlighting 
Y4813 in blue. In the Welch et al analogy model, Y4813 faces inwards into the pore, 
favouring a hydrogen-bonding network with the selectivity filter. In contrast, in the 
Yan et al RyR1 model, Y4813 is on the opposite side of the helix, rotated 180°, 
facing away from D4829 and the pore. Substituting the tyrosine with an alanine 
resulted in a compromised channel, discussed in chapter 7, strongly indicating that 
a component in the pore helix is essential in maintaining the relative functional 
characteristics of hRyR2.   
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(A)      (B) 
         
 
Figure 5.16. Comparing the location of residues between (A) the PFR RyR1 
model (Yan et al., 2015) and (B) the analogy PFR RyR2 model (Welch et al., 
2004). Highlighted residues are colour coded; Y4813 (blue), D4829 (red) and Y4839 
(green), analogous residues highlighted in Yan et al RyR1 model. One monomer is 
shown for clarity.  
 
Several groups investigating RyR channels have reported altered protein function 
upon the removal of mutant channels from the cellular environment (Gao et al., 
2000; Du et al., 2001; Li et al., 2002a; Avila et al., 2004; Wang et al., 2003; Wang et 
al., 2004; Euden et al., 2013b; Seidel et al., 2014; Mei et al., 2015). These RyR 
mutations, such as L433P and G4864P in RyR2, and D4899A and G4934V in 
RyR1, were shown to form tetrameric channels that were caffeine sensitive in 
HEK293 cells, however the consequence of point mutation affected the function of 
protein when isolated and solubilised, demonstrated by reduced [3H] ryanodine 
binding and altered single-channel function. The observations from Y4813A were 
consistent with these earlier investigations highlighting the challenges of studying 
single hRyR2 function. 
 
In K+ channels, the pore helix plays a critical role in maintaining the structural 
integrity of the selectivity filter (Doyle et al., 1998; Zhou et al., 2001; Long et al., 
2007), and there is also evidence that this region plays a crucial dynamic role during 
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selectivity filter gating (Clarke et al., 2010; Wang et al., 2011; Raghuraman et al., 
2012; Perry et al., 2013). Residue substitution in the pore helix of KcsA (W67A), in a 
proposed similar position to Y4813, yielded a protein that failed to assemble 
correctly (Cordero-Morales et al., 2006). Introducing a conservative tyrosine 
subsitituion to the pore helix at this position, W67Y, interestingly retained channel 
function similar to WT KcsA and did not affect the overall kinetics and extent of 
gating as the ability to form hydrogen bonds was preserved (Cordero-Morales et al., 
2011). The structure of the PFR of RyR is proposed to resemble a pore architecture 
similar to K+ channels (Welch et al., 2004; Samsó et al., 2005; Ludtke et al., 2005; 
Ramachandran et al., 2009; Ramachandran et al., 2013), suggesting that dynamic 
rearrangements in the pore domains may occur in RyR analogous to known gating 
mechanisms in K+ channels (Cordero-Morales et al., 2006; Cuello et al., 2010a; 
Cuello et al., 2010b).  
 
In conjunction, the initial single-channel characterisation of Y4813W provided the 
first novel insight into the importance of residue interactions in the pore helix of 
hRyR2. In contrast to Y4813A, the conservative mutant Y4813W restored channel 
function that was comparable to WT hRyR2, which also coincided with the 
preserved maximum Ca2+ release from HEK293 cells, shown in figure 4.10. 
Maintaining either the steric bulk or the physicochemical properties and hydrogen-
bonding capabilities, by replacing the phenol side chain with an indole group, 
produced a functional channel that was qualitatively comparable to WT hRyR2 with 
similar ion conductance shown in figure 5.2. Introducing a conservative residue 
within the pore helix enabled the channel to bind ryanodine at the single-channel 
level, suggesting that the structural conformation of the Y4813W pore had been 
restored in contrast to Y4813A. The functional consequence of the conservative 
tryptophan on channel gating was examined further in chapter 6. 
 
5.4.4 Initial single-channel characterisation of mutant hRyR2 channels – 
D4829 
 
As discussed in chapter 4, the aspartic acid at position D4829, located at the 
luminal mouth of the selectivity filter is highly conserved throughout RyR isoforms 
and other channels (IP3R and K
+ channels) (Balshaw et al., 1999; Taylor and Tovey, 
2010; Heginbotham et al., 1994; McCoy and Nimigean, 2012). The negative charge 
near the luminal mouth generates an ideal capture radius for cations. Previous 
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investigations that removed charge and neutralised acidic residues in the luminal 
mouth produced changes in the electric field in the pore that altered the interaction 
energies of permeant ions and the stability of the selectivity filter region that 
ultimately contributed to reduced unitary conductance and changes in ion handling 
and gating (Mead-Savery et al., 2009). Another investigation focused on D4899 in 
RyR1 (analogous to D4829 in RyR2) (Gao et al., 2000). Generating alanine 
(reduced side chain), arginine (positive charged) and asparagine (uncharged with 
similar side chain length) D4899 mutations resulted in decreased K+ conductance, 
shown in figure 5.18, and a loss of high-affinity [3H] ryanodine binding but 
maintained their response to caffeine in the cellular assay (Gao et al., 2000). The 
D4829 mutations described in this chapter supported these previous reports by Gao 
et al. In addition, mutation of the analogous residue in the inositol 1,4,5-
trisphosphate (IP3) receptor (IP3R) (D2550A) resulted in defective Ca
2+ release 
activity (van Rossum et al., 2004; Bhanumathy et al., 2006). Together, these results 
indicate that the conserved selectivity filter residue constitutes an essential part of 
the ion-conducting pore of both IP3R and RyR channels.  
 
 
 
Figure 5.17. Single-channel recordings of WT and mutant D4899 RyR1 in 
symmetrical 250 mM KCl solution. D4899 in RyR1 is analogous to the D4829 
selectivity filter residue in RyR2. Downward single-channel currents are channel 
openings. Similar channel conductance and gating characteristics were observed in 
D4829 RyR2 mutations, depicted in figures 5.5 and 5.6, compared to D4899 RyR1 
mutations. Figure adapted from Gao et al., (2000). 
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The architecture of the selectivity filter in K+ channels ensures strong K+ ion binding 
site interactions that provide optimal geometry and close coordination for 
dehydrated K+ ions (Doyle et al., 1998). The biophysical structural properties of the 
selectivity filter, lined by carbonyl oxygen atoms provide closely spaced sites that 
ensure high selectivity over relevant cations such as Na+ ions and allows for high 
ion conduction mediated by electrostatic repulsion (Yellen, 2002; Roux et al., 2011; 
Nimigean and Allen, 2011; Alam and Jiang, 2011). 
 
The dimensions of the pore in the current Yan et al RyR1 model are somewhat 
different. Comparing the Yan et al and the original Welch et al models of the PFR 
RyR depicted in figure 5.18 reveals an altered conformation of the selectivity filter. 
An arbitrary measurement using PyMol between the two adjacent D4829 residues 
reported a distance of 12.3 Å in the Welch et al analogy RyR2 model shown in 
figure 5.18B that had increased to 16.9 Å in the Yan et al RyR1 model, figure 5.18A 
(Yan et al., 2015).  
 
(A)      (B) 
         
 
Figure 5.18. Comparing the dimensions of the selectivity filter between 
structural models. The selectivity filter highlighted in blue with the residue D4829 
(D4899 RyR1) in red of (A) the current PFR RyR1 model (Yan et al., 2015) and (B) 
the analogy PFR RyR2 model (Welch et al., 2004). 
 
While the signature sequence remains the same (GGGIGD) the concave 
conformation of Yan et al PFR model, figure 5.18A, may explain the non-selective 
and relative permeability to a wide range of monovalent and divalent cations 
(Lindsay and Williams, 1991; Tinker and Williams, 1992; Tinker and Williams, 
1993a). This suggests that the conformation of the filter and the arrangement of 
residues to accommodate specific cations are less important in RyR than in K+ 
channels.  
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Reducing the side chain length in D4829A, resulted in a channel with reduced 
unitary conductance, 195.5 pS, 75 % less than WT hRyR2, figure 5.9, and also 
produced gating kinetics similar to those reported in D4899A RyR1 shown in figures 
5.5 and 5.17. In addition, the maximum Ca2+ release of HEK293 cells expressing 
D4829A channels was reduced by 22.7 % compared to cells expressing WT hRyR2 
channels (chapter 4.3.1.1). This suggests that the reduced ∆F from a population of 
D4829A channels may have been a consequence of decreased D4829A single-
channel conductance. A mechanism for the reduction in D4829A channel 
conductance could be due to the loss of negative charge in the luminal region that 
provides a mechanism for maximising rates of cation delivery to the pore (Welch et 
al., 2004).  
 
Interestingly, introducing a conservative mutation at this position, D4829E, thus 
maintaining the negative charge but extending the side chain length by a methyl 
group, increased unitary conductance compared to D4829A and maintained the 
maximum Ca2+ release compared to WT hRyR2 channels (chapter 4.3.1.1). This 
suggests that negative charge in the luminal mouth has a functional role for cation 
delivery and translocation. D4829E did however initiate two well-defined sub-
conductance states at the single-channel level. The consequence of conservative 
residue substitution and flexibility of the filter is likely to have contributed to sub-
conductance states that arise from small conformational changes that alter the 
electric field or affect the ability of this region of the channel to bind ions, discussed 
in chapter 7.1 (Dani and Fox, 1991; Mead-Savery et al., 2009). 
 
At the single-channel level, a proposed D4829E ryanodine modified channel 
depicted in figure 5.7, was only observed in the presence of ryanodine. It was 
therefore likely that the altered gating events, highlighted in red, were due to 
ryanodine interaction within the channel. Ryanodine was able to dissociate from the 
proposed modified channel, thus explaining the lower 7.18 % [3H] ryanodine binding 
results compared to WT hRyR2. Ryanodine dissociation from single-channels and 
loss of [3H] ryanodine binding has been previously reported in other studies 
investigating residue substitution within the RyR pore, Q4863A (Wang et al., 2003; 
Ranatunga et al., 2005). In this study, the single-channel observations from figure 
5.7 suggested that the access to, or the conformation of the binding site affected the 
affinity of ryanodine interaction with D4829E. Further work would be required to 
assess the consequence of glutamic acid mutation at position 4829 on the altered 
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affinity of the ryanodine-RyR2 interaction, using reversible ryanoid derivatives such 
as 21-amino-9alpha-hydroxy-ryanodine (Tanna et al., 1998). 
 
Constructing alanine and glutamic acid point mutations at position D4829 produced 
channels with reduced ion conductance and high channel-to-channel functional 
variations. The unique and varied D4829 hRyR2 mutations were ultimately 
unsuitable for further investigations in the time-scale of this project. However the 
drastic effect on channel gating and conductance suggested that the negative 
charge and also the precise side chain length of the conserved aspartic acid is 
essential in maintaining channel function.  
 
5.4.5 Initial single-channel characterisation of mutant hRyR2 channels – 
Y4839 
 
As discussed in section 5.4.2 the initial and most striking difference comparing the 
two models, Yan et al and Welch et al, was the location of Y4839. Comparing the 
proposed boundary sites of helices in the primary sequence, depicted in figure 5.15, 
revealed that in the Welch et al model of RyR2, Y4839 is located in a loop-forming 
region close to the selectivity filter region. In contrast, Y4839 in the PFR RyR1 
model by Yan et al is located in the S6 helix away from the pore and selectivity filter 
region, highlighted in green in figure 5.16. The changes in the position of Y4839 are 
due to the altered helix boundary sites between models. The loop-forming region 
consists of 18 residues between the selectivity filter and S6 helix in the Welch et al 
model of RyR2, figure 5.16B. In contrast the loop-forming region in the current Yan 
et al model is considerably shorter, with the filter and the start of S6 helix separated 
by only 6 residues. The increased length of the S6 helix in the Yan et al RyR1 
model encompasses the residue Y4839, figure 5.16A. The location and orientation 
of Y4839 within the α-helix means that the residue faces away from the selectivity 
filter region and a direct interaction of the residue within the pore would be 
implausible.  
 
Pore-forming region helices are structural domains that pass through numerous 
conformational changes and are important in the protein’s machinery to allow 
transitions of the channel between closed and open states. Previous investigations 
based on the activation gate of K+ channels proposed that the S6 helix in RyR 
undergoes conformational rearrangements in the gating process (Euden et al., 
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2013b; Mei et al., 2015). Thus, reducing the side chain length and removing residue 
interactions with the α-helix in Y4839A hRyR2 may have altered the structure and 
imposed different constraints within the spiral conformation.  
 
The initial single-channel characterisation of Y4839A revealed a functional channel 
with similar gating kinetics to WT hRyR2 shown in figures 5.2A, 5.2F and 5.2G. This 
supported earlier reports of similar maximum Ca2+ release in HEK293 cells 
expressing Y4839A compared to cells expressing WT hRyR2 channels, outlined in 
chapter 4.3.1.1. However, upon single-channel analysis, under the conditions used 
in these experiments, the alanine mutation produced a channel with a significant 
16.8 % reduction in ion conductance compared to WT hRyR2, thus a series of four 
ion handling investigations were completed to determine the mechanisms 
responsible for altered ion conduction.  
 
While the alanine mutation did not alter the ability of hRyR2 to discriminate between 
cations and anions, the relative permeability between divalent and monovalent 
cations was significantly lower than in WT hRyR2. This was surprising as in 
previous reports it had been proposed that a high density of negative charge, either 
within the pore or within vestibules at either end of the pore, was responsible for 
discrimination between cations (Tinker et al., 1992; Mead-Savery et al., 2009). 
However altered cation discrimination, due to disrupted interactions in Y4839A, may 
have been achieved through an indirect conformational change of the highly 
electronegative loop-forming region between the selectivity filter and S6 helix. The 
activity saturation curve also provided interesting insight into the consequence of 
Y4839A on channel conductance. The unitary conductance was unaltered at all K+ 
activities except for 21.50 mM, 111.3 mM and 149.9 mM when compared to WT 
hRyR2 channels. While the KD remained the same ~ 23 mM, the reduced Bmax of 
Y4839A may have been due to changes in the pore’s energy profile.  
 
Probing the dimensions and conduction properties of Y4839A channels using 
monovalent organic cations demonstrated no significant differences in relative 
permeability and unitary conductance. This indicates that reducing the size of the 
side chain of this residue in the S6 helix did not increase the minimum radius of the 
pore (or its properties) to such an extent as to allow triethanolamine to pass 
through. The minimal radius of the pore was determined to be < 3.6 Å, this value 
was in accordance to the minimum pore radius of 3.5 Å established for WT RyR2 in 
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a previous investigation that employed 23 monovalent organic cations of varying 
size and properties (Tinker and Williams, 1993a). 
 
As is the case for the pore helix mutation at Y4813, the conservative Y4839W 
mutation restored single channel conductance to a value comparable with WT 
hRyR2. The initial single-channel characterisation of Y4839W highlighted the 
importance of either the steric bulk or residue physicochemical hydrogen-bonding 
interactions of this residue within the pore region. The single-channel investigation 
of point mutations occuring at Y4839 indicated that residue interactions at this 
location are important in ion conduction and to the discrimination of cations. The 
consequence of residue subsitution at Y4839 on channel gating mechanisms was 
further examined in chapter 6. 
 
5.4.6 Investigating a potential hydrogen-bonding network in the PFR of RyR 
 
The hypothesis in which it was proposed that a hydrogen-bonding network is 
established by three residues between the selectivity filter and pore helix that 
regulates channel gating (chapter 1.5) were assessed. The distances between the 
ends of the hydroxyl and carboxyl side chains of these three residues were 
measured in PyMol, depicted in figure 5.19. The distances between Y4813-D4829 
and Y4839-D4829 in the Welch et al analogy PFR model were 2.5 Å and 3.7 Å 
respectively as shown in figure 5.19B and are ideal to form hydrogen-bonds 
(Hubbard and Haider, 2010). However, in the current Yan et al model, depicted in 
figure 5.19A, the distance between the proposed residues Y4813-D4829 and 
Y4839-D4829, 20 Å and 25.6 Å respectively, would not allow the formation of a 
hydrogen-bonding network.  
 
Therefore, the close proximity of defined pore residues occurring in K+ channels, 
that form a gate by stabilising the selectivity filter may not occur in hRyR2 
(Bernèche and Roux, 2005; Cordero-Morales et al., 2006; Ader et al., 2008; Cuello 
et al., 2010a; Cuello et al., 2010b; van der Cruijsen et al., 2013). However, 
removing the hydrogen-bonding capacity of two of the hRyR2 mutations, Y4813A 
and D4829A, significantly affected channel gating and function. This observation 
suggests that these residues, Y4813 and D4829, are essential and may be involved 
in stabilising a conformation of the pore helix and selectivity filter. 
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(A)      (B) 
              
 
Figure 5.19. Measuring the distances between residues in (A) the PFR RyR1 
model (Yan et al., 2015) and (B) the analogy PFR RyR2 model (Welch et al., 
2004). Highlighted residues are colour coded; Y4813 (blue), D4829 (red) and Y4839 
(green), analogous residues highlighted in RyR1. Labelled distances were 
determined in PyMol measured in Ångström. (A) The proposed hypothesis of a 
hydrogen-bonding network between highlighted residues would not be possible in 
the current Yan et al model. One monomer is shown for clarity.  
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In summary, although the relative position of residues Y4813 and Y4839 have been 
altered in the current Yan et al model, it is important to note that while the resolution 
of the structure has improved these models represent static structures. Membrane 
proteins are complicated dynamic molecules that interact continuously with the 
surrounding environment including lipid, ligands, accessory proteins and modulators 
that ultimately result in allosteric conformational movements between residues and 
domains. While in the model published by Yan et al, the distances between the 
three residues proposed in the hypothesis would not permit the formation of 
hydrogen-bonds due to rearrangement of helices, the selectivity filter region and 
residues are still of high importance.  
 
Initial single-channel characterisation of selectivity filter and pore helix hRyR2 
mutations has revealed interesting insight into the importance of residue properties 
and their interactions within the pore. Three hRyR2 mutant channels, Y4813W, 
Y4839A and Y4839W, were suitable for detailed investigations of gating processes 
of individual channels and these experiments form the basis of chapter 6. The 
validity of the PFR structural models and the function of residue interactions can 
only be assessed by measuring biophysical kinetics of mutated proteins at the 
single-channel level. Examining these gating mechanisms will reveal a potential role 
of the selectivity filter as a gating component and will assist in the structural-
functional relationship of residue interactions in the pore.  
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Chapter Six: 
 
Single-Channel Gating Mechanisms 
at the Selectivity Filter of WT and 
Mutant hRyR2 channels 
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Single-Channel Gating Mechanisms at the Selectivity Filter of WT and 
Mutant human Cardiac Ryanodine Receptor (hRyR2) channels 
 
Chapter Six – Aims 
 
The initial single-channel characterisation, outlined in chapter 5, revealed interesting 
insight into the functional consequence and importance of residue interactions 
around the proposed selectivity filter region. Three hRyR2 mutant channels, 
Y4813W, Y4839A and Y4839W, were suitable for detailed investigation of gating 
processes. This chapter uses the single-channel technique and sophisticated data 
analysis to assess the role of residue side chain interactions within the pore region 
and to reveal underlying channel gating mechanisms predicted to occur at the 
selectivity filter. The aims of this chapter are as follows: 
 
 To investigate the gating mechanism of WT and mutant RyR2 channels in 
response to activating Ca2+ under minimal conditions. This will initially 
involve calculating the open probabilities (Po) achieved at different 
concentrations of free Ca2+ and analysing the relationship between dwell 
times and Po. 
 
 Following data selection, according to criteria outlined in section 6.3.6, 
gating behaviour (state occupancy, time and rate constants) was analysed 
using QuB and compared to previous studies (Mukherjee et al., 2012). 
 
 To identify the prevalence and nature of flicker gating events (thought to 
originate in the selectivity filter) in mutant hRyR2 channels, to see if 
substitution has affected this particular conformational transition. 
 
 To discuss and relate novel hRyR2 gating information to recently published 
RyR1 models to enhance the credibility of these static structures.  
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6.1 – Introduction 
 
6.1.1 Understanding the mechanisms of hRyR2 channel gating  
 
Ion channels are allosteric proteins that undergo complex structural 
rearrangements, in response to specific stimuli, to allow ion conduction. The 
permeation of ions through the channel pore is regulated by distinct structural 
elements that act as intermittent barriers, or gates, in a process termed channel 
gating (Perozo et al., 1999; Cordero-Morales et al., 2006; Cuello et al., 2010a; 
Cuello et al., 2010b; Wang et al., 2011). The precise control of these gating events 
and the dynamic movement of these structural elements are critical for normal 
cellular function. Altered RyR2 channel function is a key component in the 
pathogenesis of arrhythmia in acquired and genetic diseases (Priori et al., 2001; 
George et al., 2003; Mohamed et al., 2007; Dobrev and Wehrens, 2014), and it is 
therefore essential to identify these structural elements involved in RyR2 channel 
gating to gain detailed knowledge of the fundamental processes of RyR2 function in 
health and disease.  
 
Mechanisms underlying channel gating were initially elucidated in K+ channels 
through numerous X-ray crystal structures and experimental data (Doyle et al., 
1998; Zhou et al., 2001; Jiang et al., 2002b; Jiang et al., 2003; Long et al., 2005; 
Uysal et al., 2009; Cuello et al., 2010b). As discussed in chapter 1.5.6, two gates 
exist in K+ channels; an activation gate located at the inner-helix bundle crossover 
(IHBC) and an inactivation gate located at the selectivity filter, depicted in figure 
1.22. The coupled interplay between activation and inactivation gating in K+ 
channels succinctly controls the flow of ions. The structural basis of K+ channel 
gating, and the structural analogy with RyR’s (Welch et al., 2004; Ramachandran et 
al., 2013; Yan et al., 2015) provide a useful template to predict potential 
mechanisms occurring in RyR2. It has been established that mutations at or near 
the selectivity filter lead to a variety of gating effects in K+ channels (Liu et al., 1997; 
Proks et al., 2001; Alagem et al., 2003; Chapman et al., 2006; Cordero-Morales et 
al., 2006; Cuello et al., 2010a). However in hRyR2, the identification of a putative 
structural element at the proposed selectivity filter acting as a gate remains unclear.   
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Transient elevation of cytosolic Ca2+ concentration ([Ca2+]cyt) during systole activates 
hRyR2 channels in a process termed calcium-induced calcium release described in 
chapter 1.2.1. Ligand interaction with proposed Ca2+-binding sites, distant from the 
channel pore, must therefore induce a conformational wave of movements between 
residues and chemical bonds that allow distinct gates within the pore to open. 
However the dynamic molecular pathway is still unknown.  Recent structural studies 
of rabbit RyR1 have identified EF-hands, acting as a putative Ca2+- binding domain 
depicted in figure 6.1, on the central domain that are in relatively close proximity to 
the channel pore (Zalk et al., 2014; Efremov et al., 2014; Yan et al., 2015). This 
suggests that Ca2+ binding may induce conformational changes in the EF-hand that 
transmit to the pore through contacts with either the S2-S3 loop or central domain, 
ultimately resulting in changes within the pore aperture (Zalk et al., 2014). 
 
 
 
Figure 6.1. Structural model of the rabbit RyR1 channel. Cartoon structure of 
RyR1 highlighting the EF-hands (4071 - 4132 RyR1), acting as a putative Ca2+ 
binding site, in yellow relative to the PFR colour coded as illustrated in figure 5.14. 
The EF-hands are in the central domain (highlighted in orange 3668–4251) and are 
in close proximity to the S2-S3 loop (highlighted in cyan 4675-4790) that are 
proposed to transmit conformational changes to the pore domain. Two monomers 
are shown for clarity. Figure was constructed in PyMol using the PDB file, 3J8H, 
obtained with permission from Chang-cheng Yin (Yan et al., 2015).  
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It is important to note that the RyR1 structural studies have reported the channel in 
a closed conformation (Zalk et al., 2014; Yan et al., 2015). Figure 6.2 depicts the 
constriction site at isoleucine 4937 (I4867 in hRyR2), potentially acting as one of the 
residues of an ‘activation’ gate analogous to the IHBC in K+ channels outlined in 
chapter 1.5.6.    
 
(A)      (B) 
 
 
Figure 6.2. Measuring the closed RyR1 channel. (A) The structure of the RyR1 
pore and the passage area depicted by cyan dots, calculated by a program HOLE 
described by Smart et al., (1993). (B) The pore radii along the ion-conducting 
pathway are tabulated highlighting the selectivity filter (SF) in red (~ 3 Å) and the 
constriction ‘activation gate’ site at I4937 (0.81 Å) (I4867 in hRyR2). Figure taken 
from Yan et al., (2015). (Smart et al., 1993) 
 
While there is significant indication that Ca2+-mediated activation via an IHBC gate 
exists in RyR channel isoforms, from recent structural studies (Zalk et al., 2014; 
Efremov et al., 2014; Yan et al., 2015) and experimental evidence of a proposed 
glycine hinge in the pore-lining S6 helix (Euden et al., 2013b; Ramachandran et al., 
2013; Mei et al., 2015), this project aims to elucidate the potential role of the 
selectivity filter and residue interactions in hRyR2 gating. 
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6.1.2 Investigating hRyR2 gating mechanisms using single-channel 
modelling  
 
At present, RyR2 channel gating can only be quantified using single-channel 
analysis enabling the investigation of kinetic behaviour in a well-controlled in vitro 
environment (Miller, 1986). RyR2 gating events are resolvable and quantified by 
measuring single-channel ion currents, depicted in figure 6.3. An essential feature in 
analysis is the appropriate detection and characterisation of the single-channel 
gating events known as idealisation. Idealisation of raw single-channel data 
generates important biophysical parameters such as open probability (Po), mean 
amplitudes, frequency of events and dwell-times that are used to characterise 
hRyR2 channels under defined experimental conditions. The dwell-time 
measurements of the closed (Tc) and open (To) amplitude levels are used to 
calculate the Po of the channel, which is expressed as a fraction of the total 
occupied duration in the open state, outlined in section 6.2.3.1. While Po is a good 
indicator of overall channel activity, it does not reveal underlying gating 
mechanisms.  
 
 
Figure 6.3. Idealisation of single hRyR2 channel gating events. Idealised single-
channel data (red trace) generates key biophysical parameters described in text. 
Lower trace depicts the detection of gating events.  
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As single-channel gating can be described as a stochastic process (where events 
are non-deterministic and random) under experimental conditions (Colquhoun and 
Hawkes, 1977; Colquhoun and Hawkes, 1981), the QuB software, introduced in 
chapter 5.2.3, utilises probability theory and statistical algorithms to analyse single-
channel data. Due to the vast number of interactions that occur within RyR2 at the 
molecular level during channel gating, it is implausible that an actual sequence of 
conformational events, such as the chain reaction induced by Ca2+ activation, is 
remembered (Mukherjee, 2014). Therefore, the conformational changes of single-
channels are typically modelled as a ‘memoryless’ Markov process (Qin and Li, 
2004). The challenge posed by single-channel kinetic modelling is that ion channels 
possess multiple states at the same conductance level. These discrete or ‘hidden’ 
transitions between states are concealed within the single-channel data therefore 
putative structural conformations can only be deduced statistically from their dwell-
time distributions (Qin et al., 2000).  
 
Constructing kinetic models requires idealised data from which a sequence of open 
and closed dwell-time histograms are fitted with sums of exponentials based on a 
given kinetic scheme determined in QuB, detailed in sections 6.3.6 and 6.4.3. A 
multi-state modelling scheme describes various transitions between states and 
produces useful kinetic information such as time constants, state occupancy and 
rate constants that importantly are used to reveal underlying gating mechanisms 
and assign putative structural conformational states. Modelling single-channel data 
for channels in which mutations have been made, which are proposed to alter 
gating kinetics, can therefore be compared to WT hRyR2 channels under defined 
experimental conditions.  
 
6.1.3 Describing mechanisms of hRyR2 channel gating in minimised 
conditions 
 
Due to the complex nature of RyR2 channel regulation, with numerous accessory 
proteins, modulators and ligand interactions discussed in chapter 1.4.1, groups 
studying RyR2 function have reported varied and inconsistent results (Schiefer et 
al., 1995; Saftenku et al., 2001; Rosales and Escobar, 2004; Zahradník and 
Zahradníková, 2005; Laver, 2007). The lack of general consensus between groups 
was likely due to variable single-channel conditions using different starting material, 
permeant ions and modulatory factors. This prompted the study by Mukherjee et al 
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to characterise the gating of WT hRyR2 in minimised conditions (Mukherjee et al., 
2012). Mukherjee et al generated a kinetic scheme, depicted in figure 6.4, that 
described the gating transitions of WT hRyR2 channels activated by [Ca2+]cyt, in the 
absence of accessory proteins, in a stringently regulated environment. The gating 
model serves as a template against which the effects of physiological regulatory 
factors, therapeutic compounds and, in particular for this thesis, point mutations can 
be tested.  
 
 
 
Figure 6.4. A mechanistic description of hRyR2 channel gating. A kinetic gating 
model of hRyR2, activated by [Ca2+]cyt, created under minimised conditions. The 
kinetic scheme represents a mechanistic network of transitions between different 
open and closed states describing the behaviour of hRyR2. The kinetic scheme 
revealed novel aspects of RyR2 gating including non-responsive (CNR) and 
responsive (CR) closed states and brief flicker closings (CF) outlined in section 
6.3.6.4. The states and the transitions represented by grey boxes were not 
discretely resolved from single-channel data analysis. Blue shaded boxes, 
representing unliganded open state (OUL) and an intermediate Ca
2+-bound 
preopening closed state (CI) were only resolvable at low Ca
2+ concentrations, and 
were not considered in this thesis. Figure obtained from Mukherjee et al., (2012).  
 
 
 
 
 
 
 
193 
 
6.1.4 Flicker gating transitions at the selectivity filter of the hRyR2 channel  
 
The investigation describing the gating mechanisms of WT hRyR2 in a regulated 
minimal environment identified very brief closings (~ 0.3 ms), termed ‘flicker’ gating 
(Mukherjee et al., 2012), shown in figure 6.5. These flicker transitions observed in 
the gating scheme, depicted in figure 6.4 as O2 ⇌ CF, were resolved during periods 
of high Po. The mean dwell time did not change with increasing [Ca
2+]cyt (10 – 500 
µM) indicating that these very brief flicker closings were Ca2+- independent 
(Mukherjee et al., 2012).   
 
 
Figure 6.5. Gating of single WT hRyR2 channel highlighting rapid flicker 
closing transitions occuring during periods of high open probability. The 
purple baseline represents the closed level, upward deflections are channel 
openings. The lower 1 kHz trace depicts the very brief ‘flicker’ closing events as 
partial (unresolved) downward deflections that do not fully reach the closed level. 
 
Similar flicker events have been observed in other types of channels such as BK, 
MthK and KcsA where the mechanism in these channels was proposed to occur at 
the selectivity filter, acting as a gate by rapid switching between conducting and 
non-conducting states due to the inherent flexibility of the filter (Piskorowski and 
Aldrich, 2006; Zadek and Nimigean, 2006; Cuello et al., 2010b). Modelling studies 
reveal that the selectivity filter in hRyR2 is both wider and more flexible than the 
equivalent region in K+ channels (Welch et al., 2004), suggesting that flicker 
closures would be possible.  
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6.1.5 Purpose of investigating single RyR2 channel gating mechanisms  
 
The high resolution RyR1 models reveal snapshots of the channel structure and 
provide a valuable resource for predicting channel function. However these static 
structures do not reflect the dynamic continuum of domain transitions within a single 
molecule, thus the validity of the PFR structural models and the function of residue 
interactions can only be assessed by measuring biophysical kinetics of mutated 
proteins at the single-channel level. While in the recent model published by Yan et 
al, the distances between the three residues proposed in the hypothesis, Y4813, 
D4829 and Y4839, would not be able to form hydrogen-bonds due to 
rearrangement of helices, depicted in figure 5.21, the proposed selectivity filter and 
surrounding region are still of the utmost importance (Yan et al., 2015). 
  
The biophysical characterisation of the six hRyR2 mutant channels outlined in 
chapter 5 highlighted the significance of residue properties and their interactions 
within the pore. Mutations investigated in chapter 5 which resulted in channels 
whose functional behaviour was qualitatively comparable to WT hRyR2 (i.e. 
Y4813W, Y4839A and Y4839W) were assessed in terms of their effects on gating 
mechanism. Disruption of interactions at the start of S6 helix by Y4839A was 
predicted to result in an indirect effect on the stability of the pore region and 
selectivity filter, thus affecting channel gating such as flicker transitions. The 
conservative hRyR2 mutations were proposed to be analogous to WT hRyR2 
channels by maintaining similar interaction properties, therefore stabilising the pore 
region such that normal channel gating was preserved. Gating mechanisms were 
assessed by monitoring WT and mutant hRyR2 channels, activated by 10 µM 
[Ca2+]cyt, in a stringently regulated environment where variables external to the 
channel were minimised. Biophysical parameters, outlined in section 6.3.1, were 
assessed and kinetic models, detailed in section 6.3.6, were constructed to describe 
the behavioural consequence of residue substitution on state transitions. 
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6.2 – Materials and Methods 
 
6.2.1 Materials 
 
All buffers and solutions were prepared in bottled dH2O from AnalaR 
NORMAPUR®, VWR Chemicals that were filter sterilised before use. General 
reagents are listed in chapter 2.1.8. All experiments were completed at RT 20 ± 2 
°C. 
 
6.2.1.1 Ca2+ Activation experiment  
 
CaCl2 solution: A 20 mM CaCl2 stock solution was prepared for Ca
2+ activation 
experiments.  
 
Ca2+ chelating buffers: 
Trans Ca2+ buffer: 5 mM ethylene glycol tetraacetic acid (EGTA) dissolved in 210 
KCl solution buffer. 
Cis Ca2+ buffer: 90 mM EGTA, 5 mM HEPES and 210 mM KOH adjusted to pH 
7.4. 
Cis Ca2+ buffer: 90 mM N-(2-hydroxyethyl)ethylenediamine-N,N’,N’-triacetic acid 
(HEDTA), 90 mM nitrilotriacetic acid (NTA), 5 mM HEPES and 210 mM KOH, pH 
adjusted from ~ 8.5 to 7.4 using HCl.  
 
6.2.2 Methods 
 
6.2.2.1 Single-channel experiments – Ca2+ Activation  
 
Single hRyR2 channels were generated as outlined in chapter 2.2. The cis and 
trans chambers were bathed in symmetrical 210 mM KCl solution with a holding 
potential of + 40 mV, ensuring appropriate signal-to-noise ratio for gating event 
detection, for all single-channel Ca2+ activation experiments. Ca2+ activation 
experiments were completed in three stages that are outlined below; 
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Gating in unbuffered contaminant Ca2+ solutions: Following chamber perfusion, 
single hRyR2 channels were recorded for 1 min in symmetrical 210 mM KCl 
solutions. The free [Ca2+] in KCl solutions were ~ 1 µM (termed contaminant Ca2+), 
due to trace impurities in the KCl salt, measured using a calcium probe (Orion; 
Thermo Fisher Scientific) (Mukherjee et al., 2012). The free [Ca2+]cyt was the sole 
activating ligand. 
 
Channel Shutdown: The free [Ca2+] in solutions bathing the channel from both 
sides of the membrane were stringently regulated. Single hRyR2 channels 
underwent a shutdown phase where free [Ca2+] was buffered by the addition of Ca2+ 
chelators; EGTA, HEDTA and NTA. From a 90 mM EGTA and 90 mM HEDTA/NTA 
stock, 5.5 µL was added to the cis chamber to a final concentration of 1 mM, to 
buffer [Ca2+]cyt
 to nominally 0 Ca2+ (~ 0.7 nM). In addition, a 5 mM EGTA stock was 
added (5 µL) to the trans chamber to a final concentration of 25 µM, that ensured 
the free ‘luminal’ [Ca2+] was buffered to ~ 50 nM. The concentrations of Ca2+ 
chelators were calculated using a web-based software MaxChelator 
(http://maxchelator.stanford.edu/index.html), buffering under the following 
conditions; 22 °C, pH 7.4 and 210 mM KCl. The concentration of Ca2+ was verified 
using a calcium probe (Mukherjee et al., 2012). Both chambers were stirred for a 
minimum of 1 min following the addition of Ca2+ chelators stated above. Chelating 
the free cytosolic (~ 0.7 nM) and luminal (~ 50 nM) [Ca2+]cyt/lum
 constituted the 
shutdown phase. Channel activity was recorded for 1 min under these conditions.    
 
hRyR2 Ca2+ Activation: To identify flicker closings, a high channel Po was required, 
as these transitions were only resolvable from an open conformation as shown in 
figure 6.5. The study by Mukherjee et al established that hRyR2 channels activated 
by 10 µM [Ca2+]cyt achieved an open probability above 0.6, that was satisfactory to 
resolve flicker gating events (Mukherjee et al., 2012). The final concentration of the 
cis chamber was raised to 1.75 mM CaCl2, by the addition of 46.3 µL (20 mM CaCl2 
stock) that was stirred for a minimum of 1 min, achieving free 10 µM [Ca2+]cyt. WT 
and mutant single-channel gating behaviour was recorded for up to 20 min under 
steady-state conditions monitoring activity at + 40 mV in buffered symmetrical 210 
mM KCl. 
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6.2.3 Single-channel data analysis  
 
The single-channel data were low-pass filtered at 5 kHz using a multi-step 8-pole 
Bessel filter outlined in 2.2.4.1.2. Single-channel ionic current transitions were 
idealised using the segmental K-means (SKM) algorithm based on hidden Markov 
modelling (HMM) described by Qin, (2004). Idealisation was initially performed 
using a two state model, assigning a closed and open level by highlighting regions 
of defined and continuous sequence of data points, depicted in figure 6.6. Class 1 
(black) was assigned the closed current level and Class 2 (red) was assigned the 
open current level, shown in figure 6.6B. The output is an idealised trace (red) of the 
raw trace depicted in figure 6.3.  
 
(A) 
 
(B) 
 
 
Figure 6.6. Assigning closed and open current levels for single-channel 
idealisation. (A) A single-channel trace that contains clear closed (black bar) and 
open (red bar) data point sequence. (B) The continuous closed and open levels 
were assigned to their Class 1 (black) and Class 2 (red), respectively. 
 
For consistency, data analysis and figure presentation was completed in order of 
residue sequence i.e. (1) WT hRyR2, (2) Y4813W, (3) Y4839A and (4) Y4839W. 
For presenting single-channel representative traces, current transition data were 
low-pass 1 kHz filtered in QuB, unless otherwise stated. The purple baseline in 
traces denoted the closed level with channel openings determined by upward 
current deflections at positive holding potentials. Single-channel artifacts such as 
baseline drifts, user noise and capacitance spikes were removed from the extracted 
segment prior to analysis.  
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6.2.3.1 Calculating single-channel open probability  
 
Single channel Po is the fraction of the time that the channel is in the open state. 
The probability was calculated following single-channel data idealisation in QuB by 
measuring the total open time divided by the total time of the extracted recording, 
stated in the equation below (total open (To) and closed (Tc) time);  
 
Po = To / (To + Tc) 
 
Twenty minute single-channel recordings were chopped into 15 s sequential 
segments using the “Chop Data” tool in the pre-processing tab. Data segments 
were idealised with a two state model (closed ⇌ open), calculating channel open 
probabilities that were subsequently plotted against time to generate Ca2+ activation 
distributions. 
   
The relationship between channel dwell-time and Po was assessed by chopping 
single-channel data files (20 min) into 30 s sequential segments. The idealised data 
generated mean Tc and To that were plotted against open probability.   
 
6.2.3.2 Single-channel modelling  
 
The comprehensive application of the QuB software and its modelling theory was 
used to construct kinetic models that describe hRyR2 gating. This thesis does not 
attempt to explain the mathematical algorithms used in the process of generating 
the kinetic models as it is not the focus of this project and can be reviewed 
elsewhere (Colquhoun and Hawkes, 1995; Colquhoun and Sigworth, 1995; Qin and 
Li, 2004; Qin, 2004; Sigg, 2014; Mukherjee, 2014).   
 
6.2.3.3 Data selection for modelling analysis  
 
An aim of this investigation was to resolve flicker gating transitions by building a 
model to best describe the gating behaviour of WT and mutant hRyR2 channels. To 
identify these very brief flicker closing events a high Po was required. Based on the 
results obtained from the Ca2+ activation experiments, defined criteria were imposed 
for data selection, listed in section 6.3.6. Periods of single-channel data that 
contained 30 s of homogenous gating events ranging from Po 0.6 - 0.8 were 
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extracted. The criteria ensured that data segments contained comparable general 
biophysical parameters (Po, Tc, To and number of events) between WT and mutant 
hRyR2 channels, therefore, any subtle differences in kinetics (time constants, state 
occupancy or rate constants) resulted as a consequence of residue substitution.   
 
6.2.3.4 Idealisation parameters for modelling analysis  
 
QuB settings were altered to ensure that brief events were resolved and 
distinguished from noise, and that as few as possible were missed. A certain cut-off 
duration was imposed, termed dead time (Td), which ensured that all events with 
durations longer than Td were considered as true events and those shorter were 
missed. As the single-channel data were digitised at 20 kHz (i.e. 50 µs sampling 
interval), a Td of 125 µs, 2.5 x the sampling rate was adequate for event detection 
(Mukherjee, 2014).   
 
6.2.3.5 Constructing kinetic models to describe single-channel gating 
mechanisms  
 
The Maximum Interval Likelihood (MIL) function in QuB was used to optimise the 
rate constants of the kinetic model according to the dwell times calculated by the 
SKM idealisation, generating a log likelihood (LL). Individual closed and open states 
were assigned and added to the model until further state addition did not increase 
the LL by more than 5 as shown in figure 6.20. Optimising the LL by more than 5 
ensured that the kinetic model suitably fitted the dwell time data. The model 
provided information on time constants of states, expressed in milliseconds, and the 
relative area under the exponential fit, converted into a percentage, that indicated 
the likelihood of a state being occupied.  
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6.3 – Results 
 
6.3.1 Ca2+ activation of single WT and mutant hRyR2 channels – Open 
probability 
 
The Ca2+ activation experiments, described in section 6.2.2.1, were completed in 
three stages; (1) unbuffered contaminant [Ca2+], (2) regulated Ca2+ chelated 
channel shutdown and (3) 10 µM [Ca2+]cyt activation for WT and mutant Y4813W, 
Y4839A and Y4839W hRyR2 channels. As an initial biophysical marker, open 
probability was compared between WT and mutant hRyR2 channels.   
 
6.3.1.1 Stage #1 – Gating in unbuffered contaminant [Ca2+] solutions 
 
The open probability of individual WT and mutant hRyR2 channels activated by 
contaminant [Ca2+], shown in figure 6.7, was calculated for 1 min immediately 
following the establishment of symmetrical 210 mM KCl conditions. Individual WT 
hRyR2 (n=23) channel-to-channel open probabilities were variable across the 
range, Po 0 – 1, and were characterised by either high, intermediate or low channel 
activity. A similar trend in mutant hRyR2 channel Po was observed. WT and mutant 
hRyR2 channels exhibited similar mean channel Po, listed in table 6.1, in unbuffered 
containing ~ 1 µM [Ca2+] with similar spread in the data shown in figure 6.7.  
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Figure 6.7. Comparing the open probability of individual WT and mutant 
hRyR2 channels in unbuffered contaminant [Ca2+]. Single-channels were 
recorded at + 40 mV for 1 min in symmetrical 210 mM KCl. Each data point is a 
separate channel Po; there was no significant difference between WT and mutant 
channel Po. Bars indicate SEMs and are listed in table 6.1. Individual channel Po 
varied from high, intermediate and low.  
 
6.3.1.2 Stage #2 – hRyR2 channel shutdown  
 
A combination of Ca2+ buffers, described in section 6.2.2.1, was added to regulate 
free cytosolic and luminal [Ca2+] in the KCl solutions. Channel shutdown was 
recorded for 1 min immediately following homogenous mixing of Ca2+ buffers. 
Chelating free [Ca2+] from the KCl solutions resulted in a significant reduction in 
channel Po, depicted in figure 6.8, when compared to monitoring channels in 
contaminant [Ca2+] solutions. A small proportion of very brief hRyR2 opening events 
was observed in WT and mutant channels, and is discussed in section 6.4.1. The 
open probability during channel shutdown was consistently low, Po < 0.01, for WT 
and mutant hRyR2 channels except for Y4813W, listed in table 6.1. The 
conservative pore helix mutant, Y4813W (n=23), revealed five outlier channels that 
remained active (Po > 0.05) in ~ 0.7 nM [Ca
2+]cyt and 50 nM [Ca
2+]lum. Although the 
majority of channels (78.3 %) did shutdown in response to chelating Ca2+, the mean 
open probability (Po 0.04) was significantly higher when compared to WT, Y4839A 
and Y4839W hRyR2 channels.  
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Figure 6.8. Comparing the open probability of individual WT and mutant 
hRyR2 channels during shutdown. Following stage #1, the same single-channels 
were recorded in ~ 0.7 nM and 50 nM [Ca2+]cyt/lum, respectively, at + 40 mV for 1 min 
in symmetrical 210 mM KCl solutions. The Po of Y4813W was significantly higher 
compared to WT, Y4839A and Y4839W hRyR2 channels (p<0.05). Bars (where 
visible) indicate SEMs and are listed in table 6.1. 
 
6.3.1.3 Stage #3 – hRyR2 Ca2+ activation 
 
Chelating cis (cytosolic) and trans (luminal) free [Ca2+] significantly reduced channel 
Po. In these regulated, minimised, conditions single-channels were activated by 10 
µM [Ca2+]cyt. WT and mutant hRyR2 channels were subsequently monitored under 
steady-state conditions for 20 min to evaluate the consequence of point mutations 
on the proteins biophysical function.  
 
Channel Po increased upon the addition of 10 µM [Ca
2+]cyt, depicted in figure 6.9, 
however the mean Po of the channel during the 20 min recording was lower than 
monitoring channels in unbuffered contaminant Ca2+ conditions (Stage #1). Mutant 
channel open probabilities were not significantly different and were comparable to 
WT hRyR2 (Po ~ 0.1) during the 20 min recording, listed in table 6.1. Similar to 
recording channels in KCl solutions that were unbuffered, open probability was 
variable and not consistent during steady-state conditions. 
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Figure 6.9. Comparing the open probability of individual WT and mutant 
hRyR2 channels during Ca2+ activation. Following stages #1 and 2, the same 
single-channels were activated by 10 µM [Ca2+]cyt and recorded under steady-state 
conditions at + 40 mV for 20 min in symmetrical 210 mM KCl. Each data point is a 
separate channel Po; there was no significant difference between WT and mutant 
channel Po. Bars indicate SEMs and are listed in table 6.1. 
 
 
  Contaminant [Ca
2+
]  Shutdown Ca
2+
 Activation 
  n (Po)   n  (Po)   n  (Po)   
WT hRyR2 23 0.293 ± 0.08   23 0.001 ± 0.001   21 0.121 ± 0.04   
Y4813W 26 0.316 ± 0.07  ns 23 0.041 ± 0.019 * 17 0.097 ± 0.03 ns 
Y4839A 32 0.312 ± 0.07 ns 32 0.004 ± 0.005 ns 33 0.072 ± 0.01 ns 
Y4839W 28 0.203 ± 0.06 ns 24 0.001 ± 0.001 ns 20 0.099 ± 0.03 ns 
 
Table 6.1. Comparing the mean open probability of WT and mutant hRyR2 
channels during Ca2+ activation experiment. Open probability values are means 
(± SEM). No statistically significant difference in mean Po was observed between 
hRyR2 channels activated by contaminant ~ 1 µM [Ca2+] or 10 µM [Ca2+]cyt during 
Ca2+ activation (ns), due to large variation in channel activity depicted in figures 6.7 
and 6.9. Y4813W channel Po during shutdown was significantly increased (Po 
0.041) compared to WT hRyR2 channels (Po 0.001) indicated by a single asterisk (* 
p=0.0495).  
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6.3.2 Ca2+ activation open probability distributions 
 
Distribution histograms were generated by analysing single WT hRyR2 channel Po 
in sequential 15 s segments, depicted in figure 6.10, that were extracted over the 20 
min experiment. Monitoring hRyR2 proteins for extended periods, revealed an 
intriguing phenomenon: WT hRyR2 channels switched between different gating 
modes represented by fluctuations in open probability. On occasion, the addition of 
10 µM [Ca2+]cyt did not induce typical channel activation (Po > 0.6) (Mukherjee et al 
2012), where channel Po remained consistently low (Po < 0.2) represented in figure 
6.10(ii). In contrast, the addition of cytosolic [Ca2+] induced modal channel gating on 
a macro ‘minute-to-minute’ scale that randomly shifted between periods of low and 
high Po and was represented by distributions termed ‘skyscrapers’, shown in figures 
6.10 (i) (iii) and (vi). Similar open probability distributions were observed when 
analysing the three hRyR2 mutant channels, depicted in figures 6.11, 6.12 and 
6.13.  
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(i)      (ii) 
 
(iii)      (iv) 
 
(v)      (vi) 
 
 
Figure 6.10. Ca2+ activation distribution histograms of WT hRyR2 channels. 
Six representative (i-vi) single WT hRyR2 channel distribution histograms (total 
n=21), analysing open probability under steady-state conditions in sequential 15 s 
segments over a 20 min recording. Distributions depict high channel-to-channel 
variation and modal fluctuations in open probability. A representative single-channel 
long recording is shown in appendix IV. 
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6.3.3 Categorising the population of WT and mutant hRyR2 channel 
experiments by open probability threshold 
 
Assessing timed segments over the 20 min recording, revealed the unique and 
varied nature of studying single-channels at the molecular level. The population of 
WT and mutant hRyR2 channels were categorised into subsets that were defined 
by open probability thresholds; high (Po ≥ 0.6), figure 6.11, intermediate (Po 0.2 – 
0.6) figure 6.12 and low (Po ≤ 0.2) figure 6.13. The proportion of these subset 
channels, which reached a particular threshold during any 15 s segment, were 
expressed as a percentage and were listed in table 6.2. A chi-squared contingency 
test was used to compare the threshold subset distributions and revealed that 
mutant hRyR2 channels were distributed significantly different to WT hRyR2 
(p<0.001). The distribution of WT hRyR2 channel subsets were similar and had the 
highest proportion of channels that exceeded Po 0.6 (38 %) compared to mutant 
hRyR2 channels. The likelihood of mutant hRyR2 channels reaching high Po was 
less than 24 %. Both conservative Y4813W and Y4839W mutations favoured the 
low Po threshold 53 % and 55 %, respectively, whereas the alanine Y4839 mutation 
had the highest proportion of channels in the intermediate subset (55 %).  
 
 
    Single-channel subset proportion (%) 
  n High Po ≥ 0.6  Int Po 0.2 – 0.6 Low Po ≤ 0.2  
WT hRyR2 21 38 29 33 
Y4813W 17 24 24 53 
Y4839A 33 18 55 27 
Y4839W 20 15 30 55 
 
 
Table 6.2. Categorising the population of WT and mutant hRyR2 channel Ca2+ 
activation experiments by high, intermediate and low open probability 
thresholds. Percentage values were rounded to the nearest integer. 
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(A) 
 
(B) 
 
(C) 
 
(D)  
 
 
Figure 6.11. Ca2+ activation distribution histograms of single WT and mutant 
hRyR2 channels representing high open probability. Open probability was 
measured in sequential 15 s segments for 20 min. Three representative individual 
distribution histograms from (A) WT hRyR2, (B) Y4813W, (C) Y4839A and (D) 
Y4839W channels depict a ‘skyscraper’ distribution with large modal fluctuations in 
channel activity. The grey dotted line denotes high Po threshold (Po ≥ 0.6). 
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(A) 
 
(B) 
 
(C) 
 
(D)  
 
 
Figure 6.12. Ca2+ activation distribution histograms of single WT and mutant 
hRyR2 channels representing intermediate open probability. Open probability 
was measured in sequential 15 s segments for 20 min. Three representative 
individual distribution histograms from (A) WT hRyR2, (B) Y4813W, (C) Y4839A and 
(D) Y4839W channels depict a ‘skyscraper’ distribution with modal fluctuations in 
channel activity. The grey dotted line denotes intermediate Po threshold (Po 0.2 - 
0.6). 
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(A) 
 
(B) 
 
(C) 
 
(D)  
 
 
Figure 6.13. Ca2+ activation distribution histograms of single WT and mutant 
hRyR2 channels representing low open probability. Open probability was 
measured in sequential 15 s segments for 20 min. Three representative individual 
distribution histograms from (A) WT hRyR2, (B) Y4813W, (C) Y4839A and (D) 
Y4839W channels. The grey dotted line denotes low Po threshold (Po ≤ 0.2). 
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The purpose of this investigation was to assess any difference in open probability 
between WT and mutant hRyR2 channels. While there were no differences in 
channel Po, this study identified several important features of studying hRyR2 
channels by Ca2+ activation under regulated minimised conditions: 
 
(1) Recording single hRyR2 channels for short 1 min periods in unbuffered KCl 
solutions containing ~ 1 µM [Ca2+], revealed varied snapshots of channel activity.  
(2) Chelating cytosolic and luminal free [Ca2+] from KCl solutions induced 
‘shutdown’ in all hRyR2 channels except for a proportion of Y4813W (n=5) which 
remained relatively active (Po > 0.05) in response to nominal 0 [Ca
2+] (~ 0.7 nM and 
50 nM [Ca2+]cyt/lum respectively).  
(3) WT and mutant hRyR2 channel Po, activated by 10 µM [Ca
2+]cyt over long 
periods, were lower than channels in unbuffered solutions, listed in table 6.1, 
however were not significantly different to each other due to high variability in 
channel activity.  
(4) Channel open probabilities for WT and mutant hRyR2 varied with time during the 
Ca2+ activation experiment under defined conditions.  
(5) Modal gating was observed in hRyR2 channels on a micro ‘second-to-second’ 
scale, described in section 6.3.4, during periods of high Po under steady-state 
conditions. 
(6) Large fluctuations in channel activity were observed with periods of high, 
intermediate and low Po, illustrated by the ‘skyscraper’ distribution histograms, 
during long recordings. This supported the observed variation of channel activity 
‘snapshots’ during short 1 min recordings, stated in (1). 
(7) Only a small subset of the channel population reached threshold Po 0.6, 
therefore 10 µM [Ca2+]cyt did not guarantee hRyR2 activation under the experimental 
conditions. 
(8) The population of conservative Y4813W and Y4839W mutations had the highest 
proportion of low Po channel subsets, whereas the alanine mutation favoured the 
intermediate threshold. However overall, there were no significant differences 
between mean open probabilities compared to WT hRyR2.  
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6.3.4 hRyR2 Ca2+ activation – Modal gating 
 
An extraction of single-channel WT hRyR2 data, during high Po (Po > 0.6) from the 
Ca2+ activation experiment, depicted in figure 6.14, shows the shift between 
different gating modes. Two types of modal gating were observed in all WT and 
mutant hRyR2 channels and were characterised by random switching (‘gear 
shifting’) between high and low Po (long dwell times and increased frequency of 
events) during steady-state conditions. Firstly, modal gating was observed on a 
macro ‘minute-to-minute’ scale observed as the ‘skyscraper’ distributions during the 
20 min recordings and secondly on a micro ‘second-to-second’ scale observed in 
the minute extraction. 
 
 
Figure 6.14. Single WT hRyR2 channel modal gating under steady-state 
conditions. The behaviour of a single WT hRyR2 channel, extracted from a Ca2+ 
activation experiment, was monitored for 1 min during high Po. The channel 
randomly switched between different low, intermediate and high gating modes on a 
micro ‘second-to-second’ scale under steady-state conditions. Each line represents 
5 s of data. The closed level is denoted by the purple baseline with upward 
deflections as channel openings.  
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6.3.5 Assessment of hRyR2 mean closed and open times 
 
Open probability is a useful biophysical parameter to assess the overall activity of 
single channels during a set period; however it does not reveal channel gating 
kinetics and their mechanism. While investigating the mean Po did not reveal 
differences between WT and mutant hRyR2 channels, the ‘skyscraper’ distributions 
provided an ideal template for further in-depth analysis described here and in 
section 6.3.6.  
 
To access differences in channel gating kinetics, mean closed and open times (Tc 
and To), were calculated for WT and mutant hRyR2 channels. Ca
2+ activation 
experiments that contained periods of high channel Po, exceeding Po 0.6, were 
selected (WT (n=8), Y4813W (n=4), Y4839A (n=9) and Y4839W (n=4)). These 
distributions contained periods of low, intermediate and high channel activities, 
therefore dwell-times were examined across the whole range of open probabilities 
(Po 0 – 1). The long recordings were chopped into sequential 30 s segments over 
20 min recording generating ~ 40 data point values for each experiment. The 
extracted data segments were idealised to generate mean Tc and To, and 
subsequently the relationship between these dwell-times and their open probability 
were compared in figures 6.15 and 6.16, respectively.  
 
A similar trend between WT (black dots) and mutant (red squares) hRyR2 channel 
mean dwell times were observed. As the open probability increased, the mean 
closed time decreased, figure 6.15, whereas the mean open time increased 
depicted in figure 6.16. There were no differences between overall mean open and 
closed times in mutant channels compared to WT hRyR2 across the Po range 0 - 1, 
however the relationship between dwell-time during periods of very high Po > 0.8 
were assessed in the following section 6.3.5.1. 
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Figure 6.15. The relationship between open probability and mean closed times 
of WT and mutant hRyR2 channels. Each data point represents a 30 s segment 
from the 20 min Ca2+ activation experiment. WT hRyR2 (n=8) data points (black) 
overlay mutant (A) Y4813W (n=4), (B) Y4839A (n=9) and (C) Y4839W (n=4) 
highlighted in red.  
(A) 
 
(B) 
 
(C) 
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Figure 6.16. The relationship between open probability and mean open times 
of WT and mutant hRyR2 channels. Each data point represents a 30 s segment 
from the 20 min Ca2+ activation experiment. WT hRyR2 (n=8) data points (black) 
overlay mutant (A) Y4813W (n=4), (B) Y4839A (n=9) and (C) Y4839W (n=4) 
highlighted in red.  
(A) 
 
(B) 
 
(C) 
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6.3.5.1 The relationship between dwell-time and periods of very high open 
probability for WT and mutant hRyR2 channels 
 
The relationship between mean Tc and To and periods of very high open probability, 
Po > 0.8 are listed in table 6.3. There were no differences in mean Po (Po ~ 0.89) 
from the idealised 30 s single-channel data between WT and mutant hRyR2 
channels. The mean time closed for Y4839A (1.46 ms) was longer than WT hRyR2 
(0.6 ms) however the duration of the mean time open was not significantly different. 
There were no differences in Tc and To at high Po when comparing the conservative 
Y4813W and Y4839W mutations to WT hRyR2 channels. 
 
  WT hRyR2 Y4813W Y4839A Y4839W 
  (n=13) (n=5) (n=9) (n=13) 
Po 0.899 ± 0.01 0.896 ± 0.03 0.877 ± 0.02 0.896 ± 0.02 
Tc (ms) 0.603 ± 0.03 0.624 ± 0.14 1.46 ± 0.17* 0.998 ± 0.18 
To (ms) 8.354 ± 2.26 7.695 ± 1.99 16.26 ± 4.33 14.13 ± 3.39 
 
Table 6.3. The relationship between dwell-time and Po (0.8 – 1) for WT and 
mutant hRyR2 channels. Open probability was comparable for all channel types. 
Y4839A had a significantly longer mean Tc compared to WT hRyR2, indicated by an 
asterisk. All other dwell times were not significantly different to those achieved for 
WT hRyR2. 
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6.3.6 Investigating single-channel gating mechanisms at the selectivity filter 
of hRyR2 channels 
 
6.3.6.1 Justification of hRyR2 modelling analysis 
 
The inherent fluctuations in channel activity and the highlighted modal gating in 
hRyR2 during stringently regulated steady-state conditions presented challenges in 
data analysis. To avoid selection bias and to resolve the aims of this project, listed 
in chapter 1.6.2, particular segments of data were selected in accordance with the 
specific criteria listed in section 6.3.6.2.   
 
To test the importance of interactions within the proposed pore region, and in 
particular on flicker closings occurring from the open state, a high Po (Po 0.6 – 0.8) 
was required. Using the open probability ‘skyscraper’ distribution histograms as a 
template shown in figure 6.17, 30 s segments were extracted. Only single-channel 
segments with homogenous gating events, i.e. similar dwell-times, were analysed 
depicted in figure 6.18, thus avoiding modal shifts between periods of long closings 
and openings, which satisfied the essential Markov assumption that the rate 
constants of state transitions do not change with time in a memoryless system (Qin, 
2004; Mukherjee et al., 2012). The 30 s duration of single-channel transitions at Po 
0.6 – 0.8 ensured that the number of events exceeded 3000, which was considered 
to be statistically sufficient for modelling analysis (Colquhoun and Sigworth, 1995; 
Qin, 2004).  
 
  (A)              (B) 
           
 
Figure 6.17. Utilising the open probability distribution histograms as a 
template for modelling data selection. A blue oval region highlights 
representative extraction of (A) WT and (B) mutant hRyR2 channel data. Where 
appropriate, multiple 30 s segments were extracted from a single 20 min recording 
and used for modelling analysis.  
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Figure 6.18. Representative 30 s extraction of homogenous WT single hRyR2 
channel gating for modelling analysis. Each line represents 5 s of data. The 
closed state is denoted by purple baseline with upward deflections as channel 
openings. The idealised trace (not shown) generated biophysical parameters: Po 
0.68, Tc 0.92 ms, To 1.98 ms and total number of events 20604. 
 
6.3.6.2 Data selection criteria for modelling analysis 
 
 Data from the Ca2+ activation experiments were analysed. 
 Extraction of 30 s of single-channel data. 
 Open probability between 0.6 - 0.8. 
 Homogenous single-channel gating events. 
 Modal gating indicated by atypical periods of long open or closed dwell-
times was excluded from analysis. 
 Number of events per segment exceeded 3000. 
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6.3.6.3 Homogenous single-channel data  
 
Prior to constructing the kinetic models, the extracted single-channel data were 
idealised and compared to ensure the data were homogenous for valid comparison. 
It was confirmed that there were no significant differences in the general biophysical 
markers (mean open probability, dwell-times and total number of events), listed in 
table 6.4, between WT and mutant hRyR2 data segments, thus satisfying the 
criteria for data selection. 
 
    WT hRyR2 Y4813W Y4839A Y4839W 
  (n=7) (n=7) (n=8) (n=9) 
Po 0.69 ± 0.04 0.66 ± 0.02 0.74 ± 0.02 0.71 ± 0.02 
Tc (ms) 0.87 ± 0.14 1.08 ± 0.12 1.02 ± 0.14 0.99 ± 0.14 
To (ms) 2.06 ± 0.34 1.99 ± 0.29 3.70 ± 0.93 2.45 ± 0.36 
Events 22689 ± 3023 21943 ± 2903 20371 ± 2220 19559 ± 2116 
 
Table 6.4. Key biophysical parameters for modelling analysis. Homogenous 
gating data indicated by no significant differences between open probability (Po), 
mean time closed (Tc) and open (To) and total dwell count (events). Values are 
means (± SEM). 
 
6.3.6.4 Constructing kinetic models to describe the gating behaviour of 
mutant hRyR2 channels 
 
In order to describe the behavioural consequence of residue substitutions within the 
proposed pore region of hRyR2 a kinetic model, using HMM, was constructed to 
reveal underlying channel gating mechanisms. For each WT and mutant hRyR2 
selected data set a kinetic model was constructed in QuB. The process of 
constructing the models by state additions, to maximise the log likelihood (LL), is 
shown in figure 6.20. In all cases, except for Y4839W (n=1), the three closed and 
four open state model depicted in figure 6.19 achieved the highest LL. Further 
additions of closed or open states did not affect the LL by more than 5 and in some 
cases produced rate constants that were unrealistic, and were therefore not 
included in the scheme.  
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The model generated in this investigation was consistent with a previous study 
describing hRyR2 channel gating (Mukherjee et al., 2012). The states were named 
according to Mukherjee et al, non-responsive closed (CNR), responsive closed (CR), 
flicker closed (CF), open state 1, 2, 3 and 4, and are discussed in section 6.4.3. 
 
 
 
 
Figure 6.19. Highest ranked kinetic model describing the behaviour of hRyR2 
gating when activated by 10 µM [Ca2+]cyt. Black boxes represent class 1 closed 
states; CNR (non-responsive), CR (responsive) and CF (flicker). Red boxes represent 
class 2 open states; O1, O2, O3 and O4. Arrows represent forward and backward 
state transition rate constants, listed in table 6.7. [Ca2+]cyt-dependent transitions are 
labeled by ◊ above and below the rate constant arrows (µM-1 s-1), the remaining 
transitions are [Ca2+]cyt-independent (s
-1). 
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LL: 94432.74 
 
 
LL: 94866.28 
 
 
LL: 96099.12 
 
 
LL: 96172.8 
 
 
LL: 96184.46 
 
 
LL: 96535.65 
 
 
Figure 6.20. Constructing a kinetic model to describe the gating behaviour of 
hRyR2. The addition of states increased the log likelihood (LL) by more than 5. 
Black and red squares denote closed and open states, respectively, the numbers 
within states refer to the sequence of state addition, state names were referred to 
as described in figure 6.19. Rate constants depicted in figure are representative of 
modelling a single WT hRyR2 channel using the data selection criteria outlined in 
section 6.3.6.2. The directions of forward and backward rate constants are denoted 
by arrows (units are s-1 or µM-1 s-1 as shown in figure 6.19). 
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6.3.6.5 Comparing WT and mutant hRyR2 dwell-time distribution histograms 
 
The three closed and four open state model depicted in figure 6.19, achieved the 
highest LL and fitted both the WT and mutant hRyR2 data segments suitably. Dwell-
time distribution histograms were generated and representative closed (black) and 
open (red) histograms are shown in figures 6.21 and 6.22, respectively. Due to the 
thousands of events and dwell-time intervals from extracted data segments, single-
channel distributions were expressed as the square-root of the count divided by the 
total intervals, using a log10 scale for duration (ms). The models provided important 
kinetic information on time constants and state transitions that were used to 
describe the gating behaviour and to speculate on putative structural conformations 
discussed in section 6.4.3.  
 
The time constants and relative area underneath the exponential from the three 
closed states, CF, CR and CNR, were assessed and listed in table 6.5. There were no 
differences in mean closed times between WT and mutant channels. Mean flicker 
(CF) times were ~ 0.30 ms under the defined conditions when hRyR2 channels were 
activated by 10 µM [Ca2+]cyt. The most visited and stable conformations, determined 
by the relative area, were the CF (~ 48 %) and CR (~ 42 %) states. Under the criteria 
selected in this analysis, the non-responsive closed (CNR) state with long closed 
dwell duration during high single-channel Po were the least occupied (~ 10 %). 
There were no differences in closed state occupancies (CF, CR and CNR) between 
WT and mutant hRyR2 channels discussed in sections 6.4.3 and 6.4.4.  
 
The time constants and relative area underneath the exponential from the four open 
states, O1, O2, O3 and O4, were assessed and listed in table 6.6. As is the case with 
the closed states, there were no significant differences in kinetics between mutant 
and WT hRyR2 channels. Channel opening switched between various 
conformations with variable occupancy. The most probable states visited when 
channels were activated by 10 µM [Ca2+]cyt were the O2 (~ 38 %) and O3 (~ 45 %) 
that had mean open times of ~ 0.62 ms and ~ 3.04 ms, respectively. The very brief 
open (O1) and longer open (O4) times were the least occupied under the criteria 
selected in this analysis and are discussed in sections 6.4.3 and 6.4.4. 
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Closed States 
WT hRyR2   Y4813W   Y4839A   Y4839W 
(n=7) (n=7) (n=8) (n=8) 
CF 
τ (ms) 0.29 ± 0.03 0.29 ± 0.03 0.38 ± 0.05 0.30 ± 0.02 
Area (%) 49.1 ± 7.6 36.7 ± 9.2 51.8 ± 1.0 49.9 ± 1.9 
  
    
CR 
τ (ms) 1.09 ± 0.28 1.13 ± 0.14 1.45 ± 0.19 1.18 ± 0.14 
Area (%) 37.4 ± 1.6 47.4 ± 3.8 45.6 ± 1.2 42.2 ± 1.1 
  
    
CNR 
τ (ms) 5.79 ± 1.30 4.91 ± 0.45 9.25 ± 1.50 6.53 ± 1.47 
Area (%) 13.5 ± 7.7 15.9 ± 5.7 2.6 ± 0.4 7.9 ± 1.2 
 
Table 6.5. Time constants and relative areas for exponential fits of closed 
dwell-time distributions. Values are means (± SEM). Representative examples 
are depicted in figure 6.21. 
 
 
Open States 
WT hRyR2 Y4813W Y4839A Y4839W 
(n=7) (n=7) (n=8) (n=8) 
O1 
τ (ms) 0.26 ± 0.04 0.22 ± 0.04 0.41 ± 0.08 0.23 ± 0.03 
Area (%) 2.8 ± 0.6 7.9 ± 4.4 5.9 ± 3.6 4.8 ± 2.3 
      
O2 
τ (ms) 0.49 ± 0.07 0.56 ± 0.13 0.92 ± 0.22 0.51 ± 0.07 
Area (%) 38.7 ± 3.2 34.7 ± 2.5 38.9 ± 2.3 40.1 ± 2.7 
      
O3 
τ (ms) 2.51 ± 0.47 2.69 ± 0.52 4.13 ± 0.76 2.86 ± 0.33 
Area (%) 46.2 ± 1.7 45.4 ± 2.8 44.8 ± 3.9 42.9 ± 1.8 
      
O4 
τ (ms) 10.86 ± 2.44 9.88 ± 1.69 23.71 ± 7.29 14.93 ± 3.66 
Area (%) 12.4 ± 3.3 11.9 ± 2.3 11.8 ± 1.7 12.3 ± 1.7 
 
Table 6.6. Time constants and relative areas for exponential fits of open dwell-
time distributions. Values are means (± SEM). Representative examples are 
depicted in figure 6.22. 
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Figure 6.21. Closed dwell-time histograms from a single representative hRyR2 
channel activated by 10 µM [Ca2+]cyt. (A) WT hRyR2, (B) Y4813W, (C) Y4839A 
and (D) Y4839W. Histograms fitted with sums of exponential curves, the black 
curve on each histogram represents the overall fit and the three grey curves 
underneath show the relative area for individual closed fits (CF, CR and CNR listed in 
table 6.5).  
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Figure 6.22. Open dwell-time histograms from a single representative hRyR2 
channel activated by 10 µM [Ca2+]cyt. (A) WT hRyR2, (B) Y4813W, (C) Y4839A 
and (D) Y4839W. Histograms fitted with sums of exponential curves, the red curve 
on each histogram represents the overall fit and the four grey curves underneath 
show the relative area for individual open fits (O1, O2, O3 and O4 listed in table 6.6).  
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6.3.6.6 Assessing individual state transitions between WT and mutant hRyR2 
channels  
 
The highest ranked kinetic model, depicted in figure 6.19, consisted of a total of 12 
state transitions. The mean rate constants for WT and mutant hRyR2 experiments 
were tabulated in table 6.7. Overall there were no differences in rate constants 
between channels, except for one state transition highlighted by the asterisk sign. 
When comparing the transition from the second open (O2) state to the very brief 
flicker closed (CF) state (O2 → CF), the rate constant for the alanine mutation, 
Y4839A, was significantly lower compared to WT and conservative Y4813W and 
Y4839W hRyR2 channels, depicted in figure 6.23. The kinetic model for WT and 
Y4839A hRyR2 is shown in figure 6.25 and discussed in section 6.4.4. 
 
 
  
WT hRyR2 Y4813W Y4839A Y4839W 
(n=7) (n=7) (n=8) (n=8) 
CNR → CR 222.4 ± 54.5 202 ± 11.1 137.7 ± 23.3 263.6 ± 44.4 
CR → CNR 68.9 ± 23.6 52.4 ± 13.2 23.4 ± 3.5 79.9 ± 15.2 
CR → O1 1390 ± 267.1 1147 ± 173.6 930.4 ± 155.8 1074 ± 115.9 
O1 → CR 2057 ± 276.6 2128 ± 256.9 1887 ± 227.9 2046 ± 84.2 
O1 → O2 553.1 ± 113.8 645.5 ± 81.3 486.2 ± 120.1 611.9 ± 63.1 
O2 → O1 317.4 ± 75.7 424.9 ± 107.4 267.8 ± 77.1 397.1 ± 88.4 
O2 → CF 2183 ± 472.2 1920 ± 203.2 805.6 ± 210* 1991 ± 230.9 
CF → O2 4294 ± 836.1 3116 ± 366.3 3336 ± 437.5 4306 ± 418.8 
O2 → O3 2093 ± 351.2 2899 ± 486.4 1362 ± 181.2 2777 ± 492.5 
O3 → O2 1309 ± 173.5 1301 ± 311.2 852.3 ± 127.4 1052 ± 130.3 
O3 → O4 74.8 ± 16.4 65.5 ± 14.7 47.9 ± 11.4 61.1 ± 11.4 
O4 → O3 151 ± 34.8 163.5 ± 48.7 86.3 ± 19.8 114.4 ± 17.3 
 
Table 6.7. Rate constants derived from the highest ranked kinetic model. 
Transitions between states are given as rate constants means (± SEM) with units s-1 
or µM-1 s-1, as shown in figure 6.19. State transition between O2 → CF was 
significantly lower in Y4839A compared to WT hRyR2 channels, indicated by an 
asterisks (p<0.05).  
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Figure 6.23. Rate constant from open (O2) to closed (CF) between WT and 
mutant hRyR2. Entry from the O2 to CF (O2 → CF) was significantly lower in the 
alanine mutant Y4839A compared to WT and conservative mutant hRyR2 channels 
as listed in table 6.7 (p=0.0104).  
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(A) 
 
 
 
(B) 
 
 
 
Figure 6.24. Comparing the kinetic information between (A) WT and (B) 
Y4839A hRyR2 channels. Time constants (ms) and state occupancies (%) are 
indicated above and below individual states, respectively. The direction of the mean 
rate constants are shown by the arrows (units s-1 or µM-1 s-1 as shown in figure 
6.19). A subtle trend in Y4839A kinetics was observed with longer time constants 
and slower rate constants (highlighted in blue) compared to WT hRyR2, although 
only one of these transitions (O2 → CF) was significant slower highlighted in red. 
SEMs are listed in tables 6.5, 6.6 and 6.7.    
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6.4 – Discussion 
 
The biophysical characterisation of the six hRyR2 mutant channels outlined in 
chapter 5 highlighted the significance of residue properties and their interactions 
within the pore. The drastic alteration in Y4813A, D4829A and D4829E channel 
function made these mutants unsuitable for further investigation and the 
consequences of these mutations are discussed in chapter 7. Mutations which 
resulted in channels whose functional behaviour was qualitatively comparable to 
WT hRyR2 (i.e. Y4813W, Y4839A and Y4839W) were assessed in terms of their 
effects on gating mechanisms. This was the first investigation to record hRyR2 
channels for a prolonged length of time (20 min) to evaluate the proteins’ 
biophysical properties and to identify any quantitative differences in open 
probability, dwell-time and gating kinetics between WT and mutant hRyR2 
channels.  
 
A total of 91 hRyR2 Ca2+ activated long recording experiments were analysed in this 
chapter. The duration of hRyR2 gating events were typically milliseconds, thus an 
enormous amount of continuous steady-state data was acquired (~ 30 h). Previous 
studies investigating gating mechanisms in RyRs typically monitored channels for 
short 2 – 3 min periods (Mukherjee et al., 2012; Euden et al., 2013b; 
Ramachandran et al., 2013; Mei et al., 2015), therefore this chapter revealed 
intriguing insight into the biophysical characteristics and behaviour of single-channel 
kinetics, discussed in sections 6.4.1, 6.4.2 and 6.4.4.  
 
6.4.1 Single-channel Ca2+ activation experiments – Biophysical parameters 
 
This investigation highlighted the biophysical variability of recombinantly-generated 
purified hRyR2 channel gating under regulated conditions. The open probability 
distributions revealed unique fluctuations in channel activity on a macro ‘minute-to-
minute’ scale switching between high and low periods that were observed as 
skyscraper landscapes.  
 
It is a well-documented phenomenon that the gating behaviour of single ion 
channels is random with ‘gear shifting’ between several different levels of activity 
(long dwell-times and frequency of events) under constant experimental conditions. 
Modal gating has been observed in many channels such as G protein-activated K+ 
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(GIRK) (Yakubovich et al., 2000), Cav2.1 (Luvisetto et al., 2004), KcsA (Chakrapani 
et al., 2010) and IP3R channels (Ullah et al., 2012), and has also been observed 
previously in sheep RyR2 (Saftenku et al., 2001; Galfré et al., 2012). It has been 
demonstrated that variation in Po exists and that this phenomenon is not limited to 
RyR2, however the exact mechanism underlying modal gating in RyR2 is unknown.  
 
The mean Po for both WT and mutant hRyR2 channels during the Ca
2+ activation 
experiment in unbuffered KCl solutions containing ~ 1 µM [Ca2+] (Stage #1) had a 
Po ~ 0.3, compared to channels activated by 10 µM [Ca
2+]cyt (Stage #3) that had a Po 
~ 0.1. This was a surprising difference, a higher activating [Ca2+]cyt would have been 
predicted to augment open probability as previous studies have reported a steep 
dependence of Po on cytosolic Ca
2+ from 1-500 µM (Chu et al., 1993; Mukherjee et 
al., 2012). This observation may have occurred due to the timescale of the 
recording (20 min), as modal fluctuations in channel gating were reported, thus 
periods of long low channel activity may have affected the overall mean Po. In 
addition, this may have been due to chelating free luminal Ca2+ from ~ 1 µM to 50 
nM following the channel shutdown stage. Previous studies have shown that luminal 
Ca2+ increases channel Po (albeit with much higher [Ca
2+]lum (mM) and in the 
presence of other factors such as ATP or Mg2+) (Tencerova et al., 2012; Chen et al., 
2014). The effect of luminal Ca2+ on hRyR2 in these regulated experimental 
conditions remains to be determined.  
 
The distributions of mutant channel population subsets (low, intermediate and high 
Po) were significantly different to WT hRyR2. It was more likely for WT to reach a 
threshold above Po 0.6 during the 20 min recording than mutants, which favoured 
intermediate and low Po thresholds. The difference in distributions may have been 
due to [Ca2+]cyt sensitivity. Previous [
3H] ryanodine assays, described in chapter 4, 
reported lower binding in mutant Y4813W and Y4839A hRyR2 channels (~ 30 %) 
compared to WT hRyR2, while binding in Y4839W was unaltered. The proposed 
altered Ca2+ sensitivity would need to be confirmed by monitoring [3H] ryanodine 
binding and single-channel gating at a range of activating cytosolic [Ca2+].  
 
While removing cytosolic and luminal free [Ca2+] from KCl solutions induced 
‘channel shutdown’, a small proportion of very brief hRyR2 opening events were 
observed in WT and mutant channels, described in section 6.3.1.2. These rare 
opening events were identified in a previous study by Mukherjee et al, and also in 
other ion channels (CNG, AChR and BK channels), and have been attributed to 
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spontaneous openings in absence of agonist occurring as a result of intrinsic 
thermodynamic fluctuations in the protein molecule, termed unliganded gating 
(Tibbs et al., 1997; Talukder and Aldrich, 2000; Grosman and Auerbach, 2000; 
Mukherjee et al., 2012). Interestingly, a proportion of Y4813W (~ 20 %) remained 
relatively active (Po > 0.05) in response to nominal zero [Ca
2+], the mechanism 
underlying the increased channel openings remains unclear. There were no 
differences in Y4813W channel Po compared to WT hRyR2 during stage #1 and #3 
of the Ca2+ activation experiment, however in the absence of cytosolic [Ca2+] these 
augmented spontaneous unliganded ‘leaky’ channel openings would be expected to 
occur in disease-linked point mutations (Guerrero-Hernández et al., 2014; Eisner, 
2014).  
 
6.4.2 Comparing WT and mutant hRyR2 channel biophysical properties 
 
Overall there were no differences in Y4813W, Y4839A and Y4839W mutant channel 
Po and dwell-times compared to WT hRyR2 in the Ca
2+ activation experiment. A 
similar trend of channel-to-channel open probability variation akin to WT hRyR2 was 
observed in mutant channels indicating that the point mutations had not drastically 
altered channel function. One of the key findings was that conservative side chain 
properties in the proposed pore helix at position Y4813W fully restored biophysical 
single-channel properties comparable to WT hRyR2, in contrast to the alanine 
mutation Y4813A that was non-functional in bilayers as described in chapter 5. As 
the pore helix in K+ channels undergoes complex and dynamic rearrangements 
during gating (Cuello et al., 2010b; Wang et al., 2011), the results in this chapter 
implicate a role for aromatic pore helix residues and their side chain properties in 
hRyR2 channel function. 
 
Assessing hRyR2 open probability was a useful tool to evaluate overall single-
channel activity; however it does not reveal information regarding channel gating 
kinetics and their mechanism. The open and closed dwell times were therefore 
analysed and revealed no significant changes between mutant and WT hRyR2 
channels except that at very high Po (Po > 0.8) the Y4839A mutation increased the 
duration of the mean closed time. Reducing the side chain length and disrupting 
local interactions of Y4839A, proposed to be located at the start of the S6 helix, may 
have altered the flexibility or the conformation of the α-helix, such that during high 
channel Po Y4839A may destabilise the Ca
2+-mediated IHBC S6 activation gate 
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favouring channel closings. However in the absence of crystal structures these 
predictions of channel function are speculative. Previous studies that have 
attempted to identify the RyR activation gate by alanine scanning (Wang et al., 
2003) and other residue substitutions (valine, isoleucine and proline) (Euden et al., 
2013b; Ramachandran et al., 2013; Mei et al., 2015) established that a degree of 
flexibility at the S6 helix is required. The location of Y4839A distant from the 
proposed activation gate had minor effects on channel function and, in general, 
channels containing this mutation had similar biophysical parameters compared to 
WT hRyR2. A current RyR activation model may simply entail twisting of the S6 
bundle, as depicted in figure 6.25, thus the residue at the start of the helix may be 
less important than centrally aligned residues in close proximity to the proposed 
IHBC gate (Yan et al., 2015).   
 
 
 
Figure 6.25. Putative conformational twisting of the S6 helices occurring 
during opening of the activation gate. Figure adapted from Yan et al., (2015).  
 
The open and closed dwell-times of the S6 helix conservative tryptophan mutant, 
Y4839W, were similar to WT hRyR2 and were in accordance with the conservative 
pore helix mutant in this chapter highlighting the significance of these aromatic 
residues and their side chain properties in maintaining high Po by potentially 
stabilising the pore region. 
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6.4.3 Modelling single-channel gating kinetics and assigning putative 
structural conformations 
 
Due to the inherent variability of hRyR2 channels, to assess the consequence of 
residue substitution on flicker closing transitions specific criteria were imposed on 
the single-channel data to avoid selection bias, as outlined in section 6.3.6.2. Thus, 
only a small proportion, less than 1 % (15 min), of the total single-channel data were 
analysed. These criteria ensured that data segments contained comparable general 
biophysical parameters (Po, Tc, To and number of events) for both WT and mutant 
hRyR2 channels. This ensured, as a consequence, that any subtle differences in 
kinetics (time constants, state occupancy or rate constants) resulted as an outcome 
of residue side chain substitution.  
 
The purpose of modelling single-channel data was to begin to investigate possible 
putative structural conformations based on the kinetic information generated by the 
gating scheme. RyR channels have multiple conformations with the same 
conductance, concealing their transitions between states (Mukherjee et al., 2012). 
These ‘hidden’ transitions among channel conformations can only be deduced 
statistically from their dwell-time distributions (Qin et al., 2000). As the transitions 
within channels occur in a continuum, due to the dynamic rearrangement and 
conformational wave of residues and domains (Qin, 2004), the kinetic model first 
constructed by Mukherjee et al and used as a template in this chapter, was 
composed of the minimum number of conformational states that were stable 
enough to be discretely resolved (Mukherjee et al., 2012). The kinetic model 
constructed in this chapter was composed of three closed and four open states, 
depicted in figure 6.19, and fitted the single-channel data for WT and mutant hRyR2 
generating important kinetic information that could explain, in mechanistic terms, the 
channel gating behavior during 10 µM [Ca2+]cyt activation. The effects of mutations 
on channel gating kinetics are compared in section 6.4.4. Constructing the multi-
state scheme, originally to investigate flicker gating, resolved seven states and 12 
state transitions. The rate constants in conjunction with the time constants of each 
state and the probability of a particular state occuring, determined by the area 
underneath the exponential fit, were used to assign putative conformations of the 
hRyR2 structure. A representation of proposed structural conformations during 
channel gating is shown in figure 6.26. 
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A particular closed conformation (CNR) was characterised by a long closed time 
(5.79 ms), was rarely visited in high activating 10 µM [Ca2+]cyt conditions. In addition, 
a relatively stable pre-opening closed conformation (CR) termed ‘responsive’ was 
resolved (37.4 %) and characterised by a short mean closed time (1.09 ms). From 
the CR, binding of cytosolic Ca
2+ induced a proposed structural conformational 
change that opened the putative IHBC gate, transitioning into different Ca2+ bound 
open states (O1, O2, O3 and O4) that were characterised by variable open time 
occupancy. The structural rearrangements that underlie these transitions are 
unknown. The putative conformations, shown in figure 6.26, resolved from the 
kinetic model that describes the gating behaviour of hRyR2 are predictions and the 
actual conformations during channel gating must be validated by future high-
resolution structural information.   
 
 
 
Figure 6.26. Schematic representation of putative hRyR2 channel 
conformation transitions when activated by 10 µM [Ca2+]cyt. Transitions between 
resolvable closed (black) and open (red) states are indicated by the direction of the 
black arrow. The least likely transition, under the stated conditions, occurred from 
the responsive to the non-responsive closed state (CR → CNR) highlighted by a 
reduced arrow head. Two putative gates are shown, one at the IHBC located at the 
entrance to the cytosolic vestibule and another at the selectivity filter located at the 
luminal entrance to the pore. Ca2+ ions are indicated by a yellow circle. Only two of 
the four monomers are shown, each of which is proposed to contain a Ca2+ binding 
site. The diagram does not depict the actual conformational structures of hRyR2 or 
the number of Ca2+-binding sites and are represented purely for illustration 
purposes. Figure constructed using a template from Mukherjee et al., (2012). 
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6.4.4 Comparing gating kinetics and flicker closing transitions between WT 
and mutant hRyR2 channels 
 
The kinetic information from the conservative Y4813W and Y4839W mutation 
models (time constants, state occupancy and rate constants) were comparable to 
WT hRyR2. These pieces of evidence in conjunction with the comparable 
biophysical parameters discussed in sections 6.4.1 and 6.4.2, were in accordance 
with the original hypotheses in this thesis that retaining the physicochemical 
properties and hydrogen-bonding capabilities of residues maintained the functional 
characteristics of WT hRyR2. 
 
The alanine mutant, Y4839A, did not significantly alter the brief flicker mean closed 
time (0.38 ms) compared to WT hRyR2 (0.29 ms). However, interestingly, the 
forward state transition entering into the flicker state from the second open state (O2 
→ CF) was significantly slower (805 s
-1) compared to WT and the conservative 
hRyR2 mutations (~ 2000 s-1), shown in figure 6.27.  
 
 (A)     (B) 
 
 
 
Figure 6.27. Schematic representation of putative Y4839A hRyR2 channel 
conformation transitions during flicker gating. (A) Putative open ligand-bound 
state (O2 in red and Ca
2+ in yellow) and (B) brief flicker closing event (CF in black) at 
a putative gate proposed to occur at the selectivity filter in a Ca2+-independent 
manner. Rate constant transition between O2 → CF indicated by the direction of the 
black arrow occurred slower in Y4839A compared to WT hRyR2 channels. The 
Y4839A point mutations in the pore region (S6 helix) are indicated by a blue cross.  
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The open and closed time constants for Y4839A were all longer than WT and 
conservative hRyR2 mutation channels, however were not significantly different. In 
addition, comparing the kinetic models and their rate constants shown in figure 6.24 
revealed that all 12 state transitions in Y4839A were slower than WT hRyR2, 
although only one of these transitions (O2 → CF) was significantly different. The 
subtle kinetic trends of longer time constants and slower state transitions for 
Y4839A implies that alanine mutation induced a type of channel rigidity or stiffness, 
however with the lack of statistical significance it remains unclear whether the 
Y4839A mutation had affected channel gating and this is discussed further in 
chapter 7.  
 
The overall comparable biophysical parameters (open probability and dwell-times) 
and kinetic information for Y4839A and WT hRyR2 may be due to the position of the 
mutated residue and the relative distance of this residue away from the proposed 
selectivity filter and IHBC gate shown in figure 6.28. Therefore disrupting local 
interactions at a distance from critical regions of the pore may be less important in 
regulating channel gating and function. 
 
(A)      (B) 
                   
 
Figure 6.28. Structural model of the RyR1 pore-forming region. (A) Side and (B) 
luminal view of the PFR RyR1 model of Yan et al., (2015) with helices coloured in 
grey and Y4813 highlighted in blue and Y4839 in green. The proposed selectivity 
filter is shown in red and the putative IHBC gate in yellow. The relative distance of 
residues (highlighted) away from the selectivity filter and IHBC gate may mean that 
they are less important in facilitating channel gating and function than initially 
proposed in the hypotheses tested in this thesis.  
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In summary, this was the first study to demonstrate the inherent variability of single 
hRyR2 channel gating in stringently regulated minimised conditions over periods of 
several minutes. Due to channel-to-channel variation, challenges were faced in 
establishing criteria for data analysis that avoided selection bias in the assessment 
of the consquences of residue substitution on channel gating. Analysing 
comparable WT and mutant single-channel data unsurprisingly generated similar 
kinetic results. However this was a necessary condition for the reliable assessment 
of subtle differences in channel gating.  
 
While data selection criteria were required to investigate flicker gating, acquiring an 
enormous amount of data provides the possibility for future analyses on different 
aspects of hRyR2 channel gating. It may be interesting, therefore, to investigate and 
compare different gating parameters such as inter- and intra-burst length and Po, 
prolonged closures and segments of intermediate and low Po between WT and 
mutant hRyR2 single-channel data. 
 
The conservative hRyR2 mutations reinstated the functional characteristics of the 
WT hRyR2 channel and confirmed the significance of residue side chain 
interactions within the pore region of the channel as originally hypothesised. The 
alanine mutant channel, Y4839A, had similar biophysical properties to WT hRyR2; 
however detailed analysis of gating revealed subtle alterations in gating kinetics that 
may indicate a role for Y4839 located at the start of the S6 helix in hRyR2 channel 
gating. The significance of this thesis and future work is discussed in chapter 7.  
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Chapter Seven:  
 
General Discussion 
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7.1 Investigating structural mechanisms of gating at the selectivity filter of the 
hRyR2 channel 
 
This thesis focused on investigating the structure-function relationship of hRyR2 to 
reveal gating mechanisms proposed to occur at the selectivity filter. The recent 
publication of high-resolution RyR1 structural models during the latter stage of this 
project provided detailed structural organisation and an exceptional opportunity to 
determine functional mechanisms (Zalk et al., 2014; Efremov et al., 2014; Yan et al., 
2015). The PFR in RyR1 and RyR2 isoforms share almost identical homology (93.4 
%), providing a valid model to compare structure and functional mechanisms. 
However, in the absence of these near-atomic models at the beginning of this 
project, predictions on putative structural elements were developed using the RyR2 
model based on the K+ channel, KcsA (Welch et al., 2004).  
  
In KcsA, a network of hydrogen-bonding interactions between the pore helix and 
selectivity filter forms a structural element that stabilises a conformation of the 
selectivity filter, regulating channel gating (Cordero-Morales et al., 2006; Cuello et 
al., 2010a; Cuello et al., 2010b; Cordero-Morales et al., 2011). Three residues 
(Y4813, D4829 and Y4839) were identified in the Welch et al RyR2 PFR model in 
positions analogous to KcsA (W67, E71 and D80) (Welch et al., 2004). The location 
of these residues in RyR2 and their side chain properties were predicted to be ideal 
to form a multipoint network of hydrogen-bonding interactions, therefore altering the 
properties of these residues by mutation would disrupt the proposed network 
affecting hRyR2 channel gating.  
 
In addition, previous studies in K+ channels identified very brief flicker closing events 
occurring at the selectivity filter due to its dynamic meta-stable nature (Piskorowski 
and Aldrich, 2006; Zadek and Nimigean, 2006; Cuello et al., 2010b). Structural 
modelling of the selectivity filter in hRyR2 suggested that this region was wider and 
more flexible than the K+ channel selectivity filter (Welch et al., 2004) and previous 
investigations of single hRyR2 channel gating have identified rapid flicker transitions 
(Mukherjee et al., 2012), suggesting that these closings may occur at the selectivity 
filter in hRyR2.  
 
Six full-length mutant hRyR2 channels were constructed using a cassette-based 
strategy to disrupt (Y4813A, D4829A and Y4839A) or retain (Y4813W, D4829E and 
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Y4839W) functional side chain interactions, outlined in chapter 3. No deleterious 
effects on transfection efficiency or protein expression were reported for mutant 
hRyR2 channels when compared to WT hRyR2. Therefore the successful 
generation of the six channels permitted downstream cellular and molecular 
functional assays to be undertaken to evaluate the consequence of residue 
interaction in the pore region. 
 
As an initial screen, the functional status of a population of mutant hRyR2 channels 
was examined in situ by intracellular Ca2+ imaging. Ca2+ was released from HEK293 
ER stores through the six mutant hRyR2 channels upon the addition of caffeine. 
This was indicated by a fluorescent intensity increase, suggesting that hRyR2 
containing these mutations occurring in the pore region formed functional 
homotetrameric channels that maintained the ability to translocate Ca2+ ions through 
the pore. However interestingly, the maximum Ca2+ release from HEK293 cells 
expressing Y4813A and D4829A was reduced by 25.6 % and 22.7 % compared to 
cells expressing WT hRyR2 channels, respectively. The remaining four hRyR2 
mutations (Y4813W, D4829E, Y4839A and Y4839W) maintained the maximal Ca2+ 
release compared to WT hRyR2, suggesting that alanine substitution within the 
proposed pore helix, Y4813A, and selectivity filter, D4829A, either affected the 
channel’s sensitivity to caffeine and/or calcium, or that these mutations physically 
affected Ca2+ release through the pore.  
 
The investigation of mutant hRyR2 channels using [3H] ryanodine binding and 
single-channel techniques provided insight into the significance of residue side 
chain properties in the pore region. The drastic reduction of [3H] ryanodine binding 
in the alanine pore helix mutant, Y4813A, in conditions favouring channel opening 
(10 mM caffeine and 100 µM CaCl2) and the absence of purified channels in 
bilayers, prompted the examination of Y4813A homotetramer stability when 
removed from the cellular environment. Western blot analysis of sucrose fractions of 
density at which the homotetramer would sediment, confirmed that Y4813A formed 
tetrameric channels upon isolation. This observation indicated that the absence of 
channel function in bilayers either occurred because channels did not incorporate or 
because Y4813A remained permanently closed following incorporation. The latter 
option was favoured as [3H] ryanodine binding to Y4813A channels was only 1.03 % 
of that seen with WT hRyR2. The consequence of disrupting hydrogen bond 
interactions at the pore helix may have resulted in a collapsed non-conductive 
selectivity filter, analogous to the collapsed filter seen in K+ channel crystal 
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structures resolved in low permeant K+ concentrations (Zhou et al., 2001; Cuello et 
al., 2010a). However, the proposal that hRyR2 Y4813A channels remained 
permanently closed was surprising as these channels were caffeine sensitive in 
situ, opening and facilitating the release of Ca2+ upon agonist addition.  
 
These aforementioned findings highlight limitations of the [3H] ryanodine binding 
assay, as altered binding results may have been a consequence of the mutation 
itself, producing misleading results. Mutation-dependent alterations in ryanodine 
binding to hRyR2 may occur through several factors such as; the generation of 
unstable or closed channels, modification of structural components important in the 
ryanodine-hRyR2 interaction altering the access to, or affinity of, the binding site, or 
by altering the mutant channel’s sensitivity to calcium. Therefore, altered binding 
does not exclusively determine channel function, and thus it is essential to interpret 
mutant hRyR2 [3H] ryanodine results in combination with complementary assays 
such as intracellular Ca2+ imaging and single-channel bilayers, however for Y4813A, 
the latter was not possible.      
 
Interestingly hRyR2 containing the conservative tryptophan mutation, Y4813W, had 
improved [3H] ryanodine binding (30.12 % of WT binding) compared to channels 
containing the Y4813A mutation. At the molecular level, the biophysical properties 
of ion conduction, ryanodine modification, dwell-time occupancy and gating kinetics 
of Y4813W were all comparable to WT hRyR2 channels. The replacement of 
tyrosine with tryptophan, a residue with similar steric bulk and physicochemical 
hydrogen-bonding capabilities, provided interesting insight into the importance of an 
aromatic residue at position 4813 that restored RyR2 function compared to Y4813A.  
 
The aspartic acid at position 4829, located at the luminal end of the selectivity filter 
is a highly conserved residue throughout the RyR isoforms (Welch et al., 2004; 
Lanner et al., 2010; Yan et al., 2015), IP3R (Taylor and Tovey, 2010) and K
+ 
channels (Heginbotham et al., 1994; McCoy and Nimigean, 2012). Replacing this 
residue with either an alanine, D4829A, or conservative glutamic acid, D4829E, 
reduced ryanodine binding to 45.63 % and 7.18 % compared to WT hRyR2, 
respectively. This was surprising as retaining the negative charge by D4829E, 
however extending the side chain by a methyl group significantly reduced binding 
compared to the alanine mutation. This observation suggests that the bulk of the 
residue at 4829 is much more important than its charge in maintaining a 
conformation that supports ryanodine binding. Both mutant D4829 channels were 
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characterised by channel-to-channel variability in gating and sub-conductance 
states when assessing their biophysical properties in bilayers. The full unitary 
conductance of single D4829A and D4829E channels was reduced by 75 % and 
20.5 % compared to WT hRyR2, respectively. Yan et al, (2015) proposed that the 
selectivity filter of RyR1 may constitute two cation-binding sites (AGGGIGDE), with 
one site located at the luminal mouth formed by D4899 and E4900 (equivalent to 
D4829 and E4830 in hRyR2) and another at A4893, G4894 and G4895 (equivalent 
to A4823, G4824 and G4825 in hRyR2) shown in figure 7.1A (Yan et al., 2015). In 
addition, the highly electronegative luminal loop (containing 8 aspartic acid and 
glutamic acid residues out of 16) between the S5 and pore helix above the entrance 
to the selectivity filter in the Yan et al RyR1 model provides a mechanism for 
maximising rates of cation delivery to the pore shown in figure 7.1B. A similar 
mechanism was proposed previously in the Welch et al RyR2 model, that contains a 
smaller electronegative luminal loop (Welch et al., 2004), therefore the drastic 
reduction in D4829A channel conductance may have been due to the net loss of 
negative charge within the luminal mouth region. The unique and varied biophysical 
properties of hRyR2 channels with mutations at D4829 were ultimately unsuitable 
for further investigations. The drastic effect on channel gating and conductance 
supports the proposal that D4829 may contribute to a cation-binding site, and 
suggests that the negative charge and also the precise side chain length of the 
conserved aspartic acid is essential for maintaining channel function.  
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(A)        (B) 
 
                     
 
Figure 7.1. A proposed cation-binding site at the luminal mouth of the 
selectivity filter of RyR1. (A) Two proposed cation-binding sites (AGGGIGDE) are 
highlighted in yellow. D4899 and E4900 are located at the luminal mouth and are 
equivalent to D4829 and E4830 in RyR2. (B) A highly electronegative luminal loop 
between the S5 and pore helix contains 8 aspartic and glutamic acid residues, 
highlighted in magenta. Residues are colour-coded as stated in figure 5.16. The 
figures were constructed in PyMol using the PDB file 3J8H from Yan et al., (2015). 
 
The alanine mutation at position Y4839 affected channel function, reducing [3H] 
ryanodine binding and unitary ion conductance at 210 mM KCl by 62.5 % and 16.8 
% compared to WT hRyR2, respectively. Altered ion conduction properties in 
Y4839A hRyR2 channels were assessed by a series of ion handling experiments to 
probe potential mechanistic differences in ion channel discrimination, relative 
permeability and pore dimensions. While the alanine mutation did not alter the 
ability of hRyR2 to discriminate between cations and anions, the relative 
permeability between divalent (Ba2+) and monovalent (K+) cations was 15.1 % lower 
than in WT hRyR2. This was surprising as in previous reports it had been proposed 
that a high density of negative charge, either within the pore or within vestibules at 
either end of the pore, was responsible for discrimination between cations (Tinker et 
al., 1992; Mead-Savery et al., 2009). The small changes in cation discrimination and 
ion conductance at particular K+ activities may have therefore been achieved 
through Y4839A indirectly altering the conformation of the electronegative luminal 
loop at the mouth of the selectivity filter. The radius of the narrowest region of the 
Y4839A hRyR2 channel pore was determined by monitoring the relative 
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permeability of monovalent organic cations and was found to be equivalent to that 
of WT hRyR2 channels. The assessment of the ion handling properties of Y4839A 
supported the credibility of the recent RyR1 model of Yan et al (2015), as, while in 
the Welch et al (2004) RyR2 model Y4839 is located in the loop-forming region in 
close proximity to the filter, in the more recent model it is located at the luminal end 
of the S6 helix, distant from critical regions of the pores ion permeation pathway 
(Welch et al., 2004; Yan et al., 2015).  
 
Y4839A hRyR2 channels had very minor changes in channel gating and function. A 
noticeable, but not statistically significant, trend in Y4839A gating kinetics (longer 
time constants and slower state transitions) was observed and may have been 
achieved through a type of channel stiffness by imposing different constraints within 
the S6 helix conformation. However, in general, the similarity in maximum Ca2+ 
release, open probabilities and dwell-time parameters in Y4839A compared to WT 
hRyR2 may have been due to the relative distance of Y4839 away from the 
proposed selectivity filter region as indicated by the Yan et al RyR1 model. 
Therefore disrupting local interactions distant from proposed critical regions of the 
pore may have less influence on channel gating.  
 
The conservative tryptophan mutation Y4839W fully restored both [3H] ryanodine 
binding and ion conductance, at 210 mM KCl, to values equivalent to WT hRyR2. In 
addition, the gating parameters of Y4839W (open probability, dwell time intervals, 
time constants, state occupancy and transitions) were comparable to WT hRyR2. 
The data obtained from both alanine and tryptophan substitutions at residue 4839 
are in accordance with the original hypothesis that retaining physicochemical 
properties and hydrogen-bonding capabilities of this aromatic residue is essential 
for hRyR2 function.   
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7.2 Is there a gate at the selectivity filter of hRyR2? 
 
It remains unclear whether the selectivity filter, stabilised by a network of residue 
interactions, has a role in hRyR2 channel gating. In the RyR1 model published 
recently by Yan et al (2015), the distance between the proposed residues selected 
in this thesis, Y4813-D4829 and Y4839-D4829, ~ 20 Å and ~ 25.6 Å respectively, 
would not be compatible with the formation of a hydrogen-bonding network. 
Therefore the three residues (Y4813, D4829 and Y4839) would not be involved in 
stabilising the selectivity filter region in a manner similar to the equivalent residues 
in K+ channels.  
 
However, removing the hydrogen-bonding capacity of two of the hRyR2 mutations, 
Y4813A and D4829A, significantly affected channel gating and function. This 
observation suggests that these residues, Y4813 and D4829, are essential and may 
be involved in stabilising a conformation of the pore helix and selectivity filter. 
Furthermore, it is important to note that while the resolution of the Yan et al RyR1 
model has improved compared to the Welch et al RyR2 model, these models 
represent static structures and do not reveal the nature of a functioning channel. 
The models do not account for the dynamic rearrangements of residues and 
domains, and further underlies the importance of functional single-channel 
experiments to test these models and assess their credibility.  
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7.3 Future work  
 
7.3.1 Identifying alternative residue candidates to assess the role of hRyR2 
selectivity filter gating  
 
The altered conformation and rearrangement of helix boundary sites in the RyR1 
model by Yan et al, raises the question of whether a network of hydrogen-bonding 
interactions exists between different residues in the pore. An initial screen of the 
RyR1 PDB file (Yan et al., 2015) and sequence alignment of the RyR isoforms, 
shown in figure 5.16, indicate that tyrosine residues on the pore helix, Y4818, and in 
the luminal loop-forming region, Y4793, using RyR2 residue numbering, are in close 
proximity to the selectivity filter depicted in figure 7.2. These residues may prove to 
be alternative candidates for site-directed mutagenesis and functional assays to 
examine the role of selectivity filter regulated gating. 
 
(A)            (B) 
                     
 
Figure 7.2. Identifying alternative residue candidates to assess the role of side 
chain interactions to stabilise a putative selectivity filter gate. Y4818 in the 
pore helix is highlighted in blue and Y4793 located in the luminal loop-forming 
region in green are in close proximity to the proposed selectivity filter (GGGIGD) 
highlighted red. 
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7.3.2 What is the physiological relevance of flicker closings in RyR2? 
 
The physiological relevance of flicker closings (0.30 ms) remains to be established 
in RyR2 channels. The effect of altered flicker gating has not been documented in 
the literature and is a relatively novel area of RyR2 functional studies.  
 
Kinetic models were constructed to describe the gating behaviour of WT and mutant 
hRyR2 to identify the prevalence and nature of flicker gating events (thought to 
originate in the selectivity filter) and to examine if substitution had affected this 
particular conformational transition. Flicker gating is one of the main closing events 
(~ 49 % state occupancy) to occur during Ca2+ activation experiments, suggesting 
that these closings may regulate, to some extent, the release of stored SR Ca2+. It 
has been shown that channel open time determines the spread of Ca2+ sparks from 
individual RyR2 channels into Ca2+ waves (Sato and Bers, 2011), suggesting that 
decreasing channel open times as a consequence of flicker events may play a role 
in Ca2+ termination. However due to the brief nature of these events, it remains 
unknown whether flicker events are sufficient to affect Ca2+ release.   
 
Preliminary data suggests that flicker closing events in hRyR2 occur less with 
saturating permeant monovalent cations and increase as the concentration of 
cations are decreased. It may therefore be interesting to speculate on the effect of 
permeant ions on the prevalence of flicker closings. As [Ca2+]lum is depleted from the 
SR during CICR the occurrence of these flicker closings may increase.  
 
The identification of structural elements involved in flicker closings is one part of the 
jigsaw puzzle in the overall gating process of RyR2 channels. It is essential to 
continually improve our knowledge of the mechanisms underpinning RyR2 channel 
gating to therefore understand how these systems are affected in pathological 
conditions. 
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7.4 Concluding remarks  
 
The kinetic models constructed in this thesis to examine hRyR2 channel gating can 
be used as a framework for a long term research strategy. Monitoring WT and 
mutant hRyR2 behaviour revealed unique fluctuations in channel activity switching 
between different modes of gating under steady-state conditions. Future 
investigations must therefore provide clear criteria for data selection to justifiably 
compare the effect of prospective point mutations, potential therapeutic compounds 
and physiological regulatory factors on hRyR2 channel gating, as it is essential to 
distinguish between the inherent variability of the channel and the influence of 
external factors on gating. 
 
7.5 Final summary of findings  
 
It remains unclear whether hRyR2 channel gating is regulated by the proposed 
selectivity filter stabilised by a hydrogen-bonding network due to altered residue 
distances between Y4813, D4829 and Y4839 in the recently published RyR1 
structural model by Yan et al, (2015). However, data from intracellular Ca2+ imaging, 
[3H] ryanodine binding and single-channel assays revealed that residues located in 
the pore region, and their side chain interactions, are essential in maintaining 
hRyR2 channel gating and function. Together these results indicate that the 
selectivity filter region is an important component for RyR2 function.  
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Appendix I – Measuring the maximum Ca2+ release from HEK293 cells expressing 
hRyR2 channels 
          
  
Exp 
(n) 
Cells 
(n) 
Maximum Ca2+ release  
((F-F0)/F0) p < 0.05 
WT hRyR2 6 55 5.113 ± 0.278 
 Y4813A 3 56 3.806 ± 0.261 0.0009 
Y4813W 3 44 5.424 ± 0.311 ns 
D4829A 3 53 3.947 ± 0.243 0.0022 
D4829E 3 40 5.024 ± 0.246 ns 
Y4839A 3 39 5.038 ± 0.358 ns 
Y4839W 3 61 4.587 ± 0.227 ns 
 
Table I. Measurement of maximum Ca2+ release in HEK293 cells expressing 
WT and mutant hRyR2 channels. Total number of experiments (Exp) and ROIs 
(cells) were analysed to determine maximum Ca2+ release ((F-F0)/F0), detailed in 
section 4.3.1.1. HEK293 cells expressing Y4813A and D4829A had a significantly 
reduced maximal Ca2+ release than cells expressing WT hRyR2 channels by 25.6 
% and 22.7 %, respectively.  
 
 
Appendix II – Specific [3H] ryanodine binding values  
        
  n Specific [3H] ryanodine binding (dpm) p < 0.05 
WT hRyR2 19 2695 ± 293.9 
 
Y4813A 11 27.76 ± 20.75 < 0.0001 
Y4813W 9 811.74 ± 197.9 < 0.0001 
D4829A 16 1229.7 ± 413.1 0.0197 
D4829E 9 193.50 ± 25.09 < 0.0001 
Y4839A 11 1013.05 ± 268.1 0.0041 
Y4839W 9 2886.35 ± 523.8 ns 
 
Table II. Specific [3H] ryanodine binding values. Point mutations at the proposed 
selectivity filter and pore region of hRyR2 resulted in a marked reduction in the 
ability to bind ryanodine, except for Y4839W. Normalised binding results are listed 
in table 4.5. 
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Appendix III – hRyR2 channel gating at negative holding potentials.  
 
Following the Ca2+ activation experiments described in chapter 6, single hRyR2 
channels were held at negative holding potentials (- 40 mV) for a further 20 min. 
There were no differences in mean Po for WT and mutant hRyR2 channels between 
positive and negative holding potentials, shown in table III. The proportion of 
channel Po thresholds measured at negative were categorised and compared with 
channel subsets at positive, listed in table IV. A significantly lower proportion of 
channels exceeded high (Po ≥ 0.6) during – 40 mV for WT and mutant hRyR2 (~ 11 
%) compared to + 40 mV. Therefore, there were insufficient data for modelling 
analysis using the criteria set (section 6.3.6) at – 40 mV.    
 
  Ca2+ Activation (Po) 
  n + 40 mV n           - 40 mV 
WT hRyR2 21 0.121 ± 0.038 18 0.109 ± 0.028 
Y4813W 17 0.097 ± 0.029 14 0.041 ± 0.009 
Y4839A 33 0.072 ± 0.014 26 0.076 ± 0.017 
Y4839W 20 0.099 ± 0.026 12 0.084 ± 0.027 
 
Table III. Comparing the mean open probability for WT and mutant hRyR2 
between positive and negative holding potentials from Ca2+ activation 
experiments. 
 
  Single-channel subset proportion (%) 
 
High Po ≥ 0.6  Int Po 0.2 - 0.6 Low Po ≤ 0.2  
  + 40 mV - 40 mV + 40 mV - 40 mV + 40 mV - 40 mV 
WT hRyR2 38 11 29 44 33 44 
Y4813W 24 0 24 29 53 71 
Y4839A 28 12 55 46 27 42 
Y4839W 15 16 30 42 55 42 
 
Table IV. Comparing the proportion of open probability threshold subsets 
between positive and negative holding potentials. Significantly lower proportion 
of channels exceeded high (Po ≥ 0.6) during – 40 mV. There were insufficient data 
for modelling analysis at – 40 mV.  
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Mean open probability distributions for WT and mutant hRyR2 channels at +/- 40 
mV were generated shown in figure I, and revealed consistent channel activity with 
no time dependent trend in Po. There was no evidence of a decline in Po from 
recording channels over 40 min. 
 
(A)   + 40 mV           - 40 mV 
                           
(B) 
                           
(C) 
                           
(D) 
                           
 
Figure I. Mean open probability distributions from Ca2+ activation 
experiments. Figures represent the combined Po distributions of (A) WT hRyR2, 
(B) Y4813W, (C) Y4839A and (D) Y4839W channels recorded at + 40 mV (left) and 
- 40 mV (right), analysing the mean Po in sequential 15 s segments over 20 
mintues. Mean Po are listed in table III. 
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Appendix IV - Monitoring a representative single WT hRyR2 channel at + 40 mV 
during a Ca2+ activation experiment under steady-state conditions. The single-
channel trace is a continuous 20 min recording depicting the gating transitions 
between open and closed states. The purple line denotes the closed state with 
upward deflections observed as channel openings. 
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